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ABSTRACT
The endocytic pathway in eukaryotic cells is organized into distinct compartments. 
Early endosomes are heterogeneous and dynamic organelles, which are found both 
spread through the cortical cytoplasm (sorting-early endosomes) and in the 
perinuclear region (recycling endosomes). Endocytosed molecules that enter sorting 
endosomes can be directed to the degradative pathway or recycled back to the plasma 
membrane, either directly or by passing through perinuclear-recycling endosomes. 
Very little is known about the molecular mechanisms that regulate transport between 
these different compartments and the functional properties of endocytic organelles. In 
this thesis, I have investigated the molecular regulation of the endocytic-recycling 
pathway and, in particular, how endocytosis and recycling are co-ordinated at the 
level of early endosomes. To this end, I have addressed the function of Rab5, Rab4, 
and R a b ll, three small GTPases that control trafficking from the plasma membrane 
to the early endosomes, sorting of cargo within early endosomes and recycling to the 
plasma membrane, respectively. Rab proteins function in their GTP-bound active 
state through the recruitment of effector proteins to the membrane compartment 
where they are localized. The identification of a large number of Rab5 effectors, 
together with the realization that these proteins act co-operatively, led to the proposal 
that this GTPase organizes the endosomal membrane into a biochemically and
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functionally distinct membrane domain. If generalized to other family members, this
model would predict that other Rab proteins present on endosomes such as Rab4 and
R ab ll should be localized to discrete, non-overlapping membrane domains distinct
from the one occupied by Rab5. Moreover, the finding that one Rab5 effector,
Rahaptin-5, interacts also with Rah4 raises the possibility that the activity of these
two GTPases is molecularly co-ordinated. Given the complementary role of Rab5 and
Rab4 in regulating entry in, and exit out, of early endosomes the coupling of their
activity through a common effector may ensure co-ordination of the endocytic and
recycling functions of early endosomes. I have experimentally tested the working
hypothesis predicting that divalent Rab effectors may regulate the association
between contiguous Rab domains to allow the sequential transport of cargo along the
endocytic-recycling pathway. To provide evidence for this model, two
complementary approaches have been undertaken. First, I have developed an in vitro
recycling assay to identify and characterize molecules involved in this process.
Second, I have conducted a high-resolution morphological analysis of the endocytic-
recycling pathway in stable cell lines expressing GFP-tagged versions of Rab
proteins. The results obtained support the idea that endosomes are indeed organized
into distinct domains, harbouring Rab5, Rab4 and R ab ll. The association between
these domains follows a non-random distribution giving rise to three major
P
populations of endosomes: one containing Rab5, a second with Rab4 and Rab5, and a 
third containing Rab4 and R a b ll. Upon endocytosis, recycling cargo first enters 
Rab5 domains, and then progresses through Rab5/Rab4 and Rab4/Rabll endosomes 
before returning to the plasma membrane. Based on these observations, I then 
addressed the question of how the communication between neighbouring domains is 
regulated by specifically searching for Rab5 and Rab4 common effectors using an 
affinity chromatography approach. The results of these experiments led me to 
identify Rahenosyn-5 as a novel Rab5 and Rab4 common effector. Subsequently, I 
demonstrated that Rabenosyn-5, as well as Rabaptin-5 over-expression specifically 
increased the association between Rab5 and Rab4 endosomal domains and stimulated 
transferrin recycling. Concomitantly, the fraction of Rah4+Rabll positive structures 
was reduced and transport to peri-nuclear recycling endosomes decreased. Thus, 
divalent Rab5 and Rab4 effectors regulate endocytosis and recycling by connecting 
Rab5 and Rab4 domains on early endosomes. These results provide support for the 
hypothesis that Rab proteins and their effectors regulate the compartmental 
organization and trafficking function of early endosomes.
1. INTRODUCTION
1.1 General overview of the endocytic pathway
Eukaryotic cells continuously remodel their plasma membrane composition 
by a process known as endocytosis. This process involves the internalization of 
extra-cellular components through the regulated formation of vesicles at the 
plasma membrane (for review see (Mellman, 1996; Riezman et al., 1997; 
Robinson et al., 1996)). According to the size of the internalized particles, 
endocytosis can be subdivided into phagocytosis (cell eating) and pinocytosis (cell 
drinking) (Silverstein et al., 1977). Phagocytosis is responsible for the uptake of 
large particles (> 0.5 pm diameter) which bind to specific cell surface receptors 
capable of transducing a phagocytic stimulus to the cytoplasm. This stimulus 
causes the formation of F-actin-driven pseudopods that engulf the bound particles 
into a cytoplasmic phagosome (Greenberg et al., 1990; Greenberg et al., 1991). 
This form of endocytosis is associated with specific cell types such as leukocytes 
of the mammalian immune system or phagocytic protozoa like Dictostelium. In 
contrast to phagocytosis, all eukaryotic cells exhibit one or more forms of 
pinocytosis. According to the different size of internalized vesicles, pinocytosis 
can be further subdivided into micropinocytosis and m acropinocytosis. 
Micropinocytosis refers to the constitutive formation of small vesicles (50-150 nm
diameter) carrying extracellular fluid and macromolecules specifically or non- 
speciflcally bound to cell surface receptors. These vesicles are usually initiated at 
clathrin-coated pits and depend on clathrin function although alternatives have 
been described (see below). Possible alternatives to clathrin-mediated endocytosis 
involve caveolae and/or actin based-mechanisms. To different extents, two or 
more of these mechanisms co-exist in a single cell type. Macropinocy tosis is 
characterized by the formation of relatively large vacuoles (0.5-2 pm diameter) 
and preferentially occurs in certain cell types (dendritic cells, macrophages and 
fibroblast) (Steinman and Swanson, 1995) in response to specific stimuli (growth 
factors) (Haigler et al., 1979). Although, the function of this form of endocytosis 
has not yet been elucidated, it has been suggested that the high ratio of volume to 
surface area of macropinosomes may reflect a function in sampling the fluid in the 
extracellular environment (Sallusto et al., 1995).
Following internalization, cell surface receptors, along with their ligands, 
solutes and other plasma membrane constituents, first appear in early endosomes. 
Here, components destined for degradation are transported to late endosomes and 
lysosomes, while recycling receptors and bulk membranes are returned back to the 
plasma membrane for a next round of internalization (Dunn et al., 1989; Hopkins, 
1983; Mayor et al., 1993) (see Figure 1 for a schematic representation of the 
endocytic pathway).
Sorting Endosomo
Recycling
Endoeome
Late Endosome
Lysosome
TON/
MTOC
Figure 1 : The endocytic pathway
This figure indicates the major routes of endosomal membrane transport along the 
degradative and recycling pathways. As an example, the trafficking of transferrin 
receptor (TR) is shown. MTOC: microtubule organizing centre; PM: plasma membrane. 
See text for details.
Early endosomes also act as central node in connecting membrane traffic 
between the biosynthetic and the endocytic pathway (Rohn et ah, 2000; Wilcke et 
al., 2000). Downregulation of growth factor receptors plays an essential role in 
controlling growth and differentiation, while endocytic-recycling balances the 
internalization of membrane components and avoids consumption of certain 
receptors. Beside these basic functions, common to all nucleated cells, early
endosomes also play more specialized functions in certain cell types. Endocytic- 
recycling guarantees re-utilization of synaptic vesicle components in neurons 
(Mundigl and De Camilli, 1994), and allows antigen-presenting cells to expose 
MHC-peptide complex to the cell surface to elicit an appropriate immuno- 
response (Tulp et al., 1994). Other examples include fat and muscle cells, where a 
fine tuning of the rate of endocytosis and recycling in response to insulin, 
regulates the plasma membrane localization of GLUT4, a glucose transporter 
(Herman et al., 1994). Finally, the endosomal system of polarized cells controls 
transport of trans-cytotic molecules across epithelial tissues and is important for 
the establishment of morphogenetic gradients during pattern formation and 
organogenesis (Entchev et al., 2000).
The sorting and recycling activity of early endosomes is, therefore, 
fundamental for intra and inter-cellular communication, and hence for the 
assembly of multi-cellular organisms. The endocytic pathway can be hijacked by 
parasites leading to diseases. Pathogens have indeed evolved, and are 
continuously evolving mechanisms to survive inside, and spread between host 
cells, by modulating the function of the endosomal compartment.
Like the secretory pathway, the endocytic pathway can be thought to be 
organized in functionally and physically distinct compartments, each fulfilling a 
specific function in sorting, recycling and degradation (Kornfeld and Mellman,
1989). However, different from the secretory pathway, the boundaries between 
these compartments are less clear. The reasons for this difference are several-fold. 
Firstly, the functions of endocytic organelles do not involve the predictable and 
easily determined enzymatic activities associated with the synthesis and 
processing of glycoproteins and lipids. Secondly, endosomes are extremely plastic 
and pleiomorphic organelles and their morphology can vary between different cell 
types or even within the same cell type under different conditions. Therefore, they 
cannot be identified on the basis of morphological criteria alone, which is often 
the case for organelles along the secretory pathway. Thirdly, the movement of 
internalized markers is not synchronous enough to follow their progression 
through individual membrane compartments. Nevertheless, a combination of 
different experimental approaches based on morphology, position in the 
cytoplasm, presence of biochemical markers and functional criteria, has led to the 
operational definition of distinct organelles in the endocytic pathway. In the next 
paragraph, I will describe in more detail the compartment organization of the 
endocytic pathway. Given the topic of this thesis, particular emphasis will be 
given to the organization of the early endosomal system.
1.2 Endosomes: classification and function
Endosomes are highly dynamic and heterogeneous membrane-bound 
organelles spread throughout the cytoplasm of eukaryotic cells. Functionally 
distinct, early and late endosomes have been described according to different 
kinetics of labelling upon internalization of endocytic tracers. Early and late 
endosomes differ also in their biochemical composition, morphological 
appearance and topology.
Early endosomes, also referred to as sorting endosomes (Gruenberg and 
Maxfield, 1995), are operationally defined as the first intracellular organelle 
where incoming endocytic vesicles deliver their contents (Dunn et al., 1989; 
Geuze et al., 1983). Due to their slightly acidic internal pH (-6.2), early 
endosomes facilitate the dissociation of many internalized receptor-ligand 
complexes and, therefore, functionally correspond to the previously described 
compartment of uncoupling of receptors and ligands (CURL) (Mayor et al., 1993). 
Early endosomes next engage in the physical separation, or sorting, of recycling 
components from those undergoing degradation. While the latter are delivered to 
late endosomes and lysosomes, recycling receptors are sorted into membrane 
containers destined for the plasma membrane. Although some of these containers 
may fuse directly with the plasma membrane, others accumulate in a population of 
membranes, generally named recycling endosomes, which in many cell types are
tightly clustered in the peri-nuclear region (Hopkins, 1983; Yamashiro et al., 
1984). Recycling endosomes are devoid of material destined for degradation 
suggesting that they do not play a role in receptor-ligand sorting. Moreover, their 
pH is slightly higher than that of early endosomes (Yamashiro et al., 1984) and 
certain regulatory molecules (such as Rab and SNARE proteins) differentially 
localize to these two membrane pools (Daro et al., 1996; Ullrich et al., 1996). 
Altogether these observations lead to a proposal that early and recycling 
endosomes are physically distinct compartments. Further support of this 
hypothesis is given by the recent establishment of protocols allowing purification 
of two separate populations of early and recycling endosomes (Sheff et al., 1999). 
However, the biogenesis, the boundaries and the communication routes 
connecting early and recycling endosomes remain difficult to trace. For example, 
morphological analysis using confocal and video-microscopy techniques has 
described the early endosomal compartment of an epidermoid carcinoma cell line 
(Hep-2) as a ‘’continuous network of tubular membranes and varicosity structures 
through which endocytic tracers move”  (Hopkins et al., 1990). Whether this is a 
peculiarity of the specific cell line analyzed in this study or a more general rule, is 
still unclear. Tubular elements are indeed very sensitive and tend to break down at 
low temperature incubation (below 37® C) or after exposure to common fixative
compounds. These reasons might explain why, in most cases, early endosomes 
appear as individual structures scattered throughout the cytoplasm.
Also controversial is the exact function of recycling endosomes. Trafficking 
through this compartment is apparently not mandatory, as recycling can occur 
directly from early endosomes with high efficiency (Sheff et al., 1999). A better 
understanding of its function might come from studies in polarized epithelial cells 
where, assuming that this compartment corresponds to the apical recycling 
endosomal compartment, it participates in directing membrane recycling to 
distinct apical and basolateral plasma membrane surfaces (Apodaca et al., 1994; 
Barroso and Sztul, 1994). Recycling endosomes might also perform a polarized 
function during cell locomotion. Re-directing membrane recycling to the leading 
edge (a transient polarized plasma membrane region of a migrating cell) indeed 
involves passage through this organelle (Hopkins et al., 1994).
From the ultra-structural point of view, early and recycling endosomes also 
differ. Early endosomes can be similar to the shape of an octopus. They are 
composed of a large cisternal region (0.3-0.5 nm in diameter) from which several 
narrow (60 nm in diameter) tubulo-vesicular elements emanate (Figure 2) 
(Griffiths et al., 1989; Marsh et al., 1986).
Recycling endosomes are composed mainly of tubular elements having the 
same diameter and shape as the one emanating from sorting endosomes (Hopkins,
1983). This similarity led to a proposal that recycling endosomes originate from 
early endosomes upon budding of tubular elements (Gruenberg and Maxfield, 
1995). This model is also consistent with the sequential movement of recycling
receptors from early to recycling endosomes and with the different sorting
functions these elements play along the endocytic pathway.
Figure 2: The Early endosome
Taken from Gruenberg J., 2001. Freeze-etch electron microscopy analysis of early 
endosomes containing low-density lipoprotein-gold particles (white spots).
As already mentioned above, in some cell types early and recycling
endosomes are also geographically segregated. Recycling endosomes are indeed
often localized in the peri-nuclear region close to the microtubule organizing 
centre, while early endosomes are more peripherally distributed (Hopkins, 1983). 
This segregation is dependent on intact microtubules, as treatment of cells with 
microtubules depolymerising drugs redistribute recycling endosomes to the cell 
periphery and mix them with early endosomes (Daro et al., 1996).
Late endosomes can be functionally defined as organelles that receive 
endocytic particles destined for lysosomes after their passage through early 
endosomes. Transport between early and late endosomes involves large (300-400 
nm in diameter) vesicular containers named endosomal carrier vesicles (ECV) or, 
according to their structural composition, multivesicular bodies (MVB) (Aniento 
et al., 1993; Clague et al., 1994; Felder et al., 1990; Gruenberg et al., 1989). These 
containers indeed contain internal vesicles, which are derived from invaginations 
of the limiting endosomal membrane (Cohn, 1966; McKanna et al., 1979).
An additional communication route connects late endosomes with the trans- 
Golgi network (TGN). Clathrin-coated vesicles derived from the TGN deliver 
newly synthesized lysosomal enzymes into late endosomes via the mannose-6- 
phosphate receptors (M6PR) (Kornfeld and Mellman, 1989). Owing to the 
acquisition of these enzymes and their acidic pH (5.5), late endosomes initiate 
breakdown of internalized cargo (Geuze et al., 1988; Griffiths et al., 1988). These
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lysosome-like features lead in some cases to late endosomes being referred to also 
as pre-lysosomes.
Morphologically, late endosomes appear as tubular-vesicular elements 
located in the peri-nuclear region of the cell, but differ from early endosomes 
because of typical high content of internal membranes and lack of recycling 
molecules (Griffiths et ah, 1988). According to the different organization of these 
internal membranes, late endosomes can have an onion (multilamellar) or 
pomegranate (multivesicular) type appearance. Very little is known about the 
biogenesis, the biochemical composition and the functional significance of these 
different types of membranes. Also unclear is to what extent the formation of 
these inner membranes is regulated by the same mechanisms as those controlling 
MVBs inner vesicles budding. The observation that down-regulated receptors 
accumulate in these inner membranes has led to the idea that these membranes are 
destined to be degraded in lysosomes. However, the finding that also molecules 
trafficking between late endosomes and TGN such as M6PRs are contained within 
these membranes (Griffiths et al., 1988) question this hypothesis.
Lysosomes are involved in the final degradation of internalized cargo and 
can also function as a storage place for indigestible materials (Kornfeld and 
Mellman, 1989). However, it has been very difficult to trace the boundary 
between late endosomes and lysosomes, as the communication between these two
11
organelles is very dynamic. Indeed, late endosomes and lysosomes can efficiently 
exchange contents and membrane proteins and they probably interact dynamically 
to form a hybrid intermediate. Both compartments contain lysosomal enzymes, 
their pH is similar (-5.5) and their limiting membrane is composed of the same 
glycoproteins. Lysosomes can only be distinguished from late endosomes by their 
higher density on Percoll gradients, by their electron-dense appearance (Kornfeld 
and Mellman, 1989) and by the lack of some proteins found in late endosomes 
including M6PRs, Rab7 and Rab9 (Gruenberg and Maxfield, 1995).
This elaborate array of membrane-bounded organelles allows a continual 
exchange of components among them. According to the pioneering work of 
Palade, an established mode of conununication between organelles is the transport 
of vesicular carriers (Palade, 1975). According to this model, cargo molecules are 
incorporated into nascent vesicles based on the presence of specific sorting signals 
(Pryer et al., 1992). Adaptor proteins recognize these sorting signals and regulate 
the assembly of coat proteins. Coat proteins were originally believed to bring the 
necessary mechanical force required for membrane curvature and vesicle 
formation. However, recent data have shown that this process requires the activity 
of lipid modifying enzymes which catalyze the lipid imbalance required for 
membrane bending to occur (Schmidt et al., 1999). Coat proteins might allow 
bending and vesicles budding to be controlled and localized (Sprong et al., 2001).
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upon budding from a donor compartment, vesicles are transported to their target 
compartment within an architectural framework. Cytoskeletal components, 
particularly microtubules and their associated motor proteins, regulate vesicular 
transport between geographically segregated organelles, and determine the steady- 
state localization of the organelles themselves (Cole and Lippincott-Schwartz, 
1995). The final event is the docking and fusion of carrier vesicles with the proper 
acceptor compartment and the release of their cargo (Cole and Lippincott- 
Schwartz, 1995).
The molecular mechanisms controlling membrane transport have been 
extensively characterized using different approaches such as yeast genetics, cell- 
free assays and morphological analysis. The regulatory components so far 
identified have revealed that the fundamental mechanisms of vesicular traffic are 
extremely conserved from yeast to mammals (Ferro-Novick and Jahn, 1994; 
Rothman and Warren, 1994). The following sections give an overview of how 
vesicles are a) formed at the donor compartment, b) transported along cytoskeletal 
elements, c) targeted and fuse with the appropriate acceptor compartment.
1.3 Vesicles formation
The process of vesicle formation requires the recruitment of cytosolic 
proteins to a specific site on a donor organelle where they assemble into a coat.
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Coat components ensure incorporation of cargo molecules into nascent vesicles by 
interacting with sorting signals present in their cytoplasmic tails (Rothman and 
Wieland, 1996). Two major classes of coated vesicles have been identified: those 
containing clathrin and those containing coatamer coat proteins (COPs). In the 
endocytic pathway, clathrin-coated vesicles play a major role connecting 
trafficking between the plasma membrane, the endosomal compartment and the 
TGN (Mellman, 1996). Clathrin consists of three copies each of clathrin heavy 
chain and clathrin light chain, arranged into a three-legged structure called 
triskelion (Robinson, 1994). Under certain experimental conditions, purified 
clathrin is able to self-assemble in vitro into a lattice of hexagons and pentagons to 
form a cage-like structure, virtually identical to the coat on coated vesicles present 
in vivo (Kirchhausen, 2000). In this paragraph, I will describe the different steps 
and molecules involved in the formation of clathrin-coated vesicles. Given, that 
much of our understanding of this process comes from the m olecular 
characterization of clathrin-mediated endocytosis, I will describe in detail the 
molecules involved in this process.
1.3.1 Adaptors
The assembly of clathrin coat is initiated by the binding of adaptor 
molecules to a docking site or receptor present on the membrane. To date, four
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adaptors have been identified: AP-1, AP-3 and AP-4 have been localized to TGN 
and endosome-like structures, while AP-2 is localized to the plasma membrane 
and endocytic clathrin-coated vesicles. Each adaptor complex is composed of four 
sub-units: two large (y,pi in AP-1; a ,p2 in AP-2; 5,p3 in AP-3; e,p4 in AP-4), one 
medium (p i in AP-1, p2 in AP-2, p3 in AP-3 and p4 in AP-4) and one small (a l  
in AP-1, (72 in AP-2, a3 in AP-3 and c j4 in AP-4), each performing distinct 
functions. The structure of an adaptor complex resembles the figure of Mickey 
Mouse head. The amino-terminal region of the two large sub-units together with 
the small and medium sub-units define the head, while the two ears are composed 
of the carboxyl-terminal of the two large sub-units and are connected to the head 
by flexible hinges (Robinson and Bonifacino, 2001).
AP-2 is involved in the assembly of endocytic clathrin-coated vesicles at
the plasma membrane. The large P2 sub-unit is involved in clathrin binding
through its hinge region and in cargo selection by interacting with di-leucine
sorting sequences. The medium sub-unit p2  recognizes tyrosine-based
internalization signals such as NPXY or YXXO (0 is a bulky hydrophobic
residue). The ear domain of the a  sub-unit interacts with accessory proteins
(Epsin, Eps 15, A P I80, amphiphysin) necessary for clathrin-coated pit function
(Owen and Luzio, 2000). The mechanisms, whereby the AP-2 complex is
recruited specifically to the plasma membrane, have not yet been elucidated.
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Sorting signals present in receptor tails cannot alone account for the specificity of 
adaptors recruitment, since receptors are widely distributed. A membrane-bound 
docking apparatus has therefore been postulated to account for the specific 
organelle distribution of these molecules. The identity of the putative AP-2 
docking apparatus remains unknown at the present. Recently, PI(4,5)P2 has been
proposed to act as a target signal for clathrin-coated vesicle assembly on the 
plasma membrane, as both AP-2 complexes and several of the AP-2 and clathrin- 
interacting proteins contain PI(4,5)P2 binding domains. The upstream regulators
of PI(4,5)P2 production at the plasma membrane have not yet been identified.
Once the coat is assembled, the nascent vesicle is released by membrane fission 
within the bud neck. In the case of plasma membrane-coated vesicles, this step 
requires the GTPase Dynamin (see below) (Damke, 1996; Hinshaw and Schmid, 
1995).
In contrast to AP-2, the trafficking step regulated by the AP-1 complex is
still controversial. The original proposal for the function of AP-1 was to regulate
M6PR transport from the TGN to late endosomes. Consistently, AP-1 was
localized to TGN (Robinson and Pearse, 1986), co-purified with clathrin-coated
vesicles and interacted with M6PR tails, although not with the di-leucine motive
involved in sorting at the TGN (Le Borgne et al., 1993). AP-1 recruitment to the
TGN is regulated by the small GTPase ARFl (Robinson and Kreis, 1992; Stamnes
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and Rothman, 1993). This small GTPase was first shown to regulate the 
membrane association of coatomer, the coat components of the COP-I-coated 
vesicles involved in vesicular traffic in the secretory pathway (Orci et al., 1993). 
ARF proteins exist in the cytosol in the inactive GDP-bound form. An enzyme 
localized to the donor compartment catalyses the exchange of GDP for GTP 
(Barlowe and Schekman, 1993), and the resulting ARF-GTP molecules can bind 
the membrane (Barlowe and Schekman, 1993) and recruit coat sub-units (Waters 
et al., 1991). After budding, the GTP must be hydrolyzed by ARF in order for the 
coat to dissociate (Barlowe et al., 1994; Tanigawa et al., 1993). The mechanism by 
which ARF promotes recruitment of coat components onto the membrane is still 
not clear. One possibility is that ARF acts stoichiometrically by interacting 
directly with coat proteins/adaptors (Zhao et al., 1997). A second possibility is that 
ARF interacts with the hypothesized ‘docking site’, inducing conformational 
changes that would allow the docking site to bind the adaptor complex with high 
affinity (Le Borgne et al., 1996; Traub et al., 1993). A third possibility is that ARF 
may exert its effect catalytically. ARF has been reported to activate phospholipase 
D (PLD) (Brown et al., 1993), phosphatidylinositol-4 kinase (PI(4)P-kinase) and 
phosphatidylinositol,4 phosphate,5-kinase (PI(4)P-5 kinase) (Jones et al., 2000). 
PLD catalyses the hydrolysis of phosphatidylcholine (PC) into choline and the 
negatively-charged lipid-phosphatidic acid (PtdOH). PtdOH can in turn activate
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PI(4)P-5 kinase, which phosphorylates PI(4)P, the product of the PI4-kinase, to 
PI(4,5)P2. Local increase in PI(4,5)P2 was shown to increase coatomer 
recruitment to TGN membranes (Ktistakis et al., 1996). However, given that 
PI(4,5)P2 is present also on the plasma membrane, additional docking factors 
must be envisaged to account for the specific localization of AP-1.
The function of AP-1 in regulating TGN to endosome transport has recently 
been questioned since the identification of the GGA proteins. GGAs (Golgi- 
localized, y ear-containing, ARF-binding proteins) were independently identified 
by several groups as ARF-binding proteins and as protein-containing homology to 
the ear domain of y-adaptin (Boman et al., 2000; Dell'Angelica et al., 2000; Hirst 
et al., 2000). GGA proteins are multi-modular molecules having all the features 
necessary to create a clathrin coat on Golgi membranes (Black and Pelham, 2001). 
They consist of four domains: the VHS domain, a domain of unknown function 
present in various proteins involved in vesicular traffic (Vps27, Hrs, STAM), 
which bind to the di-leucine-sorting signal of the M6PR and sortilin. The adjacent 
GAT (GGA and TOM l) domain binds ARF-1: GTP while the hinge like domain 
binds clathrin and the ear domain interacts with accessory proteins. GGA proteins 
have been shown unambiguously to regulate MPR traffic from TGN to late 
endosomes (Black and Pelham, 2000; Puertollano et al., 2001; Zhu et al., 2001). 
The obvious question raised by these findings, therefore concerns, the function of
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AP-1. Are AP-1 and GGAs localized in the same vesicles? Several scenarios 
might be envisaged: AP-1 might function in TGN to early endosome transport or 
vice versa in retrograde traffic from early endosome to TGN. In agreement with 
this last possibility are the observations that in |i lA  knockout cells M6PRs 
accumulate in endosomal membranes (Meyer et al., 2000), and that in addition to 
TGN, y-adaptin is also found on endosomes (Putter et al., 1998). Alternatively, 
AP-1 and GGAs might regulate sorting of different receptors or budding from 
different sub-domains of the TGN (Black and Pelham, 2001).
AP-3 has recently been identified and shown to localize to TGN and to 
peripheral structures partially co-localizing with endosomal markers (Simpson et 
al., 1996). The functional characterization of this adaptor complex has been 
greatly facilitated by the identification of naturally occurring mutants in 
D rosoph ila , mouse, and human, and by creating mutations in the yeast 
homologue. All together these studies led to the conclusion that AP-3 is involved 
in regulating trafficking from the TGN-endosome to lysosome and lysosome- 
related organelles such as melanosomes and platelet dense granules (Simpson et 
al., 1996). A still open issue is whether AP-3 binds to clathrin. In vitro binding 
experiments would suggest so (Delf Angelica et al., 1998), but it has not been 
possible so far to demonstrate AP-3 immuno-reactivity on purified clathrin coated 
vesicles, nor has co-localization between AP-3 sub-units and clathrin in vivo been
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detected (Simpson et al., 1996). AP-4 has been just recently discovered and its 
function is currently unknown. It is localized mainly to TGN membranes in area 
not labelled with clathrin, indicating that also this adaptor may function 
independently from clathrin (Delf Angelica et al., 1999).
The molecular characterization of clathrin-mediated endocytosis has 
revealed that the AP-2 sub-units are involved in an extensive network of protein- 
protein interactions. Many proteins that are engaged in these interactions are large 
multi-modular proteins containing one or more protein-protein interaction 
domains such as EH domain (Eps 15 homology domains), NPF (single amino acid 
code) repeats, SH3 domains (Src homology), proline rich domains (PRD) and 
coil-coiled domains. The picture emerging from the functional characterization of 
these molecules is that the process of cargo recognition and coat assembly is 
tightly coupled to the actin cytoskeleton (see below) as well as to the machinery, 
which is required for vesicles budding, targeting and fusion with early endosomes 
(Owen and Luzio, 2000).
1.3.2 Invagination and detachment of clathrin-coated vesicles
Using GFP-tagged clathrin light chain it has been shown that invagination 
of clathrin-coated pits at the plasma membrane displays limited mobility within 
the membrane (Gaidarov et al., 1999). Moreover, despite their apparent random
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distributions, coated pits form preferentially at a defined site. Treatment of cells 
with latrunculin B, a drug which interferes with actin assembly, increased the area 
of movement of coated pits suggesting that an actin-based framework is involved 
in the structural organization of clathrin-coated pits at the cell surface (Owen and 
Luzio, 2000) (see also next paragraph).
The mechanism by which an invaginated coated pit is converted into a 
vesicle is still poorly understood. One key regulator of this process is dynamin 
(Kelly, 1999). The involvement of dynamin in endocytosis was initially described 
in Drosophila. The shibire gene encoding for the fly homologue of dynamin 
(Chen et al., 1991; van der Bliek and Meyerowitz, 1991) bearing a temperature- 
sensitive mutation, presented defects in endocytosis of synaptic vesicles: the 
number of constricted vesicle profiles at the presynaptic membrane was increased 
and fewer synaptic vesicles were detected (Poodry and Edgar, 1979). In 
mammalian cells, dynamin has been localized to the clathrin lattice surface and is 
then redistributed to the neck of the invaginated coated pits. It was initially 
proposed that dynamin function was to constrict the neck of invaginated coated 
pits and that the energy was provided by the GTPase activity of dynamin (Damke 
et al., 1994; Sweitzer and Hinshaw, 1998; van der Bliek et al., 1993). More 
recently, dynamin was shown to contain a GTPase-activating domain promoting 
dynamin self-assembly. Over-expression of dynamin mutant in the GTPases-
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activating domain resulted in the unexpected increase of endocytosis (Sever et al.,
1999). These data are difficult to reconcile with the idea that dynamin is the 
mechanical driving force to sever coated pits and rather suggests that dynamin 
functions, like most GTP binding proteins, via recruiting effector proteins. Besides 
dynamin, other important molecules involved in clathrin-coated vesicle formation 
are endophilin and synaptojanin. Endophilin is localized to presynaptic terminals 
and interacts via its SH3 domains with dynamin and with synaptojanin (Micheva 
et al., 1997; Simpson et al., 1999). Both endophilin and synaptojanin are lipid- 
modifying enzymes. Endophilin exhibits lysophosphatidic acid acyl transferase 
activity (Schmidt et al., 1999). This activity results in the conversion of 
lysophosphatidic acid (LPA) to phosphatidic acid by transfer of arachidonate. On 
the basis of these results it has been proposed that membrane curvature at the neck 
of a clathrin-coated pit may be induced by the conversion of an inverted cone- 
shape lipid (LPA) into a cone-shaped lipid (phosphatidic acid) in the cytoplasmic 
leaflet (Schmidt et al., 1999; Sprong et al., 2001). Synaptojanin is a major 
presynaptic protein associated with endocytic-coated intermediates, which 
exhibits polyphosphoinositide phosphatase activity. Synaptojanin -/- mice have 
elevated levels of phosphatidylinositol 4,5-bisphosphate (PtdInsP2) and show an 
accumulation of clathrin-coated vesicles, indicative of a role for synaptojanin in 
uncoating (the uncoating process is characterized by the disassembly of clathrin
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and adaptors in the cytoplasm). Vesicles uncoating may be a pre-requisite for 
membrane fusion to occur and may allow recycling of clathrin and adaptors for a 
next round of internalization (Cremona et al., 1999). PI(4,5)P2 is required for 
clathrin-coated vesicle formation (Jost et al., 1998) and many proteins involved in 
the formation of clathrin-coated vesicles bind to PI(4,5)P2, including dynamin and 
AP-2 (Corvera et al., 1999). Therefore the polyphosphoinositide phosphatase 
activity of synaptojanin may favour uncoating by reducing the level of PI(4,5)P2 
in the vesicle, which in turn would cause the dissociation of AP2 and clathrin (Hill 
et al., 2001). Another protein involved in uncoating is auxillin. Auxillin was first 
identified as a coat protein enriched in brain (Able and Ungewickell, 1990). 
Auxillin binds to clathrin lattices and in the presence of ATP recruits the cofactor 
hsp70 and mediates coat disassembly (Ungewickell et al., 1995).
1.4 Endocytic transport: role of the cytoskeleton
Intracellular organelles are highly dynamic entities continuously changing 
their shape and position during time. Organelle motility facilitates transport of 
cargo molecules from one destination to the other and might significantly reduce 
the distance vesicles need to travel before docking and fusing with target 
compartments. The term “organelle dynamics”  refers here also to the complex 
series of events determining membrane remodelling and changes in organelle
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shape. These changes might favour vesicular budding and fusion, or, as in the case 
of early endosomes, might function as sorting mechanisms. Other examples of 
membrane remodelling include plasma membrane changes during cell migration 
and phagocytosis. All these processes are tightly regulated and require interaction 
of organelles with cytoskeletal filaments.
Actin filaments lying beneath the plasma membrane are cross-linked into a 
network by actin-binding proteins and form the so-called cell cortex (Figure 3).
Almost all components of the endocytic machinery interact directly or 
indirectly with actin or with one of the actin binding proteins (Qualmann et al.,
2000). Several lines of evidence suggest a role for the cortical actin in early steps 
of endocytosis. A functional actin cytoskeleton is essential for the receptor- 
mediated uptake of the a-Factor in yeast Saccharomyces cerevisiae (Kubler and 
Riezman, 1993; Mulholland et al., 1994). Depolymerisation of actin filaments by 
the fungal metabolite cytochalasin D completely abolishes phagocytosis by 
macrophages, a process which requires a major reorganization of the plasma 
membrane to engulf large particles (Axline and Reaven, 1974). Morphological and 
kinetic evidence for the involvement of actin in facilitating the uptake of ligands 
via coated pits, as well as the sorting of recycled ligands concentrated in the 
perinuclear area of the cells, have also been provided (Durrbach et al., 1996). 
Moreover, in polarized epithelial cells actin has been shown to be required for
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apical endocytosis of membrane-bound and fluid-phase markers (Jackman et a l,
1994).
The precise molecular mechanism underlying actin functions in endocytosis 
remains unclear. One possibility is that the rigid cortical actin lying beneath the 
plasma membrane constitutes a physical barrier and that local actin de­
polymerization is required for endocytosis to occur. Indeed the immediate vicinity 
of clathrin-coated pits is almost devoid of actin fibres (Fujimoto et al., 2000). A 
second possibility might be that the actin cytoskeleton participates in late scission 
events of clathrin vesicles formation providing the driving force leading to 
vesicular budding (Simpson et al., 1999). This function would involve an actin- 
binding motor molecule such as unconventional myosin motors. A type I myosin 
molecule represents a good candidate to act as a molecular motor, since this 
molecule was shown to be able to move actin filaments on a phospholipid 
substrate (Adams and Pollard, 1989; Zot, 1995). Recently, Myosin VI has been 
shown to associate with clathrin-coated vesicles and to modulate clathrin- 
mediated endocytosis (Buss et al., 2001). Alternatively, actin may help to organize 
the endocytic machinery at the plasma membrane by defining specific sites of 
endocytosis (Owen and Luzio, 2000; Roos and Kelly, 1999). Finally actin might 
regulate vesicle movement. Clathrin-coated vesicles and endosomes have been
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described to be associated with actin comet tails both in vivo (Frischknecht et ah, 
1999; Rozelle et ah, 2000) and in vitro (Taunton et al., 2000).
Microtubules are involved in maintaining the steady-state distribution of 
organelles in the eytoplasm and in regulating their long-range bi-directional 
movement (Kelly, 1990). Microtubules radiate outward from the perinuclear 
microtubule-organising centre (MTOC), with their plus-ends facing the cell 
periphery (Cole and Lippincott-Schwartz, 1995). They have been compared to 
highways along which endocytosed material move from peripheral sorting 
endosome to perinuclear late and recycling endosomes (see Figure 3) (Bomsel et 
al., 1990; Gruenberg et al., 1989).
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Figure 3: Organization of the actin and microtubule cytoskeletal elements.
Actin filaments are organized into a variety of linear bundles and three-dimensional 
networks most highly concentrated beneath the plasma membrane. Microtubules are 
nucleated from the MTOC and radiate out towards the cell periphery.
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Movement of organelles along microtubules requires ‘motor proteins’ that 
use the energy derived from the hydrolysis of ATP to promote organelle motility. 
Two families of microtubule-stimulated ATPases, kinesin and dynein, have been 
shown to function as motors for microtubule-based transport (Allan, 1995; Bloom, 
1992). Kinesin motors primarily move toward the plus end of microtubules, 
although some kinesins have been shown to be minus ended-directed motors 
(Schroer et al., 1988; Vale et al., 1985). Dynein moves only toward the minus end 
(Schroer et al., 1989) and is required for fusion of endosomal carrier vesicles with 
late endosomes in vitro (Aniento et al., 1993). The motors regulating early 
endosome motility have not yet been identified. Interestingly, two recent reports 
have implicated members of the Rab family of small GTPases as regulators of 
organelle motility providing an explanation of how motor proteins might be 
recruited and activated in an organelle-specific manner (see next section). 
Microtubules are not only required for endosome motility and positioning but 
determine also the extent to which processes such as endosome tabulation occur 
(Wood and Brown, 1992). The mechanisms and functional implications 
controlling endosome tubulation will be treated in more detail in the chapter 
describing the molecular regulation of endocytic-sorting and membrane recycling 
( see chapter 1.9).
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1.5 Vesicle and organelle docking and fusion
Upon budding from a donor compartment a vesicle has to find its target 
compartment, fuse and release its content. The specificity of this membrane 
transport reaction is fundamental in preserving organelle identity and to ensure 
proper flow of cargo. The SNARE (soluble NSF attachment protein receptor, 
where NSF stands for N -e th y lm ale im id e-sen sitiv e  factor) hypothesis was 
proposed to explain in molecular terms the mechanism of vesicular docking and 
fusion. It postulates that each vesicle carries a specific integral membrane protein, 
a v-SNARE, that pairs with a corresponding t-SNARE on the target membrane. 
Subsequently, NSF binds to the SNARE complex, via the soluble NSF attachment 
protein (a-SNAP), and its ATPase activity leads to SNARE complex dissociation 
and membrane fusion (Sollner et al., 1993). In detergent extract, v- and t-SNAREs 
can indeed assemble with NSF and a-SN A P into a 20S particle, which is 
dissociated upon ATP hydrolysis by NSF (Paek et al., 1997; Sogaard et al., 1994; 
Sollner et al., 1993). According to this model, therefore, NSF and SNAPs are 
universal components of a conserved docking-fusion apparatus, while SNARE 
proteins are thought to provide specificity to each single docking and fusion event.
The best-characterized members of the SNARE proteins family are the 
neuronal SNAREs involved in synaptic vesicle exocytosis. Their function has
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provided a paradigm for SNAREs function in membrane fusion. The SNAREs 
hypothesis indeed originated from the molecular dissection of proteins involved in 
synaptic vesicle exocytosis (reviewed by: (Sudhof, 1995). Synaptic transmission 
requires a v-SNARE, known as VAMP (vesicle-associated membrane protein) or 
synaptobrevin (Trimble et al., 1988) and two t-SNAREs, syntaxin-1 and SNAP25. 
Upon pairing, these SNAREs form an extremely stable ternary complex (‘SNARE 
core complex’). Many SNAREs have now been identified and localized to distinct 
organelles along both the secretory and the endocytic pathway in cells as 
evolutionary distant as yeast and neurons (Aalto et al., 1993; Becherer et al., 1996; 
Bennett and Scheller, 1994; Dascher et al., 1994; Hardwick and Pelham, 1992; 
Nagahama et al., 1996). The hallmark of all SNARE proteins is that they contain 
conserved heptad repeat sequences that form coiled-coiled structures. Recently, 
the crystal structure of the neuronal SNARE ‘core complex’ has been solved. In 
the complex, one coil of syntaxin-1 and VAMP, and two coils of SNAP-25 
intertwine to form a four-stranded coiled-coil structure. These data are in 
agreement with several other studies that predicted a parallel arrangement of the 
core complex (Hanson et al., 1997; Lin and Scheller, 1997; Poirier et al., 1998). 
This topological configuration strongly supports the hypothesis that formation of 
the SNARE complex fuses two membranes by bringing them into close apposition 
rather than simply docking them. According to this view, the SNARE complex
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‘zips’ from the membrane distal amino termini to the membrane-proximal 
carboxyl termini overcoming the energy barrier to drive fusion of the lipid 
bilayers. It is therefore the assembly and not the disassembly, as originally 
postulated, of the core complex that would drive membrane fusion. Moreover, 
although the function of NSF and a-SNAP in dissociating the SNARE complex 
has not been disproved, studies of homotypic vacuole fusion in Saccharomyces 
cerevisiae have been challenging their role in the final step of membrane fusion 
(Wickner and Haas, 2000). A current working model considers the homotypic 
vacuole fusion reaction as divided into three sequential steps: priming, docking 
and fusion (Figure 4). Priming is characterized by the set of reactions that activate 
vacuoles for subsequent docking and does not require vacuole-to- vacuole contact. 
Docking is characterized by the association of vacuoles and can be divided into a 
reversible tethering step, when vacuoles at a distance of up to 100 nm are captured 
and tethered to each other by extended coil-coiled molecules, and a subsequent 
step of close association caused by trans-SNARE  pairing. After docking, the 
paired vacuoles undergo fusion, which is assayed by the mixing of vacuoles 
contents. These studies have established that the function of NSF (Secl8p)/a- 
SNAP (SeclVp) is more consistent with a role in priming SNAREs for interaction, 
possibly by dissociating pre-existing v-t-SNARE complexes on the vacuole 
membranes (Conradt et al., 1994; Mayer and Wickner, 1997; Mayer et al., 1996;
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Ungermann et al., 1998). The ATPase activity of NSF would provide the energy 
required to disassemble v- and t-SNARE complexes on the same membrane so 
that they become available for a new round of membrane docking and fusion. In 
this way NSF/SNAP would be responsible for an early ‘priming’ reaction 
preceding docking and fusion (ATP-dependent priming and ATP-independent 
fusion). Tethering is mediated by Rab proteins and their effectors (see below and 
next section), while trans-SNAREs pairing renders docking irreversible. SNARE 
pairing does not seems to be required for the final step of vacuolar membrane 
fusion as SNARE complexes could be dissociated and prevented from reassembly 
without affecting content mixing of the vacuoles (Ungermann et al., 1998).
The relatively restricted intracellular localization of SNARE proteins, 
coupled with the observation of a stable SNARE complex in vitro led to the 
hypothesis that formation of SNARE complexes in vivo mediates the specificity of 
vesicle docking and fusion. When yeast SNAREs were reconstituted into 
liposomes in all possible combinations and content mixing was used as read-out of 
fusion, a remarkable specificity of interactions was observed. This result implies 
that, at least in vitro, SNAREs are the minimal requirement for specific vesicular 
docking and fusion (McNew et al., 2000). However, although SNAREs are 
enriched in certain organelles, they inevitably spread throughout cellular 
compartments as a consequence of vesicular traffic. SNAREs must therefore be
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kept inactive until they return to their specific site of function. For instance, 
accessory proteins are required to protect SNAREs from promiscuous binding and 
to impede their rebinding in cis after fusion and disassembly of the core complex. 
Such function seems to be the task of the yeast seel related proteins (Jahn, 2000).
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Figure 4: Working model for SNARE proteins function in homotypic vacuole fusion 
(according to Ungermann et a/., 1998)
NSF is thought to activate v- and t-SNARE marked (with an “*”) allowing them to 
interact. V= v-SNARE, t=t-SNARE. See text for details.
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Munc-18, a mammalian homologue of the yeast Seclp, has been shown to bind 
directly to the t-SNARE syntaxin-1 (Garcia et ah, 1994; Hata et ah, 1993; Pevsner 
et ah, 1994), and to be excluded from the SNARE complex, consistent with the t- 
SNARE protection model (Garcia et ah, 1995; Sollner et ah, 1993).
The role of SNAREs in docking has also been challenged by the findings of 
several laboratories. SNARE-cleaving neurotoxins do not reduce vesicle docking 
at the synapse (Hunt et al., 1994), and SNARE-deficient flies have an increased 
rather than a decreased number of docked vesicles (Schulze et ah, 1995). It seems 
therefore, that SNARE molecules alone cannot account for the high fidelity and 
specificity of vesicle docking and fusion. Such specificity is more likely provided 
at the stage of vesicular targeting and tethering by long, extended proteins 
localized to the target membrane that recognize, capture and tether the appropriate 
vesicles (Zerial and McBride, 2001). The formation of productive SNARE 
complexes may also depend on such molecules. Small GTPases of the Rab family 
have all the propriety required to provide regulation to SNARE complex assembly 
and to ensure specificity of membrane tethering.
1. 6 Yptl/Sec4/Rab family of small G-proteins
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Yptl/Sec4/Rab proteins are small Ras-related GTPases involved in regulation of 
intracellular transport. The first identified members of this class were two yeast 
proteins: Y ptlp (Gallwitz et ah, 1983) and Sec4p (Salminen and Novick, 1987). 
Further proteins belonging to this family have been discovered in both budding 
and fission yeast and other eukaryotes (reviewed by (Novick and Zerial, 1997)). 
There are more than 40 mammalian homologues of Yptl/Sec4 identified to date 
and named Rab proteins (because they were originally isolated as Ras-like genes 
from rat brain). In human there are as many as 63 family members as estimated 
from the now available genome sequence and from expressed-sequence tags 
(ESTs) (Zerial and McBride, 2001).
A characteristic feature of Rab/Ypt proteins is their specific intracellular 
distribution (Simons and Zerial, 1993). Each member of the class is localized to 
membranes of certain organelles and regulates, therefore, a particular step in 
transport pathways. For example, Y ptlp in Saccharomyces cerevisiae mediates 
ER to Golgi transport and is found in association with these organelles (Jedd et ah,
1995). In temperature-sensitive Y ptlp mutants, transport from the endoplasmic 
reticulum to the Golgi complex was impaired, leading to an accumulation of 
carrier vesicles unable to deliver their cargo (Segev et ah, 1988). The same 
phenotype was demonstrated for Sec4p mutant cells and in this case the traffic 
block was localized between the Golgi and the cell surface (Goud et ah, 1988;
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Salminen and Novick, 1987). The Sec4p localization to secretory vesicles and to 
the plasma membrane is consistent with the trafficking impairment present in 
Sec4p mutants.
The crystal structure of p21/Ras, in both its active and inactive 
conformation, has been solved and has been used as a paradigm for the function of 
individual domains of the Ras-like GTPases (de Vos et al., 1988; Krengel et al., 
1990). Based on the high degree of similarity between Rab proteins and Ras, four 
highly conserved sequence motifs have been identified and shown to be necessary 
to form the nucleotide/Mg^^binding domain (GNB), containing the key residues 
for binding and hydrolysis of GTP. Point mutations within these motifs can 
change the nucleotide affinity of p21/Ras stabilizing this GTPase either in the 
GTP-bound or in the GDP-bound conformation. Those mutations, leading to a 
protein that is constitutively active, cause neoplastic growth because they 
constitutively transduce mitogenic signals, by-passing the normal regulation by 
growth factor receptors.
By analogy to Ras, similarly Rab mutants have been engineered and 
successfully used to investigate the function of these proteins in membrane traffic.
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1.6.1 The Rab cycle(s): The dual life of a Rab protein
Like other GTPases, Rab proteins have the ability to bind guanine 
nucleotides and to hydrolyze GTP. However, their intrinsic rates of nucleotide 
exchange and GTP hydrolysis are very low and therefore Rab/Ypt proteins can 
exist in three different conformational states: inactive GDP-bound, nucleotide free 
and active GTP-bound (Novick and Brennwald, 1993). Due to alternating between 
active and inactive forms, Rab/Ypt proteins can act as “molecular switches”. In 
the GTP-bound active form Rab proteins are able to recognize specific 
downstream effectors of the transport machinery, while the GTPase activity 
ensures that the protein remains in the active conformation only for a limited 
length of time. As the spontaneous rate of nucleotide hydrolysis and exchange 
occurs at low rates, this cycle, in vivo, is regulated by the interaction with 
accessory proteins. Guanine nucleotide exchange factors (GEF), convert GDP- 
bound Rab proteins into the GTP-bound, and GTPase-activating proteins (GAP) 
convert GTP-bound Rab protein into a GDP form (Figure 5) (Boguski and 
McCormick, 1993).
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Figure 5: GTPase molecular switch
See text for details.
In a nucleotide-dependent manner Rab proteins also undergo cycles of
membrane association and dissociation. In cytosol, Rab proteins are bound to Rab
GDP dissociation inhibitor (GDI), an important co-factor in the Rab cycle that
inhibits GDP dissociation and maintains Rab proteins in their GDP-bound
conformation (Pfeffer et al., 1995; Soldati et al., 1993). RabGDl maintains Rab
proteins in a dynamic equilibrium by delivering them to their appropriate
compartment (Soldati et al., 1994; Ullrich et al., 1994) and, upon GTP hydrolysis,
by extracting them from the membrane. The mechanisms regulating the membrane
association of Rab proteins are not completely understood. A GDl-displacement
factor (GDF) is subject to the Rab:RabGDl protein complex. This factor would
cause release of GDI into the cytosol and would allow binding of RabiGDP to the
membrane. A specific GDP-GTP exchange factor/activity would then convert the
Rab protein into the GTP-bound, active conformation (Pfeffer, 1994). In
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agreement with this model, a protein functioning as GDI-displacement factor for 
endosomal Rab proteins which is lacking nucleotide exchange activity (Dirac- 
Svejstrup et al., 1997) as well as exchange factors lacking GDl-displacement 
factor activity, have been identified (Horiuchi et al., 1997). However, it is still 
unknown whether recognition of RabGDl complex and release of GDI are events 
mediated by the same factor.
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1.6.2 Post-translational modification of Rab proteins
After being synthesized as soluble proteins, Rab proteins are isoprenylated 
on cysteine residues at their C-terminus as a requisite for membrane binding. This 
reaction is catalyzed by the Rab geranylgerany 1-transferase (RabGGTase) (Seabra 
et al., 1992; Seabra et al., 1992), a multisubunit enzyme, comprising a catalytic 
heterodimer of tightly associated a  and (3 subunits, and an accessory factor, the 
Rab Escort Protein (REP) (Armstrong et al., 1993). According to the current 
model based on the mammalian system (Alexandrov et al., 1994), a newly 
synthesized Rab protein is bound by REP and the complex is recognized by Rab 
GGTase, which then allows the subsequent digeranylgeranylation of the bound 
Rab protein. The mechanism of this reaction has been described in detail and 
comprises the formation of a stable complex between monogeranylgeranylated 
Rab and REP. This complex enables the subsequent addition of an isoprenoid 
moiety to the second C-terminal cysteine residue to produce digeranylgeranylated 
Rab (Shen and Seabra, 1996). Moreover, geranylgeranylation requires Rab protein 
in its GDP-bound form (Seabra, 1996). After completing the prénylation reaction, 
REP stays associated with the modified Rab and, like GDI, acts as a chaperone to 
deliver it to its specific target membrane. Upon membrane association of Rab, 
REP is released into the cytosol for another round of prénylation.
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REP-1 protein shares structural homology and many functional features 
with Rab GDI, such as the ability to inhibit GDP dissociation from Rabs and to 
deliver and to extract Rabs from membranes (Alexandrov et al., 1994). Despite 
these similarities it has been shown that, in vivo, REP is responsible for 
prénylation and initial membrane delivery of a Rab protein, while further 
recycling is performed by Rab GDI that is unable to assist in the prénylation 
reaction (Alexandrov et al., 1994).
1.7 Functions of Rab proteins
The first function assigned to Rab proteins was to control the specificity of 
membrane fusion by regulating the pairing between v- and t-SNAREs. 
Experiments conducted in the yeast S. cerevisiae revealed a genetic link between 
Rab and SNARE proteins, although no biochemical proof for a direct link could 
be provided. Recent data have revealed additional functions of Rab proteins in 
vesicle and organelle motility along cytoskeleton elements as well as in vesicular 
budding events. These findings might indicate that sequential steps of vesicular 
transport are co-ordinated by the same GTPase (Pfeffer, 2001; Segev, 2001; Zerial 
and McBride, 2001).
As for all the other GTPases, Rab proteins function in their GTP active 
state by recruiting downstream effector proteins to the membrane compartment
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where they are localized. The identification of the molecular machinery controlled 
by these GTPases has been, and will be, therefore fundamental to understanding 
the basic principles of membrane transport. In the following paragraph, I will 
summarize the functions so far attributed to Rab proteins and their effectors in i) 
membrane tethering and SNARE assembly regulation, ii) vesicular budding and 
iii) organelle-vesicle motility. In the last section, the molecular evidence 
supporting a role of Rab proteins in organelle biogenesis and maintenance will be 
described, using Rab5 as paradigm of function for the other family members.
1.7.1 Membrane tethering
As previously discussed, the specificity of membrane targeting was 
believed to depend upon the correct pairing between v- and t-SNAREs. Although 
there is evidence for this hypothesis from in vitro studies, it appears that the 
specificity of vesicle targeting is conferred by a pre-SNARE step, when vesicles at 
a distance of up to 100 nm from their target compartment are captured and 
tethered by extended coil-coiled molecules (Chen and Scheller, 2001; Pelham, 
2001; Wickner and Haas, 2000). These molecules are therefore referred to as 
tethering molecules and several studies both in yeast and mammals have shown 
that Rab effectors are tethering factors (Zerial and McBride, 2001). According to 
this view, SNARE pairing would be required in a post-docking step, presumably
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for membrane fusion. Very likely, the specificity of Rab-mediated membrane 
tethering is directly linked and superimposed onto the specificity of SNARE- 
mediated membrane fusion ensuring the highest reliability to intracellular 
transport (Chen and Scheller, 2001). Indeed, recently several reports have 
provided evidence for a direct interaction between SNAREs and tethering 
molecules. In the yeast secretory pathway, tethering of ER-derived vesicles to the 
Golgi complex depends on the membrane recruitment of USOlp by Yptlp (Gao et 
al., 1998). Whereas in yeast U solp is recruited selectively to the Golgi complex, 
in mammalian cells p i 15, the funetional and structural ortholog of USOlp, is 
recruited already by Rabl to COPll vesicles as they bud from the ER (Allan et al., 
2000). It should be noted, however, that Rabl and p i 15 were shown to interact 
directly, whereas no direct interaction could be detected between USO lp and 
Yptlp. A multi-protein complex called TRAPP (transport protein particle) also 
functions in tethering ER-derived vesicles to the Golgi complex and catalyses 
nucleotide exchange on Y ptlp (Sacher et al., 1998). The precise function of this 
complex is still unknown. Another complex, the exocyst, functions both in 
mammalian and yeast cells, in tethering Golgi-derived vesicles to the plasma 
membrane. In yeast, Secl5p, one of the eight proteins of the exocyst, binds to the 
Rab protein Sec4p, (Guo et al., 1999) while Sec3p, another component of the 
complex, is associated with the plasma membrane (Finger et al., 1998).
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Very few tethering molecules have been identified in the endocytic 
pathway. The Rab5 effector EEAl mediates tethering/docking of early endosomes 
and of CCVs to early endosomes (Christoforidis et al., 1999; Rubino et al., 2000). 
EEA l is an extended coiled-coil molecule specifically localized to early 
endosomes and containing, at the two opposite N and C-terminal ends, a Rab5 
binding site (Lawe et al., 2000). EEAl has been proposed to confer directionality 
to vesicular transport from the plasma membrane to the early endosome by 
bringing together two membranes bearing Rab5 (Rubino et al., 2000; Simonsen et 
al., 1998). Consistent with this hypothesis Rab5 localizes to both CCVs and early 
endosomes and is required for heterotypic fusion between CCVs and early 
endosomes, as well as for homotypic fusion between early endosomes (Rubino et 
al., 2000). EEAl, interacts directly with syntaxin 13 and syntaxin 6 , two SNAREs 
involved in endosomal fusion events, providing a direct link between the tethering 
and fusion machinery (McBride et al., 1999; Simonsen et al., 1999). In yeast, the 
Rab protein Ypt7p binds to and regulates the localization of HOPS, a multi­
protein complex involved in vacuolar membrane docking. The HOPS complex 
and Ypt7p are required on both vacuolar partners undergoing homotypic fusion 
indicating also in this case, a symmetrical requirement (Haas et al., 1995; Price et 
al., 2000).
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On the basis of these results, the asymmetric requirement model originally 
proposed (Bourne, 1988) is no longer tenable. According to this view, a GEF 
localized to the donor compartment converts Rab:GDP to Rab:GTP. Rab:GTP is 
incorporated into a nascent vesicle, transported towards the acceptor compartment 
where it promotes fusion. Here, a GAP catalyses GTP hydrolysis and Rab:GDP is 
recycled for a next round of transport (Bourne, 1988). This model is, however, 
difficult to reconcile with the most recent results, especially those obtained on 
Rab5 and its sequential role in endocytosis. First, Rab5 is localized on CCVs 
(functioning as transport intermediate) (Horiuchi et al., 1995) as well as early 
endosomes (acceptor compartment) (Bucci et al., 1992) and is required on both 
CCVs and early endosomes for productive fusion to take place (Rubino et al.,
2000). Second, membrane-bound Rab5 undergoes futile cycles of nucleotide 
binding and hydrolysis even in the absence of membrane fusion. (Rybin et al., 
1996). Therefore, at least in the case of Rab5, the physical segregation model of 
active Rab proteins between acceptor and donor compartment cannot be applied.
1.7.2 Functional links between Rabs and SNAREs
Several Rab effectors have been shown to bind either directly or indirectly 
to SNARE molecules and thus regulate their assembly. Seel-related proteins (like 
Vps33p and Vps45) regulate SNARE pairing by binding to syntaxin molecules
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and preventing their binding to cognate v-SNAREs. Rab effectors, such as Vac Ip 
and Rabenosyn-5, have been shown, both in yeast and mammalian cells, to bind 
Seel related proteins (Nielsen et al., 2000; Tall et al., 1999). The function of these 
interactions might be the removal of the inhibitors from the SNAREs and/or the 
stabilization of the trans-paired conformation (Pevsner et al., 1994; Yang et al.,
2000). Other Rab effectors bind directly to SNAREs as in the case of the Rab5 
effector EEA l which, as discussed above, interacts with syntaxin 13 and 6 
(McBride et al., 1999; Simonsen et al., 1999), or the Ypt7p effector proteins and 
their interaction with the Vam3p complex (Sato and Wickner, 1998). Rab 
effectors and SNARE molecules can also form oligomeric complexes with a -  
SNAP and NSF, whose assembly is regulated by the ATPase activity of NSF 
(McBride et al., 1999). All these interactions provide convincing support to the 
hypothesis that membrane tethering and SNARE-dependent membrane fusion are 
directly linked processes co-ordinated by the same GTPase.
1.7.3 Function of Rab proteins in vesicular budding and organelle-vesicle 
motility
Rab proteins have also been implicated in vesicle budding, although the 
mechanisms of action in the regulation of this process are not clear and in  some 
cases contradictory data have been obtained from in vivo versus in vitro studies.
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Rab proteins might influence vesicle budding either by regulating the assembly of 
coat components or by controlling the sorting of cargo molecules into nascent 
vesicles.
Rabl was suggested to act at the vesicle budding stage during in vitro ER- 
to-Golgi transport (Peter et al., 1994). However, more recently it has been shown 
not to be required for the formation of COPII vesicles (Allan et al., 2000). The 
yeast Rab proteins, YptSlp and Ypt32p, seem to play a role in budding of 
secretory vesicles from the trans-Golgi network as mutations in these genes lead 
to aecumulation of aberrant Golgi structures (Benli et al., 1996). These data are 
also compatible with a role for these proteins in intra-Golgi transport or in the 
formation of vesicles at the exit point of the Golgi complex (Jedd et al., 1997). 
Rab6 was found associated with a protein complex, and this complex was shown 
to be needed for TGN-derived vesicle budding in vitro (Jones et al., 1993). 
Moreover, RabGDl abolishes vesicle formation in various cell-free systems 
indicating a possible role for Rab proteins in this process (Deretic et al., 1996). 
Rab5 has been shown to be required during the process of clathrin-coated pit 
formation (McLauchlan et al., 1998) in vitro as well as in the regulation of the 
half-life of clathrin-coated pits in vivo (Bucci et al., 1992). The small GTPase 
Rab9 was shown to be required for retrograede transport of M6PR from late 
endosomes to TGN, presumably functioning in a budding step (Lombardi et al.,
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1993). Recently, the Rab9 effector TIP47 has been shown to bind the cytoplasmic 
tail of the M6PR, thus providing an additional function for Rab effectors in cargo 
sorting (Carroll et al., 2001).
Collectively, these findings suggest that the mechanisms underlying the 
formation of transport vesicles are tightly coupled to the targeting and fusion 
machinery (i.e. Rab proteins and their effectors) necessary for later transport steps.
As already mentioned in the paragraph on vesicle and organelle motility (see 
paragraph 1.4), Rab proteins also regulate the attachment and movement of 
organelles along cytoskeletal elements. Rab6 was shown to interact with a kinesin 
motor named Rabkinesinb and to regulate retrogade transport from the Golgi back 
to the ER (Echard et al., 1998). Rab5 was shown to regulate both the attachment 
to, as well as the movement of early endosomes along, microtubules and to 
stimulate minus-end directed motility (Nielsen et al., 1999). The involvement of 
Rab proteins and their effectors in regulating vesicle budding, organelle motility, 
membrane tethering and fusion reflects the need to co-ordinate all steps of a 
vesicle transport process, ensuring that they occur at the right time and in the right 
place.
Novel evidence links the function of Rab proteins also to actin-dependent 
vesicle motility. Genetic interactions between Sec4p and the myosin heavy chain 
Myo2p suggests that exocytic vesicles are propelled by motor proteins along actin
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filaments towards their site of fusion with the plasma membrane (Pruyne et al., 
1998; Schott et al., 1999). Another genetic link between Rab and myosin proteins 
is the one between Rab27 and myosin-Va (Menasche et al., 2000). Both these 
proteins are involved in melanosome transport in melanocytes and their 
corresponding genes have been found mutated in a human disease and in a mouse 
model of melanosomes dysfunction (Bahadoran et al., 2001). R a b ll  and 
MyosinVb have been shown to interact directly, and to function in, the delivery of 
endocytic-recycling vesicles to the plasma membrane (Lapierre et al., 2001).
1.7.4 Localization of Rab proteins along the endocytic pathway
Many Rab proteins have been localized to endocytic organelles, reflecting 
the need for a sophisticated molecular machinery to control multiple membrane 
transport reactions in which these organelles are engaged. Rab5 and Rab4 are both 
localized to sorting endosomes and exert complementary functions in controlling 
entry and exit out of this compartment (Bucci et al., 1992; van der Sluijs et al., 
1992). While Rab5 controls traffic from the plasma membrane to sorting 
endosomes, Rab4 has been implicated in the regulation of a recycling step not yet 
identified. Rab4 may regulate the fusion of early endosome-derived transport 
vesicles with recycling endosomes or, alternatively, it may function in the ‘short 
circuit’ of the recycling pathway, mediating the fusion of early endosome-derived
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vesicles with the plasma membrane (Daro et ah, 1996; van der Sluijs et al., 1992). 
R ab ll was localized to pericentriolar recycling endosomes and shown to regulate 
traffic through this compartment (Ullrich et al., 1996). Since recycling endosomes 
have thus far been distinguished only on the basis of itinerant cargo and their 
position in the cytosol, this finding has provided further support for the existence 
of biochemically distinct sorting (positive for Rab5 and Rab4) and recycling 
(positive for R ab ll)  endosomes. Other Rab proteins localized to early endosomes 
include Rab 15 and Rab22 (Zuk and Elferink, 1999), Rab 17, 18, 20 and 25, some 
being expressed only in polarized cells where they associate with apical endocytic 
structures (Lutcke et al., 1993; McMurtrie et al., 1997; Zacchi et al., 1998).
Rab7 and Rab9 are both localized to late endosomes (Chavrier et al., 1990; 
Lombardi et al., 1993), and control different transport steps. Rab7 seems to be 
involved in the delivery of material from early sorting endosomes to late 
endosomes (Feng et al., 1995), whereas Rab9 regulates transport from late 
endosomes to the TGN (Lombardi et al., 1993).
1.7.5 Multiplicity of Rab5 effectors and their function in the biogenesis of a 
Rab domain.
The finding that the same Rab protein can regulate multiple membrane 
transport processes such as vesicle budding, movement and tethering provides on
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the one hand a mechanism of molecular co-ordination to sequential transport 
reactions. However, on the other hand, how can a single GTPase efficiently deal 
with such a variety of tasks? In this respect the multiple roles played by Rab5 in 
the early endocytic pathway provide a representative example. This GTPase is 
localized to the plasma membrane, CCVs and early endosomes and acts as a rate- 
limiting component in endocytosis (Bucci et al., 1992). It is involved in clathrin- 
coated vesicle formation at the plasma membrane (McLauchlan et al., 1998) and is 
required for their subsequent fusion with early endosomes as well as for 
homotypic fusion between early endosomes (Gorvel et al., 1991). Moreover, Rab5 
regulates endosome motility and attachment to microtubules (Nielsen et al., 1999). 
The recent identifieation of a large number of Rab5 effectors has given important 
insights into the mechanism of action of this GTPase. Using an affinity 
chromatography approach more than twenty proteins were shown to interact 
specifically with active GTP-bound Rab5 (Christoforidis et al., 1999). It is likely 
therefore that Rab5 uses each of these effectors- or subgroups thereof-, to carry 
out different functions.
Even if to date only some of Rab5 effectors have been identified, an 
im portant principle has nevertheless em erged from  their functional 
characterization which is unique among GTPases of the Ras superfamily: Rab5 
effectors act co-operatively. The Rabaptin-5/Rabex-5 complex activates Rab5
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(Horiuchi et al., 1997; Lippe et al., 2001) which can in turn bind to hVPS34, a 
phosphatidylinositol-3 kinase, that specifically generates phosphatidyinositol-3- 
phosphate (PI(3)P) (Christoforidis et al., 1999). The concomitant presence of 
PI(3)P in the environment of active Rab5 is essential for the localization of two 
other Rab5 effectors, EEAl (Stenmark et al., 1996) and Rabenosyn-5 (Nielsen et 
al., 2000). Both proteins bind to PI(3)P through their FYVE finger domain, a 
protein modular element that specifically interacts with this phospholipid 
(Stenmark and Aasland, 1999) and, as described above, provide complementary 
regulatory functions on the SNARE machinery (McBride et al., 1999; Nielsen et 
al., 2000). In addition, EEA l, the Rabaptin-5/Rabex-5 complex and syntaxin 13 
form large molecular weight oligomers whose assembly is regulated by the 
ATPase activity of NSF (McBride et al., 1999). On the basis of protein-lipid 
interactions, cooperativity between effectors and protein oligomerization, it has 
been proposed that Rab5, through its effector proteins, organizes a membrane 
domain defining the site of entry into early endosomes (Figure 6) (McBride et al., 
1999; Miaczynska and Zerial, 2002; Sonnichsen et al., 2000; Zerial and McBride,
2001). The biogenesis of this membrane domain depends on the localized 
production of PI(3)P and its functional properties are determined by the 
recruitment of specific molecules that bind both PI(3)P and Rab5 (Zerial and 
McBride, 2001). Rabenosyn-5 regulates SNARE pairing through VPS45 (Nielsen
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et al., 2000) while EEAl functions as a tethering molecule and interacts directly 
with syntaxinl3, the t-SNARE regulating fusion between early endosome 
(McBride et al., 1999). The compartmentalization of Rab5 effectors within a 
restricted membrane domain may contribute to ensure specificity and efficiency to 
membrane fusion events by retaining and locally activating SNARE molecules at
their site of action.
Rabaptin-SiRab
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Figure 6: Model proposing the role of Rab5 and its effectors in the organization of a 
membrane domain.
RabSGDP is indicated as a blue cirele labelled GDP. RabSGTP as a red eircle labelled 
GTP. The Rabaptin-Rabex-5 complex catalyses nucleotide exchange on Rab5. Active 
GTP-bound Rab5 interacts with the PI-3 kinase VPS34 and stimulates PI(3)P production. 
The concomitant presence of active Rab5 and PI(3)P allows the membrane recruitment 
of EEAl and Rabenosyn-5. AV indicates the putative RabS effectors controlling 
endosome motility. See text for details.
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Interestingly, the Rab5-dependent movement of endosomes along 
microtubles also requires PI(3)P production (Nielsen et al., 1999). This 
observation suggests that a Rab5 effector, possibly a microtubular associated 
protein and/or a motor protein, is also a PI(3)P binding protein or recruited via 
interaction with PI(3)P-dependent mechanisms. It appears, therefore that the 
formation of a PI(3)P-Rab5 enriched membrane domain is presumably required 
for both endosome fusion and motility. Functional specificity to this membrane 
domain would instead be conferred by the nature of the effector molecule 
recruited (Miaczynska and Zerial, 2002).
The Rab5-dependent organization of a restricted membrane domain on 
early endosomes is spatially and temporarily regulated by its GTP cycle. The 
higher the levels of GTP-Rab5, the higher the recruitment of Rab5 effectors, the 
higher the fusion activity (Bucci et al., 1992) and motility of endosomes towards 
the minus end of microtubles (Nielsen et al., 1999). Consistent with this proposal, 
over-expression of a Rab5 mutant deficient in GTP hydrolysis has profound 
effects on endosome morphology, topology and function, leading to the 
accumulation of expanded vacuoles in the peri-nuclear region (Bucci et al., 1992).
The model of membrane domain compartmentalization of Rab5 effectors 
on the early endosomes is in agreement with the heterogeneous morphological 
appearance of these organelles (see Figure 2) as well as with the most recent
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theories concerning the structural and functional organization of biological 
membranes. Since this model deals with the mechanisms of membrane 
compartmentalization, it seems appropriate now to review the current models of 
biological membrane organization and structures (see below).
1.8 Membrane domain: general considerations
The delimiting membrane of intracellular organelles is composed of proteins 
and lipids. While the latter confers mechanical stability and tendency to form 
closed structures, proteins ensure functional specificity and regulate the different 
biochemical reactions each organelle is performing. Several lines of evidence 
suggest that proteins and lipids do not randomly distribute within the plane of the 
membrane but rather aggregate and organize into compact regions or membrane 
domains (Simons and Ikonen, 1997; Sprong et al., 2001). In this context, the term 
domain bears no information about size, but just defines a membrane area of a 
given biochemical composition, which differs from its immediate neighbouring 
environment. With the term microdomain I refer to an area in the order of tens of 
nanometers in diameter.
It is now clear that the fluid mosaic model, proposing that lipids function as 
neutral solvents having little influence on protein function and distribution, is in 
contradiction with the most recent advances in membrane biology research.
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Membrane lipids have indeed been shown to exist in different phases of fluidity 
ranging from gel, liquid-ordered and liquid-disordered states (Brown and London, 
1998). Transition between these different phases might be achieved by different 
mechanisms. One such mechanisms is based on lateral interaction between lipids, 
such as cholesterol and sphingolipids, which can lead to phase separation in 
biological membranes. These lipid microdomains, also named rafts, form distinct 
liquid-ordered phases within the more fluid liquid-disordered surrounding matrix 
(Simons and van Meer, 1988). Lipid rafts are localized in the exoplasmic leaflet of 
several cellular membranes and play a key role in protein sorting and signal 
transduction (Simons and Toomre, 2000). While formation of rafts is mainly 
based on lateral interaction between lipids, protein-lipid and protein-protein 
interactions are the basis for the assembly of other membrane domains such as 
Rab-domains (see also previous section). Lipid modifying enzymes can be 
recruited to specific areas of the membrane and create homogenous lipid 
environments based on their specific enzymatic activity. These lipids act as 
targeting signals for the recruitment of effector proteins containing corresponding 
lipid-binding domains. A network of protein-protein interactions and 
oligomerization is then envisaged to stabilize the components of these membrane 
domains and impeding their diffusion in the bilayer (Gruenberg, 2001; 
Miaczynska and Zerial, 2002; Zerial and McBride, 2001).
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Combinations of various domains with different biophysical properties will 
likely determine the shape and function of cellular organelles. According to this 
view, the multitude of functions each organelle is performing would therefore be 
topologically organized into distinct domains and regulated through the 
recruitment of cytosolic proteins. This model is in agreement with morphological 
studies showing organelles, along both the biosynthetic and endocytic pathway, to 
be composed of functionally and structurally distinct territories. Moreover, the 
subcompartmentalization of intracellular organelles also provides an explanation 
for how multiple reactions can occur at the same time and with high efficiency 
without compromising the integrity of the whole organelle. Indeed, intracellular 
organelles communicate via extensive tubulo-vesicular traffic, and still maintain 
their distinct membrane composition. This implies that proteins and lipids are 
laterally segregated and specifically incorporated in one set of transporters and 
excluded from others. Proteins may be sorted differentially via targeting motifs 
within the amino acid sequence or via their preference to associate with specific 
lipid domains. Lipids are sorted depending on their structure and capability for 
inserting into nascent vesicles or tubules as they bud off from an organelle 
(Sprong et al., 2001).
5 6
1.8.1 Membrane domains in endocytic organelles
Endosomes are a good system to study the organization of membrane 
domains. Different lipid domains are indeed differentially distributed between 
sorting, recycling and late endosomes (Gruenberg, 2001; Miaczynska and Zerial,
2002). The complex geometry of sorting endosomes is a clear example of how 
multiple and functionally distinct membrane regions associate into an organelle 
(Marsh et al., 1986). The cisterna-vacuolar portion acts as a fusion-competent 
region for clathrin-coated vesicles derived from the plasma membrane or TGN, 
while tubular extensions mainly function in receptor sorting and recycling 
(Gruenberg and Maxfield, 1995; Mayor et al., 1993). The lipid composition of 
these regions has also started to be characterized. At least one lipid, 
phosphatidylinositol-3-phosphate PI(3)P, is enriched in the cisterna vacuolar 
region, and depleted from recycling tubules (Gaullier et al., 2000). The function of 
this membrane domain and the role of Rab5 in its biogenesis has been described in 
the previous section. Another phosphoinsitide PI (4,5)P2 is instead localized to 
specific region of the plasma membrane and plays an essential role in the 
formation, budding and uncoating of CCVs (lost et al., 1998). Whether this and 
other forms of phosphoinsitides PI(3,5)P2, PI(3,4)P2 and PI(3,4,5)P3 are also 
present on endosomes remains to be established.
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Purification of recycling endosomes allowed analysis of its proteins and 
lipid contents. Local enrichment of cholesterol, sphingomyelin as well as 
phosphatidylserine suggests that these organelles are enriched in raft components 
(Gagescu et ah, 2000). The first function attributed to these microdomains was to 
regulate protein sorting in the biosynthetic pathway. It is now clear that rafts 
regulate multiple aspects of vesicular trafficking in both the biosynthetic and 
endocytic pathway. As some signal transduction molecules also localize to plasma 
membrane rafts, it is likely that these microdomains play a key role also in 
signalling and differentiation (Simons and Toomre, 2000).
The exact function of lipid rafts in the endocytic-recycling pathway is 
however still elusive. Disassembly of raft microdomains through cholesterol 
depletion specifically interferes with the recycling rate of raft-associated proteins, 
such as GPI anchored proteins, but not of transferrin receptor (Chatterjee et al., 
2001; Mayor et al., 1998). This observation suggests a role of raft microdomain in 
endocytic sorting and recycling of a subset of proteins. Recently an additional 
function of lipid rafts in actin-membrane interaction has been proposed. 
Sphingolipid-cholesterol membrane lipids were identified in vesicles of both the 
biosynthetic and endocytic pathway as preferential sites for actin recruitment and 
polymerisation, implying a role of lipid rafts also in actin-mediated vesicular 
movement (Rozelle et al., 2000).
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In contrast to early endosomes, late endosomal membranes contain abundant 
internal membranes within their lumens, hence the name multi vesicular 
endosomes or multilamellar bodies. Proteins and lipids differentially distribute 
within the multivesicular system of these organelles indicating the existence of 
separate membrane domains (Griffiths et al., 1988). Highly glycosylated 
membrane proteins such as lampl and lamp2 localize exclusively to the external 
membranes, whereas down-regulated EGF receptor, MHC class II or the 
IGF2/MPR receptor distribute preferentially within internal membranes (Felder et 
al., 1990). The reasons for this differential distribution is not yet clear but the fact 
that all these proteins are found on internal membranes, and have in common the 
capacity to traffic between TGN, plasma membrane and late endosomes, suggests 
a role in protein sorting.
The lipid composition of late endosomal membranes also differs from  the 
one of early endosomes. Late endosomes are poor in free cholesterol, 
sphingomyelin and phosphatidylserine and enriched in neutral lipids such as 
triglycerides and cholesterol esters. An unusual poorly degradable phospholipid, 
Lysobisphosphatidic acid (LBPA) has been recently identified to be eniiched in 
the internal membranes of late endosomes. Antibodies against this lipid b lock  
trafficking of IGF2/MPR, indicating LBPA enriched lipid domains are im olved in 
protein sorting within the endosomal system (Kobayashi et al., 1998).
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The localization of some members of the annexin protein family to 
endosomal membranes probably reflects the existence of other membrane 
domains. Indeed, annexins are lipid and Ca++ binding proteins involved in 
membrane structure and dynamics (Kobayashi et al., 1998). In vitro experiments 
using protein-free liposomes of proper lipid composition showed that upon 
membrane binding, annexins have the property to self assemble and to organize 
the liposomes surface into regular area or annexin domains. Consistent with this 
observation, Annexin II distributes in a non-random manner on early endosomes 
and is concentrated in morphologically distinct regions (Harder et al., 1997; 
Harder and Simons, 1997). The precise function of Annexin II is not known but 
this protein seems to be involved in early endosome membrane dynamics via 
interaction with proteins of the cortical actin cytoskeleton. An additional function 
in endosome fusion and formation of MVB has also been recently proposed 
(Gruenberg, 2001).
Although the association of annexin II with membranes is cholesterol- 
dependent, this protein is depleted from recycling endosomes, whereas cholesterol 
is enriched on these membranes. This suggests the requirement of additional 
targeting determinants for annexin II membrane binding (Kobayashi et al., 2001).
Further work will be required to better define the biogenesis and function of 
those as well as other not yet identified membrane domains. For example, by
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analogy to Rab GTPases, also Arf GTPases might form distinct membrane 
domains through the recruitment of lipid modifying enzymes such as PI(4)P 5- 
kinase and phospholipase D. The products of these enzymes might indeed create 
a suitable lipid environment for recruitment of the many multi-protein complexes 
required for vesicular budding to occur.
Having described the structural and functional organization of endocytic 
organelles and, in the previous paragraphs, the general principles underlying 
membrane transport among intracellular compartments, in the next section, I will 
focus in more detail on the molecular mechanisms regulating the endocytic- 
recycling pathway.
1.9 Molecular regulation of endocytic sorting and recycling
Very little is known about the molecular regulation of the endocytic- 
recycling pathway and the principles underlying protein and lipid sorting within 
endocytic organelles are still under investigation. Endocytic sorting occurs 
primarily in tubulo-vesicular and cisternal elements, usually referred to as sorting 
endosomes, and it can be illustrated by transferrin, which recycles bound to its 
receptor and LDL, which dissociates from the LDLR and is delivered to 
lysosomes (Gruenberg and Maxfield, 1995; Mellman, 1996). It has been proposed 
that the physical structure of these organelles is the basis for a simple sorting
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mechanism based on geometrical principles (Marsh et aL, 1986; Dunn et al., 1989; 
Linderman and Lauffenburger, 1988). M em branes and solutes would 
stochastically partition between tubules (60 nm in diameter, 3-4 jim in length) and 
vacuoles (0.3-0.4 |im  in diameter), because of the different surface-to-volume 
ratios of these two structures (Dunn et al., 1989). Acid-released ligands dissociate 
from their receptors because of the low pH (6.0-6.2) found in this compartment 
and accumulate in the large vacuolar part, which will presumably form a MVB. In 
addition, specific sorting signals would ensure retention of receptors destined for 
degradation into the vacuolar region (Felder et al., 1990; Johnson and Komfeld, 
1992; Johnson and Komfeld, 1992), while recycling receptors would be passively 
incorporated into tubules. These tubules would then pinch off or serve as sites for 
budding of carrier vesicles involved in receptor recycling. Recycling components 
can return directly from sorting endosomes to the plasma membrane via a fast 
recycling route (Mayor et al., 1993; Schmid et al., 1988) or can take a slow 
recycling pathway via peri-nuclear recycling endosomes (Hopkins, 1983; 
Yamashiro et al., 1984).
Several lines of evidence support the hypothesis that recycling of 
membrane proteins can occur in the absence of any specific sorting signal. First, 
transferrin receptor mutants with complete deletion of their cytoplasmic tails 
recycle at equal rates as wild-type receptors or certain lipid analogues (Mayor et
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al., 1993; Mukherjee et al., 1999). These results indicate that at least this receptor 
follows the bulk of membrane recycling. Recently, it has been shown that lipids 
can be differentially sorted to late or recycling endosomes solely on the basis of 
their different biochemical properties (Mukherjee et al., 1999). As recycling 
tubules are particularly enriched in lipid rafts they may represent a differentiated 
membrane domain capable of concentrating receptors in an adaptor-independent 
fashion.
However, tubules in the early endosome system have been found to contain 
clathrin coats that are devoid of a -  adaptins, implying that these are different from 
plasma membrane-derived coated vesicles (Stoorvogel et al., 1996). These buds 
contain TR and are quite numerous on peripheral sorting endosomes indicating 
that they may function in recycling to the plasma membrane. The first, although 
indirect evidence, in support of a role of coat proteins in endosomal function came 
from experiments using the fungal metabolite Brefeldin A. This drug has been 
shown to inhibit transport from the ER to the Golgi compartment by interfering 
with the assembly of coatamer-containing coat complexes (Doms et al., 1989; 
Pelham, 1991). Treatment of cells with BFA causes extensive tubulation of the 
early endosomal compartment analogous to the effects on Golgi membranes 
(Lippincott-Schwartz et al., 1991). Although BFA did not block endocytosis or 
recycling per se, it did interfere with polarised recycling of transferrin receptor to
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the basolateral surface of MDCK cells (Putter et aL, 1998). The observation that in 
this cell line transferrin receptor is concentrated in endosomal clathrin-coated buds 
containing y-adaptin, and that these buds disassemble upon BFA treatment, 
suggests that AP-1 clathrin-coated vesicles function in polarised recycling (Putter 
et al., 1998). BFA is known to inhibit GDP-GTP exchange factors for the ARF 
subfamily of small GTPases. As such, its effects might be directly or indirectly 
related to defects of Arf-dependent coat complex assembly. Arf6 has been 
localized to early endosomes and shown to regulate transferrin recycling. Over­
expression of a GDP-bound inactive mutant causes accumulation of non clathrin- 
coated domains on tubular structures and inhibits transferrin recycling (D’Souza- 
Schorey et al., 1995). However, it seems that Arf6 is BFA-insensitive and 
therefore the possibility remains that other family members or other regulatory 
molecules are the target of BFA.
Rab proteins and SNARE molecules also function in the recycling 
pathway. The v-SNARE cellubrevin and t-SNARE syntaxinlS have been shown 
in an in vitro assay to be required for transferrin recycling, although their precise 
site of action remains to be established (Galli et al., 1994; Prekeris et al., 1998). 
Also, very little is known about the mechanisms of action of Rab4, Rab 11 and 
Rab5 and which step along the endocytic-recycling pathway they regulate. Rab4 
has been proposed to regulate an early sorting event as its over-expression inhibits
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iron discharge from transferrin and causes redistribution of transferrin receptor 
from the endosomes to the plasma membrane. Rab4 over-expression also 
stimulates the recycling of internalized fluid phase marker, further pointing to 
defects in endosomal sorting (van der Sluijs et al., 1992). Interestingly, the Rab5 
effector, RabaptinS, was shown to interact also with Rab4 (Vitale et al., 1998). As 
these two GTPases exert complementary function in regulating entry in, and exit 
out, of sorting endosomes, it was proposed that Rabaptin5, by interacting with 
both Rab5 and Rab4, might contribute to maintaining organelle homeostasis.
Over-expression of dominant negative mutant of Rab 11 selectively 
inhibited the slow recycling pathway, consistent with its localization to peri­
nuclear recycling endosomes (Ullrich et al., 1996). The Rab 11 effector, Rabphilin 
has been shown to interact with the mammalian homologue of the yeast Sec 13, a 
component of COP II, suggesting a potential link between this GTPase and coated 
vesicle formation and/or targeting (Mammoto et al., 2000).
The phosphatidylinositol 3-kinases are a family of lipid kinases involved in 
several vital processes including signal transduction and membrane trafficking. 
These kinases phosphorylate the 3-position of the inositol ring on 
phosphoinositides (Stenmark and Aasland, 1999). PI-3 kinases have been found to 
regulate various steps in endocytic trafficking. These effects were initially 
discovered by using wortmannin, a fungal metabolite, which binds to and inhibits
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the catalytic subunit of this enzyme. Wortmannin causes a significant down- 
regulation of cell-surface transferrin receptor resulting from increased 
internalization and decreased recycling rates (Spiro et al., 1996). In mammals 
there are three classes of PI-3 kinases displaying different substrate specificity and 
regulatory proprieties. The Class I, hVsp34 and p85-Pl lO^complex has been 
shown to interact with Rab5 and to regulate endosome fusion (see previous 
section) (Christoforidis et al., 1999). The molecular mechanisms whereby 
transferrin recycling is inhibited upon wortmannin treatment are not known. 
Presumably, one of the PI phosphorylated derivatives regulates the recruitment of 
lipid binding proteins whose activity is required for recycling.
Wortmannin was also shown to block traffic between early and late 
endosomes (Femandez-Borja et al., 1999). Transport between these compartments 
is mediated by relatively large vesicles (0.4-0.5 \xm in diameter), which have a 
typical m ultivesicular appearance (endosomal carrier vesicles EC Vs or 
multivesicular bodies MVB). Once formed on early endosomes, EC Vs move 
along microtubules until they dock and fuse with late endosomes (Aniento et al., 
1993; Gruenberg et al., 1989). PI(3)P has been specifically localized to discrete 
patches on the surface of sorting endosomes as well as on the internal membrane 
of MVB, but it is absent from late endosomes. This suggests that it is either 
modified or degraded (Gaullier et al., 2000). Recently, it has been proposed that
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PI(3)P is necessary to promote inward budding of the limiting membrane of the 
endosomal vacuolar portion to generate the multivesicular regions (Femandez- 
Borja et al., 1999). This model is supported by the observation that wortmannin 
blocks MVB formation and causes vacuolation of sorting endosomes.
As already mentioned, retention of transmembrane proteins in the vacuolar 
region and their subsequent incorporation into multivesicular bodies, is a signal- 
dependent process. In vitro and in vivo studies have shown that some components 
of the COP-I coat complex, known to regulate the early secretory pathway, play a 
role also in endocytosis. For example, down-regulation of Nef-CD4 complex is in 
part mediated via direct interaction of Nef with pCOP (Piguet et al., 1999). 
Recmitment of COP components to endosomes is pH-dependent and in vitro 
formation of ECV is both pH and COPI dependent. In the biosynthetic pathway, 
COPI recmitment requires Arf 1 and PLD activity. Arf 1 is also required for COPI 
recmitment to endosomes, whereas PLD activity is not (Gu and Gmenberg, 2000). 
Additional evidence for a role of COPI components in transport from early to late 
endosomes are also provided by studies in a temperature-sensitive 8-COP mutant 
cell line. At the non-permissive temperature transport from sorting endosomes to 
late endosomes was impeded and this defect could be rescued by over-expression 
of wild type 8-COP (Daro et al., 1997).
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More recently, the ubiquitin system has been shown to act not only to 
target cytosolic proteins for degradation by the proteosomes, but also to target 
internalized receptors to late endosomes. Ubiquitin was first implicated in the 
regulation of endocytosis of a number of yeast plasma membrane proteins, 
including transporters and signalling receptors (for review see Bonifacino and 
Weissman, 1998; Wendland et al., 1998). Ubiquitination of these proteins was 
shown to be required for their inclusion into primary endocytic vesicles budding 
from the plasma membrane. Subsequently, studies performed in mammalian cells 
on activated growth factor receptors suggested an additional role for ubiquitin in 
controlling sorting into MVBs (Levkowitz et al., 1998). More recently, 
experiments performed in yeast have further strengthened this idea. Ubiquitination 
of the cytoplasmic tail of carboxypeptidease S (CPS), a vacuolar hydrolase, was 
shown to be required for the entry of this enzyme into MVBs. Moreover, addition 
of the CPS ubiquitination site to a vacuolar membrane protein, which is normally 
not sorted into MVBs, resulted in targeting of the chimera protein into MVBs 
(Katzmann et al., 2001). Also in agreement with these studies is the finding that in 
yeast mutant cells, which have reduced levels of free ubiquitin, sorting of two 
other membrane proteins (the polyphosphatase Phm5p and a presumptive haem 
oxygenase, Ylr205p/Hmxlp) into MVBs was also impeded (Reggiori and Pelham,
2001). However, the function of ubiquitin in membrane transport is not only
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limited to regulate cargo sorting in the endocytic pathway. At least in yeast, 
ubiquitin was shown to regulate cargo sorting also in the secretory pathway at the 
level of the TGN (Beck et al., 1999; Helliwell et al., 2001). Therefore, ubiquitin 
regulates cargo sorting at the plasma membrane, late endosomes and at TGN. The 
mechanisms the cell uses to recognize and sort cargo-carrying ubiquitin signal are 
still poorly understood. The observation that, at least in some cases, adaptor 
complexes are not required for internalization of ubiquitinated receptors (D'Hondt 
et al., 2000), and that in yeast (where most proteins are endocytosed by ubiquitin 
signals) adaptors are not required for internalization, suggests an adaptor-like 
function for ubiquitin in linking cargo to the endocytic machinery. This hypothesis 
is supported by the finding that many members of the basic endocytic machinery 
(epsin, Eps 15) and proteins involved in the MVBs pathway (HRS, Vps27) 
contain a conserved peptide sequence, which can bind to ubiquitin (Hofmann and 
Falquet, 2001).
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1.10 Aim of the thesis
1.10.1 Topic
The objective of the work described in this thesis was to study the 
molecular machinery responsible for controlling transport in the endocytic- 
recycling pathway. The molecular principles underlying the regulation of this 
pathway are largely uncharacterized, owing to the poor definition of compartment 
boundaries of the organelles constituting this pathway and lack of regulatory 
molecules. Defining the limits of this system and identifying its regulatory 
mechanisms are therefore of considerable interest, especially if considering the 
important functions in which this pathway is involved.
1.10.2 Question
Endocytosis and recycling can be viewed as two directionally opposite 
membrane transport reactions ending in, and starting from, early endosomes, 
respectively. Membrane flow in and out of these organelles must be co-ordinated 
to maintain the structural and functional homeostasis of these organelles and to 
ensure sequential transport of cargo along the endocytic-recycling pathway. How 
is import to, and export from, early endosomes co-ordinated? To answer this 
question it is necessary to identify and functionally characterize the molecules
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involved in these processes. To this aim, I have been focusing on Rab5, Rab4 and 
R ab ll. These three GTPases have been previously localized to early and recycling 
endosomes and have been implicated in the regulation of the endocytic-recycling 
pathway. Moreover, recent data suggest that Rab proteins play a key role in 
organelle biogenesis and in specifying organelle identity. Therefore, the study of 
their mechanisms of action is expected to give important insights towards the 
problem that I decided to address in this thesis.
1.10.3 Hypothesis
The finding that one of the Rab5 effectors, Rabaptin-5, interacts also with 
Rab4 suggests the presence of a molecular cross-talk between these two GTPases. 
Given the complementary role of Rab5 and Rab4 in regulating entry in, and exit 
from, early endosomes, this molecular cross-talk may be part of a mechanism 
which higher eukaryotes have evolved to co-ordinate endocytosis and recycling. 
According to the hypothesis (which I will refer to as the Rab domain hypothesis) 
proposed by Zerial and co-workers, Rab proteins and their effectors are not 
randomly distributed within the plane of the membrane, but rather self-organize 
into macromolecular complexes, so called Rab domains (see paragraph 1.7.5). In 
this view Rab5 recruits its effectors, several of which being key components of 
endosome tethering and fusion, into a defined region constituting the site of entry
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into early endosomes. If generalized to other family members, this model would 
predict that Rab proteins regulating membrane recycling and their effectors should 
be localized to domains on early endosomes distinct from the one occupied by 
Rab5. The partitioning of these regulatory machineries into different membrane 
sub-compartments would allow multiple reactions to occur simultaneously and 
with high efficiency, whilst little or no intermixing between its regulatory 
elements would occur. In this context the function of divalent Rab effectors, such 
as Rabaptin-5, may be to regulate the association between different domains (in 
this specific case Rab5 and Rab4 domains) to allow the sequential flow and 
efficient distribution of cargo from one domain to another. To test this hypothesis 
three complementary approaches were undertaken.
1.11 Experimental strategy
(A) An in vitro assay was developed to reconstitute and measure the 
endocytic-recycling pathway in SL-O-permeabilized cells with the aim of 
gaining a molecular understanding of this process.
(B) An in vivo system based on a combination of cell transfection assays and 
light microscopy techniques was developed with the aim of studying the role 
of Rab proteins and their effectors in the membrane organization of the
72
endocytic-recycling pathway. This system also offers the opportunity to study 
in vivo the function of these molecules in the endocytic-recycling pathway.
(C) Having established these two assays, I went on to characterize the function 
of Rab GTPases by searching for their downstream effectors using an affinity 
chromatography approach. The role of these effectors in the endocytic- 
recycling pathway has been further characterized using both in vivo as well as 
in vitro assays.
1.11.1 The marker followed to study the endocytic-recycling pathway
To study the endocytic-recycling pathway I followed the intracellular 
trafficking of the iron binding protein Transferrin (Tf). Tf is a well-established 
marker for monitoring endocytic-recycling trafficking because it remains 
associated with its receptor until it returns to the plasma membrane. Upon 
internalization, Tf is delivered to early endosomes where the bound iron is 
released. From these organelles, Apo-Tf (iron-free) can return directly to the 
plasma membrane via a “fast” recycling route or can take a “slow” recycling 
pathway passing through peri-nuclear recycling endosomes. Given that Apo-Tf 
dissociates from its receptor at the neutral pH of the extracellular medium, the 
release of previously internalized T f can be used to monitor the endocytic- 
recycling of transferrin receptor.
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1.11.2 The cell line
The cell line selected for the vast majority of the experiments conducted in 
this thesis was the human epithelial cell line (A431) derived from a vulval 
carcinoma. The reasons for this choice are several-fold. First, the membrane 
compartments involved in the endocytic-recycling pathway have been extensively 
studied in these cells. A detailed morphological analysis and kinetic measurements 
of the endocytic-recycling transport of transferrin receptor which was conducted 
in these cells led to the first description of peripheral early endosomes and peri­
nuclear recycling endosomes (Hopkins, 1983). Therefore, the conditions and the 
criteria to identify early endosomes and peri-nuclear recycling endosomes are well 
established in this cell line. Applying these very same criteria to identify these 
organelles in other cell types may generate several problems. The morphology, the 
topology and the kinetics of transport of recycling markers through these 
organelles are indeed cell type specific. Given that the molecular definition of 
early and recycling endosomes is still very preliminary and that part of the aim of 
this thesis was to molecularly characterize these organelles, I considered it 
opportune to use A431 cells as a cellular system. Second, experiments conducted 
in the laboratory have established that, compared to other cell lines such HeLa or 
CHO, A431 cells are more resistant to the toxic side effects of SL -0 (which
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causes detachment from the solid support on which adherent cells are grown). 
Third, A431 cells express high level of transferrin receptor and thus avoid the 
need for its over-expression to follow the endocytic-recycling trafficking of 
transferrin.
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2 RESULTS
2.1 Introduction to results (part-1)
Many membrane trafficking steps have been reconstituted in cell-free and 
semi-intact cellular systems. These assays turned out to be powerful tools to study 
the molecular regulation of intracellular transport. To determine the molecular 
requirement for endocytic-recycling transport, this pathway has been reconstituted 
in semi-intact cells permeabilized with the pore-forming toxin streptolysin-0 (SL- 
O). This toxin binds to cholesterol in the plasma membrane and, upon self­
polymerisation, it creates openings (about 30 nm in diameter), through which 
endogenous cytosolic components can be washed out and /or exogenous 
molecules can be introduced into the cells. The goal of the experiments described 
below was to establish conditions that would make transferrin recycling in SL-0 
permeabilized cells dependent upon the addition of exogenously added cytosol. 
This experimental set-up offers the opportunity to manipulate the molecular 
compositions of the exogenous source of cytosol and thus to establish the 
molecular requirement for endocytic-recycling. In addressing this point I focused 
on the Rab machinery with the aim to test the hypothesis that the function of Rab5 
and Rab4 in the endocytic-recycling pathway is molecularly co-ordinated.
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2.2 In vitro reconstitution of the transferrin recycling pathway in SL-O- 
permeabilized cells
SL-0 can be used to selectively permeabilize the plasma membrane 
without damaging intracellular organelles by first allowing it to bind to the plasma 
membrane at 4°C and then, after extensive washes, warming the cells to 37°C. At 
this temperature the toxin polymerizes and forms pores. Using this protocol, the 
toxin concentration allowing efficient permeabilization with minimal cellular 
toxicity was established by monitoring the release of a cytoslic enzyme such as the 
lactate dehydrogenase (LDH). Optimal toxin concentrations were defined as those 
required for releasing 60% of the total cellular content of LDH in 20 minutes 
(Ikonen et al., 1995). This criteria was followed to determine the SL -0  
concentration required to permeabilze A431 cells grown on glass coverslips 
(Figure7A). Under the established conditions no major morphological alterations 
of the early endosom al com partm ent were detected as shown by 
immunofluorescence staining with antibodies against transferrin receptor or BEAl 
(Figure 7 B-E).
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Figure 7: Release of cytosolic LDH with increasing concentration of SL-O (A) and 
immuno fluorescence microscopy analysis of cell treated with SL-O (B-D)
(A) A431 cells grown on glass coverslips were treated in a final volume of 80 pi with 
increasing concentration of SL-O. After removing excess toxin, cells were incubated at 
37 °C for 20 minutes and the amount of LDH released was measured and expressed as 
percent of the total cellular LDH. Data represent means ± SEM from three independent 
experiments performed in duplicate.
(B-E) A431 cells non-treated (B-C) or treated with 8pg/ml SL-O (D-E) were fixed and 
incubated with antibodies against transferrin receptor or EEA l, followed by FITC- 
labelled secondary antibodies. Samples were analyzed using fluorescence microscopy. 
To ensure that cells were efficiently permeabilized by SL-O, no detergent was used in the 
antibody labelling protocol (D-E). Scale bar represents 5 microns.
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To follow transferrin recycling, rhodamine-transferrin was internalized for
30 minutes prior to SL- O permeabilization. Next, A431 cells were allowed to bind 
SL-0 for 10 minutes at 4° C, toxin excess was removed by ice-cold washes and 
cells were incubated for 3 minutes at 37° C to allow pore formation. Cells were 
then returned to ice and the endogenous cytosol was washed out by a further 20 
minutes incubation at 4° C. This procedure allows cytosol diffusion while 
transferrin recycling is blocked because of the low temperature. Recycling was 
subsequently allowed to commence by raising the temperature once more to 37°C
for 30 minutes with different reagents added to the incubation (see Figure 8).
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Figure 8: Schematic representation of the in vitro reconstituted transferrin recycling 
assay
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As shown in Figure 9, only when cells were incubated with exogenous
cytosol and an ATP regenerating system, recycling could be observed as
demonstrated by the loss of intracellular rhodamine-transferrin signal.
30’ labelling with Rh-Tfn 30’ Recycling + Cyt + ATP 30’ Recyling -Cyt -ATP
Figure 9: Fluorescent transferrin recycling assay in SL-O-permeabilized cells.
A431 cells grown on glass cover slips were loaded with rhodamine transferrin for 30 
minutes, permeabilized with SL-O and either fixed (A) or incubated for a further 30 
minutes at 37 °C with cytosol and ATP regenerating system (B) or buffer alone (C). 
Samples were fixed and analyzed using fluorescence microscopy. Scale bar represents 5 
microns.
Recycling was specific for transferrin receptor since co-intemalized EGF, a
tracer for late endosomal transport, was retained intracellularly (Figure 10). These 
results show that SL-0 permeabilization does not significantly alter the sorting 
and recycling function of early endosomes and thus validate the use of this assay
to study endocytic-recycling.
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Chase FITC-Tfn Rh-EGF Overlay
Figure 10: EGF is retained intracellularly in SL-O-permeabilized cells.
A431 cells grown on glass cover slips were loaded with FITC- transferrin for 30 minutes 
(A), or Rhodamine FGF (B), permeabilized with SL-O and either fixed (A-B) or 
incubated for a further 10 minutes (D-F) or 40 minutes (G-H) at 37 °C with cytosol and 
ATP regenerating system. Samples were fixed and analyzed using fluoreseence 
microscopy. Scale bar represents 5 microns.
In order to b io ch em ica lly  quan tify  tran sfe rrin  recy c lin g  in S L -0
perm eab ilised  cells, b io tin y la ted -tran sfe rrin  w as in te rn a liz ed  in s tead  o f 
rhodam ine-transferrin and recycling was quantified as described in the m ethods 
(see section 4.7). Upon the addition of cytosol and energy, perm eabilized cells 
could recycle as much as 60% of the total internalized transferrin w hereas cells 
incubated with buffer alone, could only recycle 20%. Im portantly , transferrin  
recycling was tim e- and tem perature-dependent and its kinetics resem ble those
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observed in intact cells. Recycling was, however, never complete, even at higher 
cytosol concentrations or after longer incubation times (Figure 11, 12). This is not 
surprising, as in general all in vitro reconstituted transport assays are not as
efficient as the corresponding reactions in vivo.
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Figure 11: Biochem ical quantification of transferrin recycling in SL-O- 
permeabilized cells.
A431 cells grown on glass cover slips were loaded with 10 pg/ml of biotinylated- 
transferrin for 30 minutes, permeabilized with SL-0 and incubated for the indicated time 
points with the indicated reagents. Intact indicates cells non-permeabilized. Data 
represent means ± SEM from three independent experiments performed in duplicate.
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Figure 12; Reconstituted transferrin recycling is dependent on the concentration of 
exogenously added cytosol.
A431 cells grown on glass cover slips were loaded with 10 |ig/ml of biotinylated- 
transferrin for 30 minutes, permeabilized with SL-0 and incubated for 30 minutes with 
the indicated concentrations of cytosol. Intact cells are non-permeabilized cells. Buffer 
indicates cells incubated only with buffer and without cytosol. Data represent means ± 
SEM from three independent experiments performed in duplicate.
Next, to verify w hether the in vitro reconstituted transferrin recycling was
really due to fusion of transport interm ediates with the plasm a m em brane and not 
due to leakage of small intracellular vesicles through the perm eabilized plasm a 
m em brane, tw o com plem entary  control experim ents w ere perform ed. First, 
following the 30 minutes recycling time point, the medium was collected and was 
spun for Ih at 100 000 X g. As shown in Figure 13 A, 85% of the biotinylated- 
transferrin  counts released  from  perm eabilized  cells w ere recovered  in the
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supernatant, indicating that the bulk of recycled transferrin was soluble and not
membrane bound. Furthermore, as estim ated by W estern blotting the total am ount 
of transferrin receptors rem ained constant throughout the tim e-course o f recycling 
(F igurel3  B), indicating that the loss of intracellular signal is not due to vesicle
leakage.
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Figure 13: transferrin recycling in SL-O permeabilized cells is not due to vesicle 
leakage.
(A) A431 cells loaded with 10 pg/ml of biotinylated- transferrin were permeabilized with 
SL-0 and incubated for 30 minutes with cytosol and ATP regenerating system in a final 
volume of 80 pi. Thereafter, the medium containing the recycled biotinylated transferrin 
was collected and either processed direetly for quantification or spun for Ih at 100 000 X 
g before quantification.
(B) Western blot analysis of SL-O-permeabilized cells with anti-transferrin receptor 
antibodies. Cells were treated as in A and at the end of the 30 minutes reeyeling time 
point, the medium was discarded and eells were lysed into 200 pi of SDS-PAGF loading 
buffer and processed for Western blot analysis as deseribed in the methods. 1= non 
permeabilized cells; 2 -  permeabilized cells at time 0 of reeyeling; 3= permeabilized cells 
after 10 minutes of recycling; 4= permeabilized cells after 30 minutes of recycling.
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2.3 Rab GDI inhibits transferrin recycling in SL-O-permeabilized cells
Various Rab proteins have been implicated in the regulation of transferrin 
recycling. However, in no case has a direct functional requirement been 
demonstrated. To address this point, I tested whether transferrin recycling in SL-0 
permeabilized cells is sensitive to RabGDL RabGDI has the dual function of both 
delivering and extracting Rab proteins to and from their resident membranes. 
These two functions depend on the concentration of free RabGDI versus RabGDI 
complexed to Rab proteins. If permeabilized cells or purified organelles are 
incubated with an excess of RabGDI, this molecule will extract endogenous Rab 
proteins from the organelle where they localize. However, if RabGDI is 
complexed in an equimolar ratio with a given Rab protein, it will deliver that 
specific Rab protein to the appropriate organelle. It has been previously 
demonstrated that bacterially expressed RabGDI is functional. I therefore 
expressed RabGDI as histidine tagged fusion protein using an E.coli expression 
system and purified it over a nickel-nitrilotriacetic acid column as described in the 
methods (see section 4.12.2) (Figure 14A). As shown in Figure 14B, treatment of 
permeabilized cells with increasing concentrations of purified RabGDI 
increasingly inhibited the cytosol-dependent stimulation of transferrin recycling. 
Maximal inhibition was observed at a concentration of 5|liM.
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Figure 14: Recombinant RabGDI inhibits transferrin  recycling in SL-O- 
permeabilized cells.
(A) Histidine-tagged RabGDI was purified as described in methods.
(B) A431 cells loaded with 10 pg/ml of biotinylated- transferrin were permeabilized with 
SL-0 and incubated for 30 minutes with recombinant RabGDI at the indicated 
concentrations together with cytosol and an ATP regenerating system. Results are 
expressed as percent of inhibition of transferrin recycling after 30 minutes. 100% = 
transferrin recycling in the absence of RabGDI.
To verify whether under these conditions RabGDI effectively extracted 
Rab proteins from the membrane, SL-0 permeabilized cells were incubated with 
RabGDI and the membrane association of two Rab proteins (Rab5 and R ab ll)
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was estim ated by W estern blot analysis -transferrin receptor served as control-. 
Figure 15 shows that at 5|aM, the concentration of recom binant RabGDI required
to inhibit transferrin recycling, both Rab5 and R a b l l  were also quantitatively
rem oved from the m embrane.
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Figure 15: Recombinant RabGDI extracts Rab5 and R ab ll from the membranes in 
SL-O-permeabilized cells.
Recombinant RabGDI was incubated with SL-O-permeabilized cells for 30 minutes. 
Thereafter cells were extensively washed and solubilised in SDS-PAGE loading buffer. 
Samples were then processed for Western blot analysis using antibodies against 
transferrin receptor (TfnR) upper panel, R ab ll middle panel, Rab5 lower panel. Lane 1 = 
Intact cells (-SL-0) -+- 10 pM  RabGDI. Lane 2= SL-O-permeabilized cells -RabGDI. 
Lane 3= SL-O-permeabilized cells -f 5pM RabGDI. Lane 4= SL-O-permeabilized cells 
10 pM RabGDI.
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2.4 Rab 4 and R a b ll are required for transferrin recycling in SL-O 
permeabilized cells
The inhibitory effect of RabGDI, described in Figure 14 establishes that 
Rab proteins are required for transferrin recycling. As both Rab4 and R ab ll have 
been involved in the regulation of this pathway, I wished to test whether they were 
also functionally required. To perform this experiment, it was necessary to express 
these two GTPases in insect cells using the baculovirus expression system. This 
procedure ensures the appropriate post-translational m odification (i.e. 
isoprenylation), necessary for Rab protein membrane association. Rab4 and R ab ll 
cDNAs were cloned in frame with a N-terminal histidine-tag sequence into an 
appropriate vector and recombinant baculoviruses were constructed (see methods 
section). Isoprenylated Rab4 and R ab ll were purified by solublising total cellular 
membranes of infected cells and by passing the supernatant of the so obtained 
membrane homogenate on a Ni- column. Bound proteins were eluted, separated 
by SDS-PAGE and stained with Coomassie blue. As shown in Figure 16, this 
procedure yielded recombinant Rab proteins with a purity close to 90%. To be 
delivered to their correct target membrane compartment, Rab proteins need to be 
complexed to RabGDI. To that aim, prenylated and purified Rab4 or R ab ll were 
incubated together with RabGDI and the dimeric complexes were further purified 
by gel filtration chromatography to remove any free RabGDI (Figure 17).
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Figure 16: Histidine-tagged purified Rab4 and R a b ll expressed using the 
baculovirus expression system
Histidine-tagged Rab4 and R ab ll were expressed in insect cells and purified from total 
cellular membranes as described in the methods (see section 4.12.3).
H aving generated these tools I eould address the question w hether Rab4
and R abl 1 are required for transferrin recycling. To this aim, A431 cells labelled 
w ith b io tiny la ted -transferrin  w ere S L -0  perm eabilized  and incubated  w ith 
RabG D I for 20 m inutes at 30° C to rem ove endogenous Rab p ro te ins. 
Subsequently, cells were washed two times to remove RabGDI and ineubated for
a further 30 m inutes at 37° C w ith different reagents. As shown in Figure 18,
addition o f both  R abG D I:R ab4 and R abG D L R abl 1, bu t not R abG D I:R ab5
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complexes, could rescue the inhibitory effect of RabGDL The rescue, however, 
was not complete even though both Rab4 and R a b ll were added together, 
suggesting that either 1) the recombinant protein complexes were very partially 
active, or 2) that other(s) Rab protein(s) are also required. Possible candidates 
include R ab l5, which has also been implicated in the regulation of transferrin 
recycling. As no other functional assay to measure the activity of these complexes 
(e. g. recruitment of effector proteins) was available, I could not address this point 
further. Nonetheless, these experiments suggest for the first time that Rab4 and 
R ab ll are indeed required for transferrin recycling. Furthermore, the in vitro 
assay I developed could be a suitable system to further investigate the molecular 
requirement for Rab effectors in the endocytic-recycling pathway.
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Figure 17: Purification of Rab4- and Rab 11-RabGDI complexes by gel filtration 
chromatography.
Purified Rab4 (panel A) or Rabl 1 (panel B) were ineubated together with RabGDI for 10 
minutes at 30°C to allow Rab-RabGDI complex formation. The so-formed complexes 
were purified by gel filtration chromatography to remove any excess of RabGDI and 
unbound Rab4 or R ab ll. Lane 1= Rab4 (A), R ab ll (B). Lane 2= RabGDI. Lane 3= 
Rab4 -I- RabGDI (A), or R ab ll + RabGDI (B) before gel filtration chromatography. Lane 
4 = Rab4 -I- RabGDI (A), or R ab ll -f RabGDI (B) before gel filtration chromatography 
and after spinning for 10 minutes at 14000 Xg to remove any precipitate. Lanes 5-15= 
collected fractions from gel filtration chromatography. The fractions indicated with an 
arrow containing the Rab-RabGDI complexes were pooled and used in the subsequent 
experiments.
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Figure 18: Purified Rab4- and R abll-R abG D I complexes partially rescue the 
RabGDI inhibitory effect on transferrin recycling in SL-O-permeabilized cells.
A431 cells labelled with biotinylated transferrin and SLO-permeabilized were ineubated 
with the indicated reagents in the presence of cytosol and an ATP-regenerating system 
for 30 minutes. Results are expressed as percentage of biotinylated transferrin recycled 
into the medium after 30 minutes. Data represent means ± SEM from three independent 
experiments performed in duplicate.
2.5 Studies on the function of Rabaptin-5 using the in vitro reconstituted 
transferrin  recycling assay
Given the established function of Rab4 in regulating recycling, I further 
tested whether Rabaptin-5 is also required for endocytic-recycling. To address this 
point, cytosol im m uno-depleted o f this m olecule was prepared and tested for its
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com petency to support transferrin  recycling in S L -0  perm eabilized cells. As 
shown in Figure 19 cytosol im m uno-depleted of Rabaptin -5 supports transferrin 
recycling to the same extent as non-treated cytosol or cytosol treated w ith pre- 
immune serum.
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Figure 19: Rabaptin-5 immuno-depleted cytosol does not inhibit transferrin  
recycling in SL-O- permeabilized cells.
(A) Western blot analysis of HeLa cytosol immuno-depleted of Rabaptin-5. Lane l=non 
treated cytosol; lane 2= Rabaptin-5 immunodepleted cytosol; lane 3= cytosol treated with 
pre-immune serum.
(B) Transferrin recycling assay in SL-O-permeabilized cells using Rabaptin-5 immuno- 
depleted cytosol. Basal indicates recycling in the presence of non treated (control) 
cytosol. Data represent means ± SEM from three independent experiments performed in 
duplicate.
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These results do not necessarily exclude an involvement of Rabaptin-5 in 
endocytic-recycling. Indeed, a fraction of Rabaptin-5 remain associated with 
endosomes (Stenmark et ah, 1995) and might be unaffected by cytosol-washout. 
As Rabaptin-5 membrane binding is Rab5- dependent, treatment of SL-0 
permeabilized cells with RabGDI should result in the release of the endosome- 
associated pool. This is indeed the case as shown in Figure 20 A. This strategy 
offers the possibility to test once more the effect of Rabaptin-5 immuno-depleted 
cytosol on transferrin recycling having removed any endogenous source of this 
protein. More precisely, this experiment was performed in the following way: 
cells were labelled and permeabilized as usual, then they were incubated for 20 
minutes at 30° C with RabGDI and then recycling was started at 37° C by adding 
RabGDI:Rab4 complex and cytosol ± Rabaptin-5. However, with this approach as 
well no difference was measured between the different conditions (Figure 20B).
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Figure 20: Rab GDI treatment of SLO-permeabilized cells increases the extraction 
of Rabaptin-5 from the membranes.
(A) Western blot analysis of SL-O-permeabilized cells treated with RabGDI using, anti- 
Rabaptin-5 antibodies.
(B) Transferrin recycling assay in SL-O-permeabilized cells treated with RabGDI. 
Basal= + cytosol -i-ATP regenerating system. -i-GDI= 4-cytosol 4-ATP regenerating system 
-kRabGDI. 4-GDl4-Rab4= 4-cytosol -t-ATP regenerating system -t- pre-treatment with 
RabGDI+Rab4:RabGDI complex. 4-GDl4-Rab4-Rabaptin-5= as in 4-GDl4-Rab4, but in 
the presence of cytosol immuno-depleted from Rabaptin-5.4-GDl4-Rab4 pre-immune= as 
in 4-GDI-t-Rab4 in the presence of pre-immune cytosol. Data represent means ± SEM 
from three independent experiments performed in duplicate.
Altogether, these results have several interpretations: 1) the experimental 
conditions established did not reconstitute but by-passed the transport steps which 
requires the co-ordination between Rab5 and Rab4 and thus the activity of 
Rabaptin-5. This is possible since the protocol of membrane permeabilization and
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incubation times are such that transferrin may partially flow through peripheral 
recycling endosomes
2) Rabaptin-5 is not required for recycling and Rab4 regulates recycling through 
other effectors and independently from Rab5. 3) Rabaptin-5 is required for 
recycling but its immuno-depletion did not inhibit recycling because other 
proteins may perform a similar function.
On the basis of these considerations, I decided that the most important 
aspect to establish was the timing of action and compartmentalization of Rab5 and 
Rab4 in the endocytic-recycling pathway. Understanding this point may help in 
re-defining the experimental strategy required to address the co-ordination 
between the endocytic and recycling function of these two GTPases. In previous 
studies, Rab5 and Rab4 have been localized to early endosomes as indicated by 
their co-localization with the transferrin receptor (Bucci et al., 1992; Van Der 
Sluijs et al., 1991). However, not all the transferrin-receptor-containing structures 
harboured Rab5 or Rab4. Therefore, either these two GTPases are localized only 
to specific regions of the early endosomes or early endosomes are comprised of 
multiple populations. As these studies did not address directly the co-localization 
between Rab5 and Rab4, multiple scenarios could be envisaged: a) Rab5 and 
Rab4 localize to different endosomes; b) Rab5 and Rab4 localize to the same 
endosomes but in different membrane regions; c) Rab5 and Rab4 completely co-
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localize to the same endosomes. The situations described in a) and b) were 
consistent with a series of surprising findings made in our laboratory which led to 
the proposal of a novel working model for the function of Rab proteins. As 
discussed in detail in the Introduction (see paragraph 1.7.5), this hypothesis is 
based on the mechanism of action of Rab5 and postulates that this GTPase, 
through the recruitment of effector proteins, organizes a membrane domain 
defining the site of entry into early endosomes. This model would predict that Rab 
proteins regulating membrane recycling (for example Rab4 and R ab ll) should be 
localized to domains on early endosomes distinct from the ones occupied by Rab5. 
In the following section, I will describe the experiments conducted to address this 
hypothesis.
97
2.6 Introduction to results (part-2)
To get insight into the membrane compartmentalization of Rab proteins, I 
decided to perform a morphological analysis to visualize the trafficking of 
transferrin with respect to the endosomes where Rab4, Rab5 and R ab ll are 
localized. Although these three GTPases have already been localized to early 
(Rab4 and Rab5) and recycling (R ab ll) endosomes, their co-localization with 
each other has never been investigated. Moreover, as the co-localization of each of 
these GTPases with the transferrin receptor was shown to be partial and the 
compartment boundaries between early and recycling endosomes are still poorly 
defined, the membrane compartmentalization of these three GTPases is still an 
open issue. Firstly, do Rab5, Rab4 and R ab ll localize to different endosomal 
populations? And secondly, do they occupy distinct domains on the same 
endosome or are they uniformly distributed within the plane of the membrane? To 
address these questions 1 decided to develop an in vivo system which would allow 
visualizing the membrane distribution of Rab5, Rab4 and R a b ll on cargo 
(transferrin) filled endosomes. To this aim stable cell lines expressing each of 
these three GTPases as GFP (green fluorescent protein) fusion protein were 
generated and their sub-cellular localization was studied using confocal 
microscopy. In combination with post imaging processing techniques, this system 
also offered the possibility to measure the transferrin kinetics of transport through
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Rab5, Rab4 and Rabll-containing endosomes. This project was carried out in 
collaboration with two other members of the laboratory, Dr. Sonnichsen and Dr. 
Nielsen. In this thesis, 1 describe the experiments 1 have performed alone and 1 
only summarize the conclusion of the experiments conducted by my colleagues. In 
the following paragraphs, 1 explain in more detail the experimental strategy of the 
in vivo -localization assay.
2.6.1 Why the GFP tag ?
Tagging Rab5, Rab4 and R ab ll for sub-cellular localization was required 
because: 1) As yet, despite extensive efforts, no antibodies against Rab4, sensitive 
enough to detect the endogenous protein, have been generated, and 2) antibodies 
against Rab5 and R ab ll are difficult to work with, since they require time­
intensive affinity-purification and rapidly lose activity thereafter. GFP was chosen 
as a tag because its intrinsic fluorescent property allows studies of protein 
localization and dynamics in living cells. Moreover the fact that many GFP tagged 
proteins have been shown to behave indistinguishably from the WT-protein 
indicates that, in many cases, GFP interferes little with protein function in vivo. 
Indeed GFP chimeras have been successfully used to monitor cell migration, 
trafficking between organelles and many other cellular processes. Recently, GFP 
spectral variants (cyan fluorescent protein (GFP) and yellow fluorescent protein
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(YFP)) differing in their fluorescent excitation and emission spectra have been 
created, thereby offering the option of double labelling with two different 
coloured GFP fusion proteins. Altogether, these considerations prompted me to 
use the GFP-tag to visualize Rab4, Rab5 and R a b ll. To minimize possible 
interference with their functions, Rab5, Rab4 and R ab ll were tagged at their 
amino-terminal end as the Rab carboxy-terminal region (see Introduction) 
contains important determinants for Rab prénylation and localization. The cell line 
selected for these experiments was A431 for the reasons explained above (see 
section 1.11.2).
2.6.2 Why fluorescence microscopy ?
1 used epi-fluorescence and confocal laser scanning microscopy to study 
the sub-cellular localization of the GFP-constructs. Confocal microscopy allows 
analysis of multiple focal planes of the same specimen, ensuring high resolution in 
the z-direction. Thus it is a more appropriate technique than non-confocal 
microscopy to analyze endocytic organelles, which can be relatively small (200- 
500 nm in diameter) and located in multiple focal planes (both underneath the 
plasma membrane as well as in the peri-nuclear region). The limit of resolution of 
light microscopy is ~ 200 nm, which is clearly a constraint in studying the sub- 
compartmentalization of organelles with diameters in the range of the resolution
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limit. However, in comparison to higher resolution techniques such as electron 
microscopy, fluorescence microscopy allows a comparatively rapid analysis of a 
large number of samples and was therefore preferable in the initial phase of the 
project.
Moreover, fluorescence microscopy offers also other advantages. First, the 
fluorescent signal of GFP avoids all the problems connected with the use of 
antibodies (i.e. differences in density of labelling between different antibodies) 
required to visualize proteins by electron-microscopy. This point is particularly 
important for this project, given the lack of sensitive antibodies against Rab5, 
Rab4 and R ab ll. Second, light microscopy allows the imaging of living cells. 
This firstly avoids possible artefacts of fixation and secondly, time-lapse 
sequences can be obtained, allowing dynamic processes to be followed.
2.7 The GFP-Rab4 A431 cell line.
In this paragraph, 1 describe the experiments 1 performed to generate the 
A431-GFP-Rab4 stable cell line. The protocol 1 followed comprised of four steps 
1) Construction of an eukaryotic expression vector carrying the Rab4cDNA fused 
in frame to the GFP cDNA; 2) transfection of this vector into A431 cells; 3) 
selection of transfected cells and isolation of stable transfectant clones and 4) 
characterization of the isolated clones.
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1) The human Rab4a cDNA was sub-cloned in frame with GFP cDNA into 
the pCEGFP eukaryotic expression vector (Clontech) using standard molecular 
biology techniques (see methods, section 4.17). pCEGFP contains the GFP cDNA 
under control of the Cyotomegalovirus (CMV) promoter. The CMV promoter is 
recognized by the transcription machinery of most mammalian cells and can be 
efficiently used to drive expression of exogenous genes when transfected into 
mammalian cells. The pEGFP vector also contains the neomycin-resistance gene. 
Thus cells transfected with this vector can be isolated from non-transfected cells 
on the basis of their resistance to this antibiotic. 2) The GFP-Rab4 expression 
vector was transfected into A431 cells using the lipofection technique (see 
methods, section 4.3) and cells were incubated for 48 hours to allow protein 
expressions. 3) Transfected-positive clones were selected by the following 
criteria: i) Capability to grow in the presence of the neomycin analogue G418 ii) 
GFP-Rab4 signal must be membrane associated with minor cytosolic background; 
iii) no major morphological alterations of endosomal compartments are tolerated 
and iv) each clone must exhibit a homogeneous cell population i.e. the majority 
(>90) of the cells in the clone must exhibit these characteristics.
Figure 21 shows a representative cell expressing GFP-Rab4. Given the lack 
of sensitive antibodies against Rab4, I could not estimate the extent of over­
expression relative to the endogenous Rab4 protein. However, Rab5 and R ab ll
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over-expression in GFP-Rab5 and G FP-Rabll cell lines was estimated (by 
Western blot experiments) to be in the range of 5- to 10- fold over endogenous
level. Given that GFP-Rab5 and GFP-Rabll cell lines were generated with the
same expression vectors and the same protocol used to generated the GFP-Rab4
cell line, the over-expression level of Rab4 is probably in the same range.
Figure 21: A431 cells expressing GFP-Rab4.
A431 cells transfected with GFP-Rab4 were fixed and analyzed by fluorescence 
microscopy. Scale bar represents 2 microns.
To verify whether GFP-Rab4 was correctly targeted to early endosomes, its
co-localization with transferrin receptor was analyzed by immunofluorescence. As
103
shown in Figure 22 many structures containing GFP-Rab4 were also positive for 
transferrin receptor indicating that the GFP tag did not cause mistargeting of 
Rab4.
Figure 22: GFP-Rab4 is correctly localized to early endosomes.
A431 cells expressing GFP-Rab4 were fixed and stained with antibodies against 
transferrin receptor, followed by secondary antibodies coupled to rhodamine. This image 
represents an individual confoeal section. Scale bar represents 2 microns.
Next, I tested whether the GFP-tag interfered with the proper shuttling of
Rab4 between membrane and cytosol. To this aim, GFP-Rab4 cells were SL-0-
permeabilised and incubated for 20 minutes at 37°C either with recombinant
RabGDI or control buffer alone. After extensive washes, cells were fixed and
analyzed by fluorescence microscopy. As shown in Figure 23, RabGDI efficiently
extracted GFP-Rab4 from the endosomes, as judged by the decrease in GFP
fluorescent signal. This result is further evidenee that the GFP tag does not
interfere with the localization and the membrane/cytosol cycle of Rab4. I next
tested whether the over-expression of GFP-Rab4 interferes with the kinetics of
transport along the endocytic-recycling pathway. To this end, the recycling of
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transferrin was quantified. Biotinylated transferrin was internalized for 2 minutes 
at 37° C, surface-bound transferrin was removed by ice-cold acid washes and the 
amount of transferrin recycled to the medium over time was quantified (as 
deseribed the methods). As shown in Figure 24 the kinetics of recycling in WT 
and GFP-Rab4 cells are almost identical (except a minor increase at early time 
points). Altogether, these results indicate that the GFP-Rab4 stable cell line 
represents a faithful system to analyze the membrane organization of the early 
endosomal compartment.
-SLO +SLO+RabGDI +SLO-RabGDI
Figure 23: Fluorescence microscopy analysis of GFP-Rab4 expressing cell line 
treated with RabGDI.
GFP-Rab4 expressing cells were either directly fixed (-SL-0) or SL-O-permeabilised and 
treated either with 5 pM  RabGDI (+SL-0+RabGDI) or with buffer alone (+SL-0- 
RabGDI) before fixation. Scale bar represents 10 microns.
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Figure 24: Biochemical measurement of transferrin recycling in A431 cells 
expressing GFP-Rab4.
A431 wild type cells (pink line) or A431 GFP-Rab4 expressing cells (blue line) were 
allowed to internalize 10 p.g/ml of biotinylated transferrin for 2 minutes at 37 °C, 
followed by incubation in the presence of an excess of non-labelled transferrin. Medium 
was collected at the indicated time points and the amount of biotinylated tranferrin 
recycled quantified. Results are expressed as percentage of total (total=recycled+ 
intracellular). Data represent means ± SEM from three independent experiments 
performed in duplicate.
2.8 Transferrin moves sequentially through Rab5-Rab4 and R a b ll positive 
endosomes.
In agreement with previous studies, at steady state, the transferrin receptor 
only partially co-localizes with Rab4 (see Figure 22), suggesting that Rab4 is 
localized only to a sub-populations of early endosomes. To determine at which
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stage of its trafficking cycle transferrin transit through Rab4 positive structures, 
GFP-Rab4 cells were allowed to internalize rhodamine transferrin for 2 minutes 
and then chased for various periods of times in medium without transferrin. After 
fixation, images were acquired and the overlap of fluorescence signal was 
quantified to assess co-localisation (see methods). As shown in Figure 25, after 
two minutes of internalization, 50% of transferrin positive endosomes also 
contained Rab4. This fraction rapidly increased up to 90% after the first five 
minutes of chase and then slowly decreased in the following 10 minutes to remain 
constant at about 70% as long as the rhodamine-transferrin signal was still 
detectable. These data indicate that Rab4 is localized only to a sub-population of 
early endosomes and that transferrin moves sequentially from Rab4-negative to 
Rab4-positive endosomes before recycling back to the plasma membrane.
Rab5 and Rabl 1 have been proposed to regulate endocytosis and 
recycling, respectively. It was therefore interesting to determine the kinetics of 
transport of transferrin through Rab5 and R ab ll positive endosomes. To this aim, 
GFP-Rab5 and G FP-R abll cell lines (which have been generated and 
characterized by Dr s. Nielsen and Sonnichsen) were allowed to internalize 
rhodamine transferrin for 2 minutes and then chased in medium without 
transferrin for different time points. The extent of co-localisation between 
transferrin and either Rab5 or R ab ll at the different time points was calculated as
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for Rab4. Consistent with the role of Rab5 in endocytosis, 2 minutes after 
internalization 70% of transferrin labelled endosomes contained also Rab5 (Figure 
25). This association was transient and rapidly decreased after two minutes of 
chase, when transferrin started to fill Rab4 positive endosomes. In contrast to 
Rab5, only 20% of transferrin-labelled endosomes contained also R ab ll at the 
early time points. This number slowly increased up to 55% during the 30 minutes 
chase (Figure25), in agreement with the role of R ab ll in the slow recycling loop. 
Therefore, these results indicate that transferrin travels sequentially through Rab5, 
Rab4 and R ab ll structures and thus, are in agreement with the idea that these 
GTPases are not overlapping on the same endosomes, but are rather segregated 
either on different endosomes and /or on different sub-compartments of the same 
endosomes.
The sequential movement of transferrin from Rab5 to Rab4 positive 
structures could occur either in cis (i.e. if  these two GTPases are 
compartmentalized within distinct membrane domains on the same endosomes) or 
in trans between two different endosomes, one carrying Rab5 and the other Rab4.
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Figure 25: Morphological quantification of rhodamine transferrin trafficking in 
GFP-Rab4“, Rab5- and Rabll- cell lines.
A431 cells expressing Rab4 (blue) Rab5 (pink) and Rabll (green) were allowed to 
internalize rhodamine transferrin for 2 minutes at 37 °C, followed by incubation in the 
presence of an excess of non-labelled transferrin for the indicated time points. Images of 
fixed cells were analyzed for fluorescent overlap as described in methods. Data represent 
means ± SEM from three independent experiments performed in duplicate.
To address this point it was necessary to visualize the trafficking of 
transferrin with respect to both Rab5 and Rab4 in the same cell. To this aim, 
eukaryotic expression vectors expressing CFP-Rab5 and YFP-Rab4 (CFP and 
YFP are colour-shifted variants of GFP that can be discriminated from each other 
as well as from fluorophores emitting in the red region of the spectrum) were 
microinjected directly into the nucleus of A431 cells. This technique of 
transfection allows precise control of over-expression level and it ensures co-
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expression o f two or m ore plasm ids in the same cell. Six hours post-injection, 
Texas-red labelled transferrin was internalized for different lengths of tim e and, 
after fixation, confocal sections were obtained and processed with a deconvolution
software before quantification of overlapping fluorescent signal (Figure 26).
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Figure 26: Schematic representation of the methods used to quantify the endosomal 
distribution of Rab4, Rab5 and R ab ll
Empty circles represent unlabelled endosomes. Green circles represent endosomes 
labelled by YFP-Rab. Red circles represent endosomes labelled by CFP-Rab. Yellow 
circles represent endosomes labelled by both YFP- and CFP-Rab.
As shown in Figure 27 the Rab5 and Rab4 fluorescence signal was often
seen to be segregated within the same continuous transferrin-filled endosomes.
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Figure 27: Confocal analysis of YFP-Rab4 and CFP-RabS on transferrin-filled 
endosomes.
A431 cells co-expressing YFP-Rab4 and CFP-Rab5 were allowed to internalize Texas- 
red transferrin for 30 minutes, fixed and analyzed by confocal microscopy. This image 
represents an individual confocal section. Tfn= transferrin. The scale bar represents 2 
microns.
R ecycling cargo is sorted from  Rab5 to R ab4-positive structures early 
(within 5 minutes) after internalization. W ithin this tim e-fram e, as m uch as 60% 
of transferrin-labelled endosom es contained both Rab5 and Rab4 (see Table 1), 
suggesting  that transferrin  is transported  through d istinc t Rab5 and R ab4 
m em brane dom ains, residing on the same endosom e. T ransport through these 
endosomes is relatively fast com pared to the overall length o f the transferrin cycle. 
Indeed, at steady-state labelling, only -2 5 %  of transferrin-positive endosom es 
harboured both Rab5 and Rab4 and transferrin was mainly found in Rab4 positive 
endosom es (Table 1). Cargo transport through R a b ll  structures follow s transit
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through Rab4 endosomes. Consistently, experiments conducted in collaboration 
with Dr. Sonnichsen indicate that at steady state -70%  of transferrin-positive 
endosomes contained both Rab4 and R ab ll, while only 20% contained Rab5 and 
R ab ll (Tablel). Just like Rab5 and Rab4, Rab4 and R ab ll seemed to occupy 
distinct membrane domains on the same transferrin-filled endosome (Figure 28). It 
is therefore possible that also the sorting of cargo from Rab4 to Rabll-positive 
elements occurs within a continuous endosomal element.
Table 1. Quantification of Rab5, Rab4 and Rabll on transferrin-labelled endosomes
Rab5 Rab4 Overlap
Tfn endosomes, 2 min. 66 ±6 
internalization, 3 min. chase
68 ±1 51 ±8
Tfn endosomes, 30 min. 51.5±8 
internalization (steady state)
79±4 23.5 ±7
Rab5 R ab ll Overlap
Tfn endosomes, 30 min. 54 ±3 
internalization (steady state)
65 ±1 19 ±8
Rab4 R ab ll Overlap
Tfn endosomes, 30 min. 84 ±1 
internalization (steady state)
68 ± 4 63.5 ± 5
Fluorescence analysis: plasmids coding for two Rab proteins fused to YFP and CFP 
were expressed and Texas red-labelled transferrin was internalized for the indicated 
time. Numbers represent the percentage of endosomes labelled for the indicated 
combination of Rab proteins.______________________________________________
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Figure 28: Confocal analysis of YFP-Rab4 and CFP-Rab 11 on transferrin-filled 
endosomes.
A431 cells co-expressing YFP-Rab4 and CFP-Rab 11 were allowed to internalize Texas- 
red transferrin for 30 minutes, fixed and analyzed by confocal microscopy. This image 
represents an individual confocal section. Tfn=transferrin. Scale bar represents 2 
microns.
These data indicate that Rab4 is localized  to tw o d istinc t endosom al
populations: one earrying Rab5+Rab4 and another one R ab4-fR ab ll. To quantify 
this distribution, all the Rab4 endosom es w ere counted and the ex tent o f co ­
localization w ith Rab5 and R a b l l  was determ ined (Figure 29). A bout 50%  of
R ab4-positive endosom es contained also Rab5. A nother pool sim ilar in size
contained Rab4 and R a b ll  and about 20% of all the Rab4 endosom es contained
all the three Rab proteins together. In contrast to the majority of Rab4-endosom es, 
w hich co-labelled  w ith either Rab5 or R a b l l ,  a significant portion  o f Rab5
endosomes (50%) did not co-label for Rab4 or R abl 1.
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Rab5 only = 48 ± 5 
RabS + Rab4 = 43 ± 8 
RabS + R a b ll = 23 ± 2 
Rab5 + Rab4 + R ab ll = 15 ± 5
Figure 29: Confocal analysis of Rab4, RabS and R ab ll endosomes.
A431 cells co-expressing YFP-Rab4 and CFP-Rab5 were fixed and stained with 
antibodies against R ab ll followed by secondary antibodies conjugated to Texas-red. The 
image shown in A represents a single confocal section. Scale bar represents 2 microns. In 
B is shown the quantification of the overlapping fluorescence signal for Rab5, Rab4 and 
R ab ll. Numbers represent the percentage of Rab5 endosomes alone or in combination 
with Rab4 and Rab 11.
T herefore , w ith respect to the R ab5, Rab4 and R a b l l  m ach inery .
endosom es can be sub-divided in three m ajor categories: one containing Rab5, 
another one harbouring both Rab5 and Rab4, and a third carrying Rab4 and 
R a b l l .  Upon in ternalization from  the plasm a m em brane transferrin  first enters
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Rab5-positive endosomes, then it moves into endosomes harbouring both Rab5 
and Rab4 and eventually accumulates in Rab4 and R ab ll positive endosomes, 
before recycling back to the plasma membrane. Altogether, these data suggest that 
cargo move sequentially through endosomes that are structured in distinct Rab 
domains.
2.9 The RabS effector EEAl is specifically localized to RabS domains
The results so far obtained are consistent with the hypothesis that Rab5, Rab4 and 
R ab ll are compartmentalized within defined membrane domains. Given that Rab 
proteins function through membrane recruitment of specific sets of effector 
protein, one prediction is that also these effectors are compartmentalized within 
the corresponding Rab domain. For example, internalized cargo enters into early 
endosomes via the Rab5-domain presumably because the molecular machinery 
required for the fusion of incoming CCVs with early endosomes is localized in 
this membrane sub-compartment. A key component regulating the fusion between 
incoming vesicles and early endosomes is the Rab5 effector EEA l (see 
Introduction). To test whether EEAl is localized to the same membrane region as 
Rab5, the GFP-Rab5 cell line, or the GFP-Rab4 cell line as control, were stained 
with antibodies against EEAl. As shown in Figure 30, EEAl completely co­
localized with Rab5 and only partially with Rab4. Very interestingly, while the
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EEAl fluorescent signal always seemed to originate from round, dot-like 
structures, the Rab4 signal defines more tubular elongated structures. This
difference was also evident in cases where Rab4 and EEAl localized to the same
endosome (see inset Figure 30 A-C).
EEAl Overlay
GFP-RabS EEAl Overlay
Figure 30: Localization of EEAl in the GFP-Rab4 and GFP-RabS stable cell lines.
A431 cells expressing GFP-Rab4 (A-C) or GFP-RabS (D-F) were fixed and stained with 
antibodies against EEAl, followed by secondary antibodies conjugated with Texas-red. 
Each image represents a single confocal section. Scale bar represents 2 microns (A-C) 
and 4 microns (D-F).
From ultra-structural investigations, early endosomes have been described
to be composed of morphologically and functionally distinct vacuolar, cisternal
and tubular sub-compartments (see Introduction). Endosome tubulation can be
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enhanced by treating cells with Brefeldin A (BFA) (Lippincott-Schwartz et al., 
1991). Treatment of GFP-Rab4 cells with BFA results in the formation of an 
extensive tubular network where Rab4 localized (Figure 31). Intriguingly, a 
fraction of membranes positive for Rab4, did not tubulate and remained in 
distinct globular structures, which were also positive for EEA l. Consistently, 
EEAl-positive endosomes were completely insensitive to BFA. I therefore tested 
whether Rab5 positive membranes were also BFA-insensitive. As shown in Figure 
31, treatment of the GFP-Rab5 cell line with BFA did not cause tubulation of the 
Rab5 endosomes and, as in non-treated cells, EEAl and Rab5 still co-localized on 
the same globular structures. However, Rabll-positive structures also responded 
to BFA and co-localized with Rab4 extensively in the tubular network. In contrast 
to Rab4, all the Rab 11-positive membranes tubulate in response to BFA, whereas 
the non-tubulated Rab4 structures did not contain R ab ll (Figure 32). In summary, 
endosomes comprised of Rab5 and Rab4 domains are insensitive to BFA, while 
the opposite is true for those endosomes composed of Rab4 and R ab ll domains. 
The different pharmacological sensitivity supports the idea that Rab5, Rab4 and 
R a b ll domains represents biochemical and presumably functionally distinct 
environments.
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Figure 31: Differential response of RabS and Rab4-positive endosomes to BFA.
A431 cells expressing GFP-Rab5 (A-C) or GFP-Rab4 (D-F) were treated for 10 minutes 
with BFA (5 g g/ml), fixed and stained with antibodies against EEA l, followed by 
seeondary antibodies eonjugated to Texas-red. This image represents an individual 
eonfoeal section. Scale bar represents 2 mierons.
Figure 32: Differential response of Rab4 and R abll positive endosomes to BFA.
A431 eells co-expressing CFP-Rab 11 and YFP-Rab4 were treated for 10 minutes with 
BFA (5 pg/ml), fixed and processed for fluoreseence mieroscopy analysis. Seale bar 
represents 1 mieron.
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2.10 Introduction to results (part-3)
The morphological analysis performed in the previous section support the 
hypothesis that Rab5, Rab4 and R ab ll are compartmentalized within defined 
membrane domains. Multiple combinations of these domains define three major 
endosomal populations: one containing only Rab5, a second Rab5 and Rab4, and a 
third Rab4 and R ab ll. The steady-state association between these domains is not 
random and recycling cargo moves sequentially from Rab5 to Rab4 and from 
Rab4 to R ab ll domains. Therefore, regulatory mechanisms must exist to control 
the association and to ensure co-ordination between neighbouring domains. For 
example Rab5 and Rab4 domains must be joined together to allow fast recycling. 
The R ab ll domain should then be connected to the Rab4 domain, as these two 
sub-compartments are located in the peri-nuclear recycling endosomes.
Since Rab proteins regulate membrane tethering and Rab effectors have been 
demonstrated to be tethering molecules, one possible point of regulation for 
combining Rab domains would be at the level of Rab effectors. In particular, the 
finding that Rabaptin-5 interacts with both Rab5 and Rab4 supports this 
hypothesis. How can this model be experimentally tested? Once, a recycling 
receptor (like the transferrin receptor) is internalized, it first enters the Rab5 
domain in early endosomes, and then progresses through Rab5/Rab4 and
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Rab4/Rabll endosomes before recycling back to the surface. According to the 
experiments depicted in Figure 25, the sorting of recycling cargo from Rab5 to 
Rab4 domains occurs within the first five minutes after internalization and thus 
the function of the common Rab5 and Rab4 effectors might be limited to this time 
frame. Therefore, it is likely that the in vitro recycling assay, which I have 
developed, is not a suitable system to study this transport step. As shown in Figure 
25, after 30 minutes of internalization (the time of internalization used in this 
assay), transferrin has already exited from Rab5 structures and is mainly found in 
Rab4 and R ab ll positive-endosomes. These observations may also explain why 
im m unodepletion of Rabaptin-5 did not inhibit recycling despite the 
demonstration of a Rab4-requirement for recycling. Due to technical limitations 
the time of internalization and the time required to achieve permeabilisation can 
not be reduced to less than eight minutes. Thus, the only possibility to reconstitute 
the transition of cargo from Rab5 to Rab4 positive structures in this in vitro assay, 
would be to reconstitute both endocytosis and recycling in permeabilised cells by 
internalizing transferrin after permeabilisation. However, the results of such 
experiments would always be difficult to interpret because any putative effect on 
recycling may always be an indirect consequence of an inhibition of endocytosis. 
Given the difficulties with the biochemical assay, I turned to the in vivo Rab 
localization assay to examine the possibility of Rab5-Rab4 co-ordination. This
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system allows high resolution mapping of endosomal morphology and might 
therefore be useful in assessing possible functions of Rab effectors in controlling 
domains association. Furthermore, the assay can simultaneously detect kinetic 
effects on transferrin trafficking, possibly resulting from altered domain 
architecture. In particular, I have used this assay to test the hypothesis whether 
molecules, which have the ability to bind both Rab5 and Rab4, can regulate the 
association between Rab5 and Rab4 domains and thus affect the transport of cargo 
along the endocytic-recycling pathway. In the following paragraphs, I will 
describe the experiments I have performed to this aim.
2.11 Identification of proteins interacting with both active RabS and Rab4.
By developing an affinity chromatography approach, Christoforidis and co­
workers in our laboratories could show that active (GTP-Bound) RabS specifically 
interacts with over twenty-two proteins (Christoforidis et al., 1999). This finding 
raises the question whether Rab4 would also interact with a similar multitude of 
effectors and if so, whether Rabaptin-5 is the only common Rab5 and Rab4 
effector. To approach this problem, I developed an experimental strategy based on 
two sequential steps of affinity chromatography. The first step served to purify the 
Rab5 interacting proteins and the second step consisted of the absorption of these
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proteins on GST (glutathione S-transferase)-Rab4 bound to glutathione beads (see 
Figure 33 for a schematic representation of the methods).
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Figure 33: Schematic representation of sequential affinity chromatography strategy.
The purification of Rab5 effectors was conducted according to the protocol 
established by Christoforidis and co-workers. This m ethod is based on the ability 
of bacterially expressed GST-Rab5 (im m obilized on glutathione beads) to interact 
w ith its effectors in a nucleotide-dependent m anner. Rab5 can be efficien tly  
stabilized in its active G TP-bound conform ation in the presence o f the slowly 
hydrolysable GTP analogue GTPyS. Thus, when glutathione beads contain ing 
GST-Rab5 loaded with GTPyS are incubated with a source o f cellu lar proteins
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(such as bovine brain cytosol), Rab5 effectors will be specifically retained on the 
beads. As the interaction of Rab proteins with their effectors is GTP dependent, 
Rab5 effectors can be specifically eluted from the beads by changing the 
nucleotide-bound state of Rab5 via removal of the nucleotide from the binding 
pocket.
To perform the sequential affinity chromatography experiment, glutathione 
beads coated with GST-Rab5 loaded with GTPyS, were incubated with bovine 
brain cytosol. The bound proteins were eluted, dialyzed against nucleotide-free 
buffer and applied to a column containing GST-Rab4 in the presence of GTPyS, or 
as control, GDP. Bound proteins were eluted from the beads, separated on SDS- 
PAGE and stained with silver nitrate. Figure 34 shows the results of this 
experiment. Rabaptin-5 has already been shown to interact with both Rab5 and 
Rab4. Therefore, I was expecting to find at least three proteins on the Rab4 
column: Rabaptin-5, its binding partner Rabex-5 and Rabaptin5-p. However, four 
bands instead of three were found in the eluate from Rab4-GTPys (lane 2) but not 
Rab4-GDP column (lane 3). By using a combination of mass spectrometry and 
Western blot experiments, these bands were found to correspond to Rabaptin-5, 
Rabaptin-5p, Rabex-5 and, the fourth one to Rabenosyn-5 (see Figure 34B lane 2). 
The specificity of these interactions is validated by the observation that, under the 
same experimental conditions, two of the most abundant Rab5 effectors, EEAl
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and p l i  Op did not interact with Rab4 (Figure 34B lane 1-2). Rabenosyn-5 was 
previously identified as a Rab5 effector regulating membrane tethering/fusion at 
the stage of entry into early endosomes. Similar to the Rab5 effector EEA l, it 
binds PI(3)P through a FYVE finger domain and it is recruited to early endosomes 
in a Rab5 and Pl-3-kinase-dependent fashion. Consistently, both Rabenosyn5 and 
EEAl co-localise within the Rab5-positive endosomal domain (Nielsen et al., 
2000). The finding that this protein can also interact with Rab4 suggests an 
additional role for Rabenosyn-5 in early endosome function. I therefore decided to 
further characterize the interaction between Rab4 and Rabenosyn-5.
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Figure 34: Purification and identification of RabS and Rab4 common effectors using 
sequential affinity chromatography
(A) GST-Rab5:GTPyS affinity columns were incubated with bovine brain cytosol. Bound 
proteins were eluted (lane 1), and subsequently incubated with GST-Rab4:GTPyS (lane 
2) or GST-Rab4;GDP (lane 3). Bound proteins were eluted and analyzed by gradient 
SDS- (PAGE) and silver staining.
(B) Western blot analysis of proteins interacting with both active Rab5 and Rab4 (lanel- 
2) purified as in (A). The four bands indicated with an asterisk in (A) were detected by 
anti-Rabaptin-5, -Rabaptin-5p, -Rabex-5 and -Rabenosyn-5 antibodies (lane 2).
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2.12 Biochemical characterization of the interaction between Rabenosyn-5 
and Rab4.
To confirm  that the interaction of Rabenosyn-5 with Rab4 was not peculiar 
to the experim ental condition used, I tested whether Rab4 and Rabenosyn-5 were 
also able to in teract independently  o f the pre-Rab5 purifieation  on the Rab5 
affinity chrom atography. G ST-R ab4 was incubated directly w ith bovine brain 
cytosol, bound proteins w ere eluted and analyzed by W estern b lot with an anti- 
R abenosyn-5 antibody. F igure  35 shows that also under these conditions, 
R abenosyn-5 specifically  in teracted  w ith R ab4:G T PyS  (lane3) but not w ith 
Rab4:GDP (lane2).
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Figure 35: Cytosolic Rabenosyn-5 interacts with Rab4.
Bovine brain cytosol (lane 1) was incubated with GST-Rab4:GDP (lane 2) or GST- 
Rab4:GTPyS (lane 3). Bound proteins were eluted, separated by SDS-PAGE and 
analyzed by immunoblotting with antibodies against Rabenosyn-5.
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Next, I tested whether the interaction between Rabenosyn-5 and Rab4 is 
direct or is mediated by a third cytosolic component. In cytosol, Rabenosyn-5 is 
complexed with hVPS45, a Sec-1 related protein regulating the assembly between 
endosomal v- and t-SNAREs. The interaction between Rab5 and Rabenosyn-5 is 
direct, whereas hVPS45 interacts with Rab5 only through Rabenosyn-5 (Nielsen et 
al., 2000). To test if similar molecular principles control the interaction between 
Rab4, Rabenosyn-5 and hVPS45 I perform ed affinity chrom atography 
experiments using in vitro translated proteins. Rabenosyn-5 and hVPS45 were 
either translated separately or co-translated and incubated with glutathione beads 
containing GST-Rab4. Rabenosyn-5 interacted directly with Rab4 in a nucleotide- 
specific manner (Figure 36 lanes 1-2). No interaction was detected between 
hVPS45 and Rab4, unless it was co-translated with Rabenosyn-5 (Figure 36, 
compare lanes 3-4 with lanes 4-5). These results showed that Rabenosyn-5 binds 
directly to Rab4 and, by analogy to Rab5, this interaction might serve as a link 
between Rab4 and hVPS45.
The binding of Rabenosyn-5 to both Rab5 and Rab4 raises the question 
whether Rabenosyn-5 would interact also with other Rab proteins localized to 
early and recycling endosomes. In particular, due to the double association of 
Rab4 domains with both Rab5 and R ab ll domains, I investigated whether R ab ll 
and Rabenosyn-5 also interact. To this aim, GST-Rabll or, as control GST-Rab4,
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were incubated with in vitro translated Rabenosyn-5 in the presence of GDP or 
G TPyS. Figure 37 (lanes 2-3) shows that Rabenosyn-5 does not interact w ith
R abll.
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Figure 36: Rabenosyn-5 interacts directly with Rab4 and recruits hVPS45 to Rab4
GST-Rab4;GDP (lanes 1-3-5) or GST-Rab4:GTPyS (lanes 2-4-6) were incubated with 
methionine-labelled in vitro translated Rabenosyn-5 alone (lanes 1-2), hVPS45 alone 
(lanes 3-4) or co-translated Rabenosyn-5 and hVPS45 (lanes 5-6). Bound proteins were 
eluted and analyzed by SDS-PAGE followed by autoradiography.
GST-Rab4 GST-Rabll
Figure 37: Rabenosyn-5 does not interact with R ab ll.
GST-Rab4:GDP (lane 1), GST-Rab4:GTPyS (lane 2), GST-Rabll:G DP (lane 3), GST- 
Rab4:GTPyS (lane 4), were incubated with ^^ S methionine-labelled in v/?ro-translated 
Rabenosyn-5. Bound proteins were eluted and analyzed by SDS-PAGE followed by 
autoradiography.
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2.13 Rabenosyn-5 labels the endosomes where Rab5 and Rab4 co-localise.
In addition to its established role in Rab5-dependent endocytic membrane 
fusion, Rabenosyn-5 may play a role in the functional connection between Rab5 
and Rab4 domains. In this case, one would expect this protein to localize to those 
endosomes that contain both Rab proteins. Alternatively, if the interaction with 
Rab4 is functionally independent of that with Rab5, Rabenosyn-5 may be 
localized to membranes harbouring only Rab4 or Rab5. To distinguish between 
these two possibilities, I used the same approach as described in the previous 
sections used to visualize and quantify the distribution of Rab5, Rab4 and R ab ll 
to distinct domains of early and recycling endosomes.
A431 cells co-expressing CFP-Rab5 and YFP-Rab4 were fixed and stained 
with affinity-purified anti-Rabenosyn-5 antibodies. Confocal serial sections were 
obtained and processed with a deconvolution software before quantification of 
overlapping fluorescence signal. The result of this triple labelling experiment is 
shown in Figure 38. Ninety-five percent of the endosomes harbouring Rabenosyn- 
5 contained also Rab5 (Figure 38D) and, of those, 55% were positive for Rab4 
(Figure 38E). Importantly, the latter pool corresponds to those endosomes 
containing both Rab5 and Rab4 (Figure 38F) as well as all three together (Figure 
38G). Therefore, whenever endosomes contained both Rab5 and Rab4, they were 
also positive for Rabenosyn-5 (arrows in Figure 38 D, E, F, G and for
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quantification, panel H). Interestingly, as shown in the inset of Figure 38, while 
Rab5 and Rabenosyn-5 localized always to the same endosomal domain, Rab4 
was often seen to segregate into elongated structures. These morphological data 
support the hypothesis that Rabenosyn-5 may regulate the functional link between 
Rab5 and Rab4 domains.
The particular localization of Rabenosyn-5 might reflect a higher affinity 
for Rab5 over Rab4 or being the consequence of both Rab5 and PI(3)P binding 
sites as co-operative targeting determinants. To discriminate between these two 
different possibilities I sought to measure the affinity constant of the interaetion 
between Rab5 and Rab4 with Rabenosyn-5. To this aim, in v/tro-translated 
Rabenosyn-5 was incubated for 1 hour at room temperature with serial dilutions of 
glutathione-sepharose beads containing GST-Rab4 or -Rab5 (with the total 
concentration of Rabenosyn-5 being always well below that of GST-Rab to ensure 
maximal binding). Beads were spun through a 1 ml 40 % sucrose cushion to 
separate bound from unbound Rabenosyn-5. Proportional aliquots of bound, 
unbound and total fractions were separated by SDS-PAGE, and analyzed with a 
phosphoimager reader for quantification.
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Figure 38: Confocal immunofluorescence analysis of RabS, Rab4 and Rabenosyn-5 
labelled endosomes
(A-G) A431 cells expressing CFP-Rab5 and YFP-Rab4 were fixed and stained with 
antibodies against Rabenosyn-5 followed by secondary antibodies conjugated to Texas- 
red. Individual eonfoeal sections are shown. Bar = 3 microns.
(H) The extent of co-localization between Rab5, Rab4 and Rabenosyn-5 was quantified 
as described in the methods seetion. Colours in the histogram correspond to the colours 
used in the merge of double or triple fluorescent signals in the overlay panels.
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Binding of Rabenosyn-5 to empty GST beads was considered as 
background and therefore subtracted from each binding value before calculating 
percentage of binding. The result of this experiment showed that Rab5 and Rab4 
interact with Rabenosyn-5 with similar affinity (Kd ~400nM, Figure 39). 
Therefore, I favour the possibility that targeting of this protein to Rab5 domain is 
the consequence of both Rab5 and PI(3)P binding. In agreement with this proposal 
is the observation that the FYVE finger domain of Rabenosyn-5 is necessary for 
its endosomal localization (Nielsen et al., 2000). In addition, as in the case of Rab4 
endosomes, a substantial fraction of Rab5 positive structures (ca. 40%) do not co- 
localize with Rabenosyn-5, indicating that Rab binding alone is not sufficient for 
Rabenosyn-5 localization.
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Figure 39: Rabenosyn-5 interacts with similar affinity with RahS and Rah4.
Rabenosyn-5 was in vitro transcribed-translated in the presence of 35S-methionine and 
the percentage of binding to Rab5 and Rab4 was calculated as described in the methods 
(see section 4.11). Data represent means ( SEM from two independent experiments 
performed in duplicate.
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2.14 Rabenosyn-5 interacts simultaneously with both active Rab5 and Rab4
I next sought to determine whether Rab5 and Rab4 bind simultaneously or 
if their binding is mutually exclusive. To this aim, Rabenosyn-5/hVPS45 were co­
expressed in insect cells using the baculovirus expression system, as bacterially 
expressed Rabenosyn-5 alone was found to be insoluble. Forty-eight hours post 
infection, cytosol from either mock- or Rabenosyn-5/hVPS45 infected cells was 
prepared and analyzed by Western-blotting to assay Rabenosyn-5 over-expression. 
As shown in Figure 40 Rabenosyn-5 was expressed only in the Rabenosyn- 
5/hVPS45 infected lysate, and when cytosol was separated from total membranes 
by ultracentrifugation, Rabenosyn-5 was quantitatively recovered in the cytosolic 
fraction.
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Figure 40: Western blot analysis of Rabenosyn-5 over-expression in insect cells.
Insect cells over-expressing Rabenosyn-5 and hVPS45 were harvested, lysed and lysate 
samples were either directly processed for Western blot analysis or first spun for 1 hour at 
40000 Xg to separate total membranes from cytosolic extract.
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GST-Rab4 immobilized on sepharose beads and loaded with GTPyS was 
incubated with Rabenosyn-5/hVPS45 over-expressing cytosol for two hours. 
Unbound Rabenosyn-5/hVPS45 complex was removed by three washes and the 
GST-Rab4 column was further incubated with purified Rab5, or as control R ab ll, 
loaded with GTPyS. After extensive washes, bound proteins were eluted and 
analyzed by Ponceau staining and Western blotting (Figure 41 A and B). Rab5 
specifically interacted with GST-Rab4 only if GST-Rab4 was pre-incubated with 
Rabenosyn-5/hVPS45 over-expressing cytosol but not if the pre-incubation was 
performed with either mock cytosol or BSA (Figure 41 A and B). Besides Rab5, 
four other proteins were eluted from the column. Two were common to all the 
lanes and corresponded to BSA (used to block non-specific binding) and to GST- 
Rab4 leaked during the elution step, respectively. The second and the third one, 
corresponded to Rabenosyn-5 and hVPS45. This result indicates that in vitro Rab5 
and Rab4 can bind to Rabenosyn-5 at the same time.
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Figure 41; Rabenosyn-5 can bind simultaneously to Rab5 and Rab4.
(A) Ponceau staining of GST-Rab4 bound proteins. GST-Rab4 was incubated either with 
Rabenosyn-5/hVPS45 over-expressing cytosol either with mock infected cytosol or BSA. 
After extensive washes a second incubation was performed with purified Rab5 and BSA. 
Bound proteins were eluted, separated by SDS-PAGE and transferred to nitrocellulose for 
Ponceau staining or for Western blot analysis (B).
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2.15 Over-expression of Rabenosyn-5 increases the overlap between Rab5 
and Rab4, but not between Rab5 and R a b ll endosomal domains.
Under basal conditions, -50% of early endosomes contain both Rab5 and 
Rab4 domains, the rest being segregated. To examine if the amount of Rabenosyn- 
5 influences the co-distribution of Rab5 and Rab4 on endosomes I tested whether 
its over-expression could result in an increase in the population of endosomes 
containing both Rab5 and Rab4. A431 cells were microinjected with plasmids 
encoding CFP-Rab5, YFP-Rab4 and Rabenosyn-5 and the number of endosomes 
containing both Rab5 and Rab4 was quantified as before (Figure 38). As 
illustrated in Figure 42 (panels A, B, C) over-expression of Rabenosyn-5 had two 
effects. First, it induced the appearance of large endosomal structures. Second, it 
drastically altered the segregation between Rab4 and Rab5 endosomes. Rab4 now 
almost completely co-localized with Rab5 and Rabenosyn-5 on the same 
endosomal structures (-90% vs.-55% control; see also Table 2).
Since Rabenosyn-5 is complexed with hVPS45 in cytosol and this complex 
interacts with Rab4, the possibility existed that the phenotype observed could be 
due to a titration of endogenous hVPS45. However, co-expression of hVPS45 and 
Rabenosyn-5 did not revert the phenotype observed upon over-expression of 
Rabenosyn-5 (Table 2). Over-expression of hVPS45 alone had also no effect on
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the segregation between Rab5 and Rab4 domains, indicating that the phenotype 
observed is caused by Rabenosyn-5.1 therefore tested whether overexpression of 
Rabaptin-5, that also interacts with both Rab5 and Rab4, can induce a 
redistribution of Rab5- and Rab4-positive structures. Indeed, a similar phenotype 
was observed upon over-expression of Rabaptin-5 (80% of Rab4 endosomes 
containing Rab5 versus 52% control; Figure 42 D, E, F and Table 2). In contrast, 
over-expression of EEAl, which binds to PI(3)P and Rab5 but not to Rab4, caused 
a significant enlargement of the Rab5-positive compartment but did not 
significantly alter the distribution of Rab5 and Rab4 domains (Figure 42 G, H, I 
and Table 2). Therefore, the ability to cluster and/or fuse Rab5 and Rab4 domains 
together seems to be restricted to proteins that bind directly to both Rab5 and 
Rab4.
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Figure 42: Over-expression of Rabenosyn-5 and Rabaptin-5, but not of E E A l, 
increases the co-localization between Rab5 and Rab4
(A-I) Rabenosyn-5 (A-C), Rabaptin-5 (D-F), or EEAl (G-I) were co-expressed together 
with CFP-Rab5 and YEP-Rab4 in A431 cells. Cells were fixed and stained with 
antibodies against Rabenosyn-5 (A-C), Rabaptin-5 (D-E), and EEAl (G-I). Individual 
confocal sections are shown. Bar = 4pm (A-D) and 5pm (G).
At the light microscopy level, over-expression of Rabenosyn-5 caused an 
apparent enlargement of endosomes. To examine if this phenotype is analogous to 
the vacuolation induced by uncontrolled homotypic early endosome fusion upon 
expression of the active mutant of Rab5 (Rab5Q79L) (Bucci et al., 1992), 1 
inspected the morphology of the enlarged structures at the ultra-structural level. To 
this end, I performed immunoelectron microscopy experiments (in collaboration 
with Gareth Griffith) on cells over-expressing Rabenosyn-5. Affinity-purified anti-
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Rabenosyn-5 antibodies followed by protein A coupled to lOnm gold, were used 
to identify the endosomes where this protein localized. Rather than single big 
vacuoles, Rabenosyn-5-positive endosomes appeared as clustered tubulo-vesicular 
membranes (Figure 43). These results suggest that the phenotypic alterations 
induced by Rabenosyn-5 are not due to massive homotypic endosome fusion but 
primarily to clustering of endosomal elements. Whether this reflects de novo 
formation of tubular extensions, or tethering/docking of pre-existing endosomes, 
remains to be determined.
To determine whether Rabenosyn-5/Rab4 interaction is necessary to 
redistribute Rab4 endosomes, a Rabenosyn-5 mutant missing the Rab4 binding 
sites was designed and the effect of its over-expression was analyzed. To this end, 
a series of Rabenosyn-5 truncation mutants were constructed and tested for their 
ability to interact with Rab5 and Rab4 using affinity chromatography (see Figure 
44). The Rab4 binding site was mapped between amino-acids 264-500, 
immediately downstream of the FYVE finger domain.
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Figure 43: Electron microscopy analysis of cells over-expressing Rabenosyn-5.
A431 cells over-expressing Rabenosyn-5 were fixed and stained with an affinity purified 
anti-Rabenosyn-5 antibody followed by protein A coupled to 10 nm gold. Bar =250nm
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This region shared no homology with Rabaptin-5 or Rabip4 another FYVE 
finger containing protein recently identified as a novel Rab4 effector (Cormont et 
al., 2001). The Rab5 binding site was mapped to the very c-terminal end of the 
protein from amino acid 627 to 784. A second low affinity Rab5 binding site (-15- 
20% of total binding) is also located in the region containing the Rab4 binding 
site. Based on these mapping studies, I therefore succeeded in generating a 
Rabenosyn-5 mutant (5 264-500) devoid of the Rab4 binding site, but still capable 
of interacting with Rab5 and PI(3)P.
Rab5 Rab4
1 261 784
1-784 N I I C Æ M F Y V FI I N P F  I Ip  +  +
1-263 U C J i2 U F Y \ F l
264-784 ■ I N P F  l l  +  +
501-784 I I N P F  I I +
264-500 I I +  -h
501-626 — —
627-784 I N P F  i~l +  —
Ô (264-500) I I n p f " T I  +  —
Figure 44: Summary of the in vitro binding assay results to determine Rab4 and 
Rab5 binding sites of Rabenosyn-5.
Rabenosyn-5 full length or truncation mutants were in v/rra-translated in the presence of 
^^S-methionine and incubated with glutathione beads containing GST-Rab4 or GST- 
Rab5. Bound proteins were eluted and analyzed by SDS-PAGE, followed by 
autoradiography.
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Over-expression of this mutant failed to re-distribute Rab4 endosomes
(F igure 45 and table 2), a lthough com pletely  co-localized  to R ab5-positive 
endosom es and caused m orphological alteration (clustering-enlargem ent) of these
structures. This resu lt dem onstrates that R abenosyn-5  over-exp ression  re ­
distributes Rab4 endosomes because of its interaction with Rab4.
Rab4+Rab5= Rab5+Rabenosyn-5 ô(
Rab4+Rabenosyn-5 5(264-500)=# Rab4+Rab5+Rabenosyn-5 0(264-500)=O
Figure 45: Rabenosyn-5/Rab4 interaction is necessary to redistribute Rab4 
endosomes.
Myc-tagged Rabenosyn-5 5264-500 was co-expressed together with CFP-Rab5 and YFP- 
Rab4 in A431 cells. Cells were fixed and stained with antibodies against Myc. Individual 
confocal sections are shown. Scale bar represents 4 microns.
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Rabenosyn-5 does not interact with R ab ll. If the effect of Rabenosyn-5 on 
the distribution of Rab5 and Rab4 domains is specific, the fraction of endosomes 
harbouring both Rab5 and R ab ll domains should remain unaffected upon 
Rabenosyn-5 over-expression. Consistent with this assumption, I found that the 
typical peri-nuclear localization of Rabll-positive membranes was not changed 
upon Rabenosyn-5 over-expression (Figure 46). Moreover, concomitant with the 
increase in endosomes harbouring both Rab5 and Rab4, over-expression of 
Rabenosyn-5 reduced the proportion of endosomes labelled for both Rab4 and 
R ab ll (Table 2). In summary, over-expression of Rabenosyn-5 selectively shifted 
the distribution of Rab4 domains from the R ab4-R abll to the Rab5-Rab4 
endosomal population. Therefore, the selective re-distribution of Rab5, Rab4 and 
R ab ll endosomes observed morphologically, is consistent with the selective 
pattern of biochemical interactions between Rabenosyn-5 and these Rab proteins.
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Figure 46: Rabenosyn-5 over-expression does not change the peri nuclear 
localization of Rabll-postive membranes
A431 cells expressing CFP-Rab5, YFP-Rabl 1 and Rabenosyn-5 were fixed and stained 
with anti-Rabenosyn-5 affinity-purified antibodies followed by secondary antibodies 
conjugated to Texas red. Individual confocal sections are shown. Scale bar represents 5 
microns.
Table 2. Quantification of Rab5, Rab4 and R a b ll overlap on the same endosomes
Rab5+Rab4 Rab4+Rabll Rab5+Rab4+Rabll
Control 52 ± 4 50 ± 1 23 ± 2
-t-Rabenosyn-5 90 ± 6 1 7 ± 3 ND
-t-Rabenosyn-5 (5 264-500) 58 ± 5 ND ND
+hVPS45 50 ± 3 ND ND
-i-Rabenosyn-54-hVPS45 92 ± 4 ND ND
-t-Rabaptin-5 80 ± 3 ND ND
+EEA1 60 ± 5 ND ND
Fluorescence analysis; plasmids coding for the proteins indicated in the first column 
were microinjected into the nucleus of A431 cells. Numbers represent the percentage 
of endosomes labelled for the indicated combination of Rab proteins.________________
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2.16 Over-expression of Rabenosyn-5 stimulates transferrin recycling and 
diverts it from peri-nuclear recycling endosomes.
Endocytosed transferrin moves sequentially through Rab5, Rab4 and R ab ll 
endosomal domains before recycling back to the plasma membrane. Since over­
expression of Rabenosyn-5 increases the association between Rab5 and Rab4 at 
the expense of the connection with R ab ll, 1 tested whether these changes imply 
qualitative or quantitative differences in the sorting activity of endosomes and in 
recycling of endocytic markers. I therefore analyzed the transport of transferrin 
receptor through the endocytic and recycling pathway in cells over-expressing 
Rabenosyn-5. In control cells, after 15 minutes of continuous internalization, 
transferrin localized both in peripheral small structures corresponding to early 
endosomes as well as in peri-nuclear recyling endosomes (Figure 47 A). In 
contrast, in cells over-expressing Rabenosyn-5, transferrin accumulated in 
peripheral enlarged structures, but peri-nuclear recycling endosomes were poorly 
labelled (Figure 47 C, D, E). Quantification of these data is shown in Figure 47 B. 
It is unlikely that this effect is due to a general block of exit from early endosomes, 
as transferrin was efficiently internalized, implying that its receptor can cycle 
between endosomes and the plasma membrane. It is possible instead that 
transferrin is less efficiently transported to perinuclear recycling endosomes. To 
test this, I performed the following experiment. Cells were allowed to internalize
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two consecutive pulses of transferrin, the first (rhodamine-labelled transferrin) for 
1 hour and the second (Alexa-488-labelled transferrin) for 15 minutes. In control 
cells (Fig.7 F, G, and H), both rhodamine and Alexa-488 transferrin co-localized 
in peri-nuclear recycling endosomes. Single peripheral structures labelled either by 
Alexa-488- transferrin or by rhodamine-transferrin were also observed. In contrast, 
in cells over-expressing Rabenosyn-5, recycling endosomes were not labelled by 
transferrin after 15 minutes of internalization (Figure 47 I). Only after 1 h of 
internalization, could labelling of peri-nuclear recycling endosomes be observed 
(Figure 47 L). Whereas in control cells, the two consecutively internalized 
transferrin pulses co-localized in peri-nuclear recycling endosomes (Figure 47 H), 
in Rabenosyn-5 over-expressing cells co-localization between the two markers 
was restricted to the peripheral enlarged structures (Figure 47 M). These results 
therefore indicate that Rabenosyn-5 over-expression favours the recycling of 
transferrin directly from early endosomes and diminishes transport to peri-nuclear 
recycling endosomes.
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Figure 47: Morphological analysis of transferrin trafficking
(A and C-E) CHO cells (A) and CHO cells over-expressing Rabenosyn-5 (C-E) were 
allowed to internalize 30|Lig/ml of rhodamine-transferrin for 15 minutes at 37° C. After 
extensive washes, cells were fixed and stained with anti-Rabenosyn-5 antibodies 
followed by secondary antibodies conjugated to Alexa-488. Individual confocal sections 
are shown. Scale bar represents 4pm.
(B) Percentage of cells showing labelling of peri-nuclear recycling endosomes after 15 
minutes of rhodamine-transferrin internalization (n=200).
(F-M) CHO (F-H) or CHO cells over-expressing Rabenosyn-5 (I-M) were allowed to 
internalize two consecutive pulses of transferrin. Rhodamine- transferrin was internalized 
for 1 hour and Alexa-488-transferrin for 15 minutes. Individual confocal sections are 
shown. Scale bar represents 4pm.
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To substantiate this conclusion, I measured the kinetics of transferrin 
recycling in cells over-expressing Rabenosyn-5. To quickly obtain homogenous 
level of strong over-expression, cells v^ere transfected with plasmids carrying the 
desired cDNAs under the control of T7 promoter. Over-expression was then 
achieved by infecting cells with recombinant vaccinia virus encoding the T7 
polymerase and by a subsequent four hours incubation. Transfection efficiency 
was verified by immuno-fluorescence on duplicate samples and only if more than 
80% of cells were transfected, biochemical measurements were performed. First, 
Rabenosyn-5 over-expression induced a moderate, but significant increase in the 
steady-state distribution of transferrin receptor on the plasma membrane (35% on 
the surface versus 25% control). Second, to test whether the overall efficiency of 
the recycling pathway was perturbed, cells were labelled to steady state by 
internalizing biotinylated-transferrin for 1 hour at 37°C. Surface bound ligand was 
removed by ice-cold acid washes and recycling was restored by switching the 
temperature back to 37°C. The amount of transferrin recycled into the medium was 
quantified as described in methods. As shown in Figure 48, over-expression of 
Rabenosyn-5 did not alter the total amount of recycled cargo but rather accelerated 
the initial rate of recycling.
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Figure 48: Effects of Rabenosyn-5 over-expression on transferrin recycling.
HeLa cells were transfected with the indicated plasmids and infected with recombinant 
T7 RNA polymerase vaccinia virus. Cells were allowed to internalize 10 jxg/ml of 
biotinylated transferrin for 1 hour at 37° C. Cells were washed, stripped of surface bound 
transferrin, and incubated at 37° C in medium containing an excess of transferrin. The 
extent of release of biotinylated transferrin into the medium was monitored at various 
times. Results are expressed as percentage of recycled biotinylated transferrin (ratio 
between marker in the medium/ total= medium+intracellular). Data represent means ± 
SEM from three independent experiments performed in duplicate.
The stimulation of recycling was even more evident after a short pulse (two 
minutes) of transferrin internalization at 37°C. Under these conditions, I observed 
that over-expression of Rabenosyn-5 but not of Rabenosyn-5 ô (264-500), the 
Rab4 binding mutants, induced a ~3-to 4-fold stimulation of transferrin recycling 
(Figure 49). The stimulation was particularly evident in the first 4 minutes of the 
cycle, which corresponds to a Ti/2 of transferrin recycling < 3 minutes.
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Figure 49: Effects of Rabenosyn-5 over-expression on transferrin recycling.
HeLa cells were transfected with the indicated plasmids and infected with recombinant 
T7 RNA polymerase vaccinia virus. Cells were allowed to internalize 10 pg/ml of 
biotinylated transferrin for 2 minutes at 37° C. Cells were washed, stripped of surface 
bound transferrin, and incubated at 37° C in medium containing unlabeled transferrin. 
The extent of release of biotinylated transferrin into the medium was monitored at various 
time points. Results are expressed as percentage of recycled biotinylated transferrin (ratio 
between marker in the medium/ total= medium+intracellular). Data represent means ± 
SEM from three independent experiments performed in duplicate.
Third, to synchronize recycling from early endosomes, transfected cells
were allowed to internalize biotinylated-transferrin for 1 hour at 16°C. At this
temperature, transferrin receptor is still efficiently internalized into early
endosomes but subsequent exit either to recycling endosome or to the cell surface
is impeded (Sipe et al., 1991). Consistent with the results of Figure 49,
Rabenosyn-5 over-expression significantly stimulated transferrin recycling during
the first five minutes (Figure 50), without inhibiting the total amount of recycling
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at later time points. Importantly, this increase was dependent on the Rabenosyn- 
5/Rab4 interaction as 1) over-expression of the Rabenosyn-5 5-264-500 mutant
failed to stimulate recycling and 2) co-expression of the Rab4 dominant negative
mutant (Rab4S22N, GDP-bound) neutralized this stimulation.
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Figure 50: Effects of Rabenosyn-5 over-expression on transferrin recycling.
HeLa cells were transfected with the indicated plasmids and infected with recombinant 
T7 RNA polymerase vaccinia virus. Cells were allowed to internalize 10 pg/ml of 
biotinylated transferrin for 1 hour at 16° C. Cells were washed, stripped of surface-bound 
transferrin, and incubated at 37° C in medium containing unlabeled transferrin. The 
extent of release of biotinylated transferrin into the medium was monitored at various 
time points. Results are expressed as percentage of recycled biotinylated transferrin (ratio 
between marker in the medium/ total= medium+intracellular). Data represent means ± 
SEM from three independent experiments performed in duplicate.
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Finally, I tested w hether Rabenosyn-5 over-expression affects also 
an o th e r stage  o f en d o cy tic  tran sp o rt, i.e . from  early  to la te  
endosom es/lysosom es. To this aim, I m easured the effect o f its over­
expression on EGF degradation and found only a m oderate kinetic delay 
(30% inhibition during the first 20 m in.) (Figure 51). As for transferrin  
receptor, also the EGF receptor may be more efficiently recycled to the cell 
surface. N evertheless, these results ind icate that R abenosyn-5  over­
expression does not block transport to late endosomes and lysosomes.
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Figure 51: Effects of Rabenosyn-5 over-expression on EGF degradation.
HeLa cells were transfected with the indicated plasmids and infected with recombinant 
T7 RNA polymerase vaccinia virus. Cells were allowed to internalize InM of 
biotinylated-EGF for five minutes at 37°C and chased at the same temperature for the 
indicated time after extensive washes. EGF degradation was estimated by quantifying the 
amount of biotinylated-EGF accessible to anti-EGF antibody, by using the same 
eleetroehemilumineseenee detection system utilized to quantify biotinylated-transferrin 
recycling. Data represent means ± SEMfrom three independent experiments performed in 
duplicate.
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3. DISCUSSION
In this thesis I have investigated the role of Rab5, Rab4 and R ab ll in the 
structural and functional organization of the early endosomal compartment. The 
results of the experiments I performed provide molecular support to the Rab 
domain hypothesis and to the idea that the function of these three GTPases along 
the endocytic-recycling pathway is molecularly co-ordinated through the binding 
of conunon effector proteins.
Visualization of Rab5, Rab4 and R ab ll showed that these three GTPases 
are localized in distinct membrane domains, which can reside on the same cargo- 
filled endosome. The different combinations of Rab5, Rab4 and R ab ll domains 
define multiple early endosomal populations: one containing only Rab5, a second 
Rab5 and Rab4 and a third Rab4 and R a b ll . These different endosomal 
populations display different kinetics of transport and specific pharmacological 
proprieties, reflecting their biochemical and functional diversity. Recycling cargo 
en route to the plasma membrane moves sequentially from Rab5 to Rab4 and from 
Rab4 to R ab ll domains with the overall domain composition of the endosomes 
being constant during the cycle.
These observations are therefore in agreement with the idea that Rab5, 
Rab4 and R ab ll belong to the intrinsic structural and functional machinery of 
endosomes. These results led to the next point addressed in this thesis, that can be
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formulated in the two following and related questions: i) what are the molecular 
principles regulating the association between distinct Rab domains? ii) How is 
membrane transport between adjacent domains co-ordinated? The answers to 
these questions would provide an im portant step forward towards an 
understanding of the mechanisms responsible for the sequential transport of 
endocytosed cargo through early endosomes. Given that Rab effectors have been 
recognized to be membrane-tethering molecules (Allan et al., 2000; Cao et al., 
1998; Christoforidis et al., 1999; Guo et al., 1999; Price et al., 2000), one possible 
point of regulation for joining Rab domains would be at the level of these proteins. 
The findings that the Rab5 effector Rabaptin-5 binds also to Rab4 (Vitale et al., 
1998) and that a significant fraction of Rab5 containing endosomes harboured also 
Rab4 domains provides support for this idea. On this basis, I have hypothesized 
that bridging molecules, which have the property to bind or to regulate the activity 
of two distinct Rab proteins, may regulate the association between the 
corresponding Rab domains. To test this model I focused on the link between 
Rab5 and Rab4 domains by searching for, and investigating the function of, 
divalent Rab5 and Rab4 effectors. Consistent with the hypothesis formulated 
above, I could demonstrate that over-expression of the bi-functional Rab5/Rab4 
effectors changes the compositions of early endosomes by specifically increasing 
the link between Rab5 and Rab4 domains. Importantly, this effect is dependent on
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the capacity of these proteins to bind both Rab5 and Rab4. Moreover, these 
changes are accompanied by corresponding changes in the sorting and recycling 
capacity of early endosomes. Altogether these results are significant because they 
contribute to the understanding in molecular terms of the membrane organization 
and function of early endosomes and provide novel insights into the regulation of 
the endocytic-recycling pathway.
3.1 Visualization of Rab4, RabS and R a b ll domains on early endosomes
The correct localization of the GFP-tagged-Rab proteins, their accessibility to 
RabGDI and the kinetic of transferrin recycling indicate that the experimental 
strategy I have followed allows the faithful visualization of early endosomal 
organelles. The morphological quantification I have performed to determine the 
distribution of RabS, Rab4 and R ab ll on the different endosomal populations is in 
good agreement with two other independent studies. Using a gradient fractionation 
method, Sheff could isolate endosome populations with a remarkably similar Rab 
protein composition to the one shown in Table 1 (Sheff et al., 1999). Trischler 
obtained almost identical results by using an immuno-isolation approach, 
(Trischler et al., 1999). However, these biochemical studies did not provide any 
information concerning the topological distribution of Rab proteins.
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The observed segregation of Rab proteins on cargo-filled endosomes is a 
good indication that these regulatory components occupy distinct domains onto 
continuous membrane structures. However, it has to be noted that, theoretically, 
the segregation I have observed could also represent physically distinct elements 
at a distance < of 200nm and therefore below the resolution power of light 
microscopy. This seems not to be the case, as immuno-electron microscopy 
analysis of purified early endosomes also showed segregation of Rab proteins and 
their effectors within discrete regions of the same organelle (Sonnichsen et al., 
2000). Nevertheless, assuming that the structures harbouring different Rab 
proteins are indeed separate vesicles rather than contiguous subcompartments of 
the same endosomes, these data would demonstrate an unexpected diversification 
of early endosomal species (i. e. Rab5 endosomes, Rab4 endosomes, etc.).
The compartmentalization of Rab proteins within restricted membrane 
domains establishes an important point for the functional understanding and the 
molecular definition of early endosomes. Most importantly, this concept implies 
that the membrane surface of these organelles is functionally polarised. This 
model is also in agreement with the structure of the early endosomes. Indeed, the 
membrane of these organelles is partitioned in morphologically and functionally 
distinct sub-compartments, vesicles, cistemae and tubules (Marsh et al., 1986). 
The molecular principles that lead to partitioning of the endosome membrane into
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different areas would ensure that little or no intermixing between domains occur, 
despite the extensive flow of membrane through the early endosomes. Moreover, 
the arrangement of the machineries controlling membrane targeting, protein 
sorting and membrane-cytoskeleton interactions into domains may have the 
advantage to increase efficiency and co-ordination between these processes. For 
example, in the case of Rab5, this mechanism may guarantee functional co­
ordination and correct timing between endosome fusion and motility events. At 
the same time the segregation of functional distinct machineries may allow 
multiple reactions to occur simultaneously while avoiding mixing between its 
regulatory elements. In addition, the polarised distribution of Rab proteins 
determines directionality of membrane transport through endocytic organelles. 
Recycling cargo enters into early endosomes through the Rab5 domain and exits it 
through Rab4 and R ab ll domains. The role of Rab5 in regulating the inward leg 
of the endocytic pathway is well established and is therefore consistent with this 
order of events. It is in the membrane region specified by this GTPase that the 
membrane tethering and fusion machinery is concentrated and localized (Zerial 
and McBride, 2001). Rab4 and R ab ll are involved in the endocytic-recycling 
pathway presumably by regulating the formation and/or targeting of recycling 
vesicles (Ullrich et al., 1996; van der Sluijs et al., 1992). Consistently, these two
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GTPases occupy distinct membrane domains from Rab5 and cargo transit through 
these structures after leaving Rab5 domains.
According to this model, early endosomes can be considered to be 
organized as a mosaic of different Rab domains (see model in Figure 52). These 
domains would be organized by Rab proteins themselves (as suggested by the 
mechanism of action of Rab5) through the recruitment of specific effector 
proteins. It is therefore the ensem ble  of these effectors that specifies the 
function(s) of each domain. As Rab proteins belong to the intrinsic-resident 
machinery, which specify organelle functionality, their specific distribution has 
important consequences for the definition of organelles of the early endosomal 
system. The distinction between peripheral early endosomes and peri-nuclear 
recycling endosomes as two separate compartments interconnected by vesicular 
traffic has to be revisited. With respect to the distribution of Rab proteins both 
sorting and recycling endosomes are structured into Rab5, Rab4 and Rab 11 
domains (see model in Figure 52). Only the relative amount of these domains is 
different. According to the kinetics of cargo transport I have measured, early 
endosomes are composed of Rab5 and Rab4 domains and fewer Rab 11 domains. 
Whereas, recycling endosomes contain mainly Rab4 and Rab 11 domains and 
fewer Rab5. Also the geographical segregation between these different endosomal 
populations is not as stringent as previously proposed. Rab4-Rab 11-containing
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endosomes are localized both in the peri-nuclear region as well as in the cell 
periphery. The same is true for Rab5 and Rab4 domains.
The model that Rab proteins define functionally distinct membrane 
domains is in agreement with the most recent advances in the organization of 
biological membranes (see Introduction). Recent developments in light 
microscopy techniques have allowed the visualization of membrane fusion
Rab-domains in endosomes: a modular system
Sorting
Endosomes
^  A
nucleus
V  J
Recycling
Endosomes
Figure 52: Model proposing the sub-compartment organization of the early 
endosomal system in different Rab domains.
Rab5, Rab4 and Rab 11 domains are depicted as mint, red and blue ovals. Arrows trace 
the endocytic-recycling trafficking of transferrin receptor. Sorting-early endosomes are 
mainly composed of Rab5 and Rab4 and fewer Rab 11 domains while Rab4 and Rab 11 
domains mainly define recycling endosomes.
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events at the plasma membrane. Using total internal reflection fluorescence 
microscopy (TIRF) it was possible to follow fusion of post-Golgi derived vesicles 
with the plasma membrane. One striking observation of these studies was that 
fusion seemed to occur preferentially at specific sites (hot spots) of the plasma 
membrane (Toomre et al., 2000). These results are consistent with the idea that the 
membrane docking and fusion machinery controlling this transport step is not 
randomly distributed on the plane of the plasma membrane but rather concentrated 
in defined regions. Using a similar approach it was possible to visualize also the 
assembly of the AP-2 machinery on the plasma membrane. Again, this process 
occurred preferentially in specific regions, suggesting that the budding machinery 
is also preferentially assembled in specific regions (Gaidarov et al., 1999). By 
analogy, Rab domains on the endosomes define hot spot for membrane fusion or 
fission reaction events. Consistent with this model is the different pharmacological 
sensitivity of Rab5, Rab4 and Rab 11 domains. The tubulation of the Rab4-Rabll 
domains induced by Brefeldin A is most likely due to the inhibition of Arf 
dependent processes and implies that these two domains act as a platform for the 
assembly of components required for vesicle budding. Indeed coated buds have 
been observed on tubular extension on the early endosomes (Stoorvogel et al., 
1996). The AP-1 sub-unit y-adaptin has been localized to these structures and, at 
least in polarised cells, seems to play a role in transferrin recycling (Putter et al.,
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1998). Interesting in this respect is the observation that Rabaptin-5 interacts with 
y-adaptin (Page et al., 1999). The functional meaning of this interaction has not 
yet been investigated. One possibility is that Rab4 through Rabaptin-5 participates 
in the formation of y-adaptin-containing vesicles. This possibility may reflect the 
finding that over-expression of dominant negative mutant of Rab4 inhibits coated 
bud assembly on endosomes (de Wit et al., 2001). Conversely to Rab4 and R ab ll, 
Rab5 domains do not tubulate in response to BFA but they are sensitive to the PI- 
3 kinases inhibitor, wortmannin (Sonnichsen et al., 2000). The function of Rab5 is 
indeed centred on the formation of a PI(3)P enriched membrane domain on its site 
of action. Local clustering of active Rab5 and PI(3)P is essential for the 
recruitment of a group of regulatory molecules that have in common the capability 
to bind both Rab5 and PI(3)P. It is via these effectors that Rab5 functions 
(Miaczynska and Zerial, 2002). PI(3)P is specifically localized to sub-domains on 
sorting endosomes (Gaullier et al., 2000) and pharmaceutical inhibition of its 
production alters both the morphology as well as the functionality of these 
domains . Upon inhibition of PI(3)P synthesis, all Rab5-dependent functions are 
impeded. In a few minutes the Rab5 domain disorganizes and its effectors 
redistribute to cytosol: fusion events are reduced by more than 80% (as measured 
in an in vitro endosomes fusion assay) (Simonsen et al., 1998), binding of 
endosomes to cytoskeleton elements is mis-regulated and minus end directed
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motility of endosomes along microtubules is inhibited (Nielsen et al., 1999). 
These functional alterations correspond also to morphological changes: the 
spherical cisternal shape of the Rab5 domain is converted into a tubular one 
(Sonnichsen et al., 2000).
It has been long appreciated that the kinetics of transferrin recycling are 
biphasic being composed of a fast and a slow component (Hopkins, 1983). By 
mathematical modelling, Sheff and co-workers proposed that the kinetics of 
transferrin recycling pathway are best described by two recycling stations. The 
first is filled within the first five minutes after internalization and subsequently 
transferrin accumulates in the second one, which displays slower recycling 
kinetics (Sheff et al., 1999). According to the data presented in Figure 25, fast 
recycling coincides with transferrin transit from Rab5 to Rab4 domains. At a later 
stage of the cycle, transferrin accumulates in Rab4-Rab 11-containing endosomes 
which presumably exert slower kinetics of recycling and sorting proprieties. Thus, 
Rab4 may be involved in both fast and slow recycling, while Rabl 1 would mainly 
regulate slow recycling. The obvious question raised by this model is why are 
there two recycling stations with different kinetic properties? W hat is the 
advantage of this system? To understand these problems it is necessary to consider 
the role of the early endosomal system in polarised cells. In these cells endocytic- 
recycling must be polarised in order to maintain distinct basolateral and apical
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plasma membrane composition. Moreover, transport of trans-cytotic cargo across 
the épithélia requires an additional sorting step. Studies conducted in polarised 
MDCK cells showed that recycling from sorting endosomes is rapid being 
completed within the first ten minutes after internalization. These organelles seem, 
however, not to be able to sort trans-cytotic cargo. This function appears to be a 
prerogative of the recycling compartment. According to this order of events, at 
each endocytic cycle a fraction of receptors are transported from sorting to 
recycling endosomes. It is in this latest compartment that polarised sorting occurs 
and trans-cytotic receptors are sorted away from the rest of recycling components, 
which return to the plasma membrane (Sheff et al., 1999). The simplest 
interpretation for the different kinetics of recycling is that the fast recycling 
implies a single transport route, whereas slower recycling reflects passage through 
recycling endosomes. By this view the recycling pathway consists of two 
compartments which function in tandem to ensure efficient recycling and accurate 
sorting.
3.2 Molecular regulation of transport through Rab domains
The sequential transport of cargo through membrane domains selectively 
occupied by Rab proteins implies the existence of mechanisms co-ordinating
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neighbouring domains, and dictating the timing and the specificity of each 
coupling event.
In the second part of my thesis I address the molecular link between Rab5 
and Rab4 domains. I tested the hypothesis that bi-functional Rab effectors could 
regulate the communication between two consecutive Rab-domains on the 
endosome membrane. First, I designed a strategy of sequential affinity 
chromatography to search for Rab5 effectors that could also interact with Rab4. 
Besides the Rabaptin-5 proteins, I identified Rabenosyn-5, as a novel Rab4- 
interacting protein. I also provide experimental evidence for a role of Rabenosyn- 
5 and Rabaptin-5 in the functional link between Rab5 and Rab4 domains 
supporting a role for these Rab effectors in the recycling pathway. First, 
Rabenosyn-5 was localized to endosomal structures harbouring both Rab5 and 
Rab4. Second, over-expression of Rabenosyn-5 and Rabaptin-5 increased the 
fraction of endosomal structures that were positive for both Rab5 and Rab4 at the 
expense of Rab4 and Rabll-containing structures. Importantly, neither the Rab5 
effector EEAl nor the SNARE regulator hVPS45 had a similar effect. Third, over­
expression of Rabenosyn-5 increased the rate of transferrin recycling from early 
endosomes to the plasma membrane. Since this phenotype was accompanied by a 
reduced passage of transferrin from peripheral early endosomes to perinuclear 
recycling endosomes, these results suggest that transferrin has been deviated from
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recycling endosomes and preferentially recycled via the fast route. Rabenosyn-5 is 
therefore a Rab effector that plays a dual role in entry of cargo into the early 
endosome and sorting in the recycling pathway.
Based on these data, I propose the following order of events in the 
endocytic/recycling pathway. Cargo molecules incorporated into CCVs budding 
from the plasma membrane are delivered to early endosomes. This process is 
regulated by Rab5 and requires its downstream effectors Rabaptin-5 (Stenmark et 
al., 1995), the PI3-K hV PS34/pl50 (Christoforidis et al., 1999), EEA l 
(Christoforidis et al., 1999) and Rabenosyn-5 (Nielsen et al., 2000). The functional 
link between Rab5 and PI3-K is important for the membrane recruitment of EEAl 
and Rabenosyn-5, which are clustered in a specific region of the early endosome. 
Following entry into the Rab5- PI3(P)-positive domain, recycling molecules are 
sorted away from the degradative pathway and transported back to the surface. 
Rab4 and Rabl 1 have been implicated in this regulation. Over-expression of Rab4 
alters the transferrin receptor cycle by redistributing the receptor to the surface, 
with the internal pool accumulating in vesicles and tubules (van der Sluijs et al., 
1992). This phenotype suggests a sorting function for Rab4 in the “fast” recycling 
loop at the level of the early endosome, regulating the access of cargo to recycling 
structures. R a b ll regulates the “slow” branch of the recycling route through 
perinuclear recycling endosomes (Ullrich et al., 1996). Indeed, endocytosed
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transferrin sequentially travels through Rab5, Rab4 and Rabll-positive domains 
on endosomes. My data indicate that Rabenosyn-5, in conjunction with Rabaptin- 
5, regulates the transition of cargo from the Rab5- and PI(3)P-positive domain to 
the subsequent Rab4-domain. This transport step must be regulated since at steady 
state, only about half of the membranes labelled for Rab5 also harbour Rab4. In 
line with the membrane tethering function of Rab effectors (Allan et al., 2000; 
Cao et al., 1998; Christoforidis et al., 1999; Guo et al., 1999; Price et al., 2000), 
Rabenosyn-5 may tether Rab5-with Rab4-containing membranes. Rabenosyn-5 is 
complexed to the Sec-1-related protein hVPS45 and this protein interacts with 
various syntaxins (syntaxin4, 6 and 13) of the early endocytic pathway (Nielsen et 
al., 2000). It is easy to imagine that the Rabenosyn-5/hVPS45 complex could 
provide a regulatory function to the pairing of SNAREs following Rab5-Rab4 
membrane tethering and/or during recycling from early endosomes to the plasma 
membrane. Another possibility is that Rabenosyn-5 stimulates the homotypic 
fusion between domains of the same type, i.e. Rab5-Rab5 and Rab4-Rab4. 
However, while this is possible for Rab5, it seems unlikely in the case of the Rab4 
domain which, when uncoupled from Rab5, harbours no detectable Rabenosyn-5. 
Furthermore, instead of the expected equal increase in Rab5-Rab4 and Rab4- 
R ab ll positive structures, Rabenosyn-5 overexpression led Rab4 to shift from 
R ab ll to Rab5 (Table II). A third possibility considers that, if Rab5 and Rab4
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domains are in dynamic equilibrium between fusion and fission events, 
Rabenosyn-5 and Rabaptin-5 may stabilize the connection between the two 
domains and counteract fission. They may also confer a specific structural 
configuration to the junction between endosomal sub-compartments (e.g. connect
vacuoles and tubules) (see model in Figure 53).
A) t  FUSION
B) \  FISSION
C)X j u n c t io n
Figure 53: Model proposing the function of Rabenosyn-5 in coupling Rab5 and 
Rab4 domains.
Rab5 and Rab4 labelled endosomes are depicted as red and green ovals, respectively. At 
steady state, Rab5 and Rab4 domains are in equilibrium between fusion and fission 
reactions. Three possibilities, not necessary mutually exclusive, may explain why over­
expression of Rabenosyn-5 increases the association between Rab5 and Rab4 domains. 
Possibility A), Rabenosyn-5 facilitates the fusion between Rab5 and Rab4 domains. 
Possibility B), Rabenosyn-5 inhibits fission between Rab5 and Rab4 domains. Possibility 
C), Rabenosyn-5 confers structural integrity to the junction between Rab5 (vacuolar) and 
Rab4 (tubular) domains.
167
Several molecular requirements may be needed for a physical connection 
between Rab5 and Rab4 domains. I have determined that a key regulatory step of 
this process lies in the ability of Rabenosyn-5 to directly interact with Rab4. First, 
Rabenosyn-5 contains separate Rab5- and Rab4-binding sites displaying similar 
binding affinities. Furthermore, binding to these two GTPases is not mutually 
exclusive. Second, a mutant of Rabenosyn-5 lacking the Rab4-binding activity 
failed to enhance the association between Rab5 and Rab4 domains. The 
distribution of Rab5 and Rab4 domains together with the localization of 
Rabenosyn-5 implies that only a fraction of Rabenosyn-5 is bound to Rab4 at 
steady state. This interaction depends on several factors. Firstly, the ability of 
Rabenosyn-5 and Rabaptin-5 to interact with Rab4 depends on the GTP-bound 
state of this GTPase (Figure 34 A and B). Rabaptin-5 is complexed to Rabex-5 
and the exchange activity of the latter may ensure the activation of Rab5 at the 
Rab5-Rab4 junction for the recruitment of Rabenosyn-5. An open question is 
which guanine nucleotide exchange factor (GEF) activates Rab4? An interesting 
possibility is that Rabex-5 itself may catalyze GDP/GTP exchange also on Rab4. 
In this case, the activation of Rab4 would be dependent on the prior activation of 
Rab5 and recruitment of the Rabaptin-Rabex-5 complex. Secondly, Rabenosyn-5, 
as well as Rabaptin-5, appear to be rate-limiting components for the coupling 
between Rab5 and Rab4 domains. A single Rabenosyn-5 molecule is probably not
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sufficient and multiple Rabenosyn-5-Rab4 complexes may be required to bridge 
the Rab5 and Rab4 domains. This implies that an important regulatory factor is 
the density of free and active Rab4 in the Rab4 domain. However, Rab4 is 
presumably engaged in interactions with other Rab4 effectors such as Rabip4 
(Cormont et al., 2001). An exciting possibility raised by my findings is that some 
of these molecules may regulate the specific association between Rab4 and Rabl 1 
domains. Thirdly, other Rabenosyn-5-interacting factors may participate in the 
Rab5-Rab4 coupling. Rabenosyn-5 shows structural and functional similarity to 
V aclp (Nielsen et al., 2000), which mediates transport from the Golgi complex to 
a pre-vacuolar endosome in yeast (Weisman and Wickner, 1992). However, 
Rabenosyn-5 appears to have additional structural features that are absent in the 
yeast protein. Most notably, it contains a much longer carboxyl-terminal region 
downstream of the FYVE finger that includes 5 NPF motifs. The presence of these 
protein-protein interaction motifs suggests that Rabenosyn-5 can functionally 
associate with other proteins of early endosomes in addition to Rab5 and Rab4. In 
particular, NPF motifs have been shown to interact with proteins containing EH- 
domains, such as those involved in clathrin-coated vesicles formation (Salcini et 
al., 1997), suggesting a possible link between Rabenosyn-5 and clathrin coat 
assembly on endosomes. These structural features suggest that Rabenosyn-5 has 
acquired additional functional properties throughout evolution that are peculiar to
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animal cells. Interestingly, Rabaptin-5 is not found in yeast. It could be that the 
activity of these two Rab effectors has evolved to support the Rab4-dependent role 
in protein sorting and transport from endosomes to the surface.
The reasons why Rabenosyn-5 stimulates transferrin recycling are 
presumably two-fold. First, assuming that the transition from the Rab5 to the Rab4 
domain is necessary for recycling, Rabenosyn-5 over-expression would facilitate 
this process as most Rab5 domains are joined to Rab4 (see Table I). Second, by 
favouring the link between Rab5 and Rab4 against R ab4/R abll domains, an 
excess of Rabenosyn-5 would increase the probability of transferrin receptor to 
recycle via the fast route. One might envisage a similar coupling between Rab4 
and R ab ll domains via distinct Rab effectors. Over-expression of Rabenosyn-5 
would sequester the fraction of Rab4 available for such interactions reducing the 
pool of Rab4 normally coupled to R ab ll. This explanation is consistent with the 
reduction in structures positive for both Rab4 and R ab ll. Upon entry in the Rab4 
and R ab ll domains, cargo would then be incorporated in tubular structures that 
bud from endosomes and fuse with the plasma membrane. In this process, 
recycling receptors may be selectively and efficiently captured by coat proteins, 
since coated buds were observed on the tubules (Stoorvogel et al., 1996). 
Interestingly, conditions that inhibit coat assembly on the endosomes also perturb 
the structural organization of Rab4 and R ab ll domains. Coated vesicles may also
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serve to recycle components back to the plasma membrane although this 
mechanism does not appear to be essential.
In conclusion, the function of divalent Rab effectors such as Rabenosyn-5 
may define a novel mechanism regulating the structure, sorting and transport 
activities of the early endosomal compartment. This mechanism is based on the 
functional link between distinct Rab domains and could in principle operate also 
in biosynthetic transport. The activity of divalent Rab effectors should help in 
understanding how recycling from early endosomes is regulated and, hopefully, 
clarify the yet elusive function of recycling endosomes. In relation to this, 
particularly informative will be the studies of polarised cells, where recycling 
endosomes have been implicated in the trafficking of molecules along the trans- 
cytotic route.
3.3 Open questions and future directions
The conclusions drawn from this study opens a series of questions whose 
answers may have an important impact on the understanding of the biogenesis and 
function of endocytic organelles. Firstly, to what extent do Rab proteins organize a 
membrane domain? The molecular characterization of the Rab5 effectors would 
argue that this GTPase plays an active role in the biogenesis of a membrane 
domain, although formal proof for this proposal has not yet been provided.
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However, to generalize this concept it will be necessary to provide experimental 
evidence also that other Rab proteins function in a similar way. In this context, it 
will be important to characterize the Rab4 and R ab ll effectors. This approach will 
not only address this point, but will also help to define more precisely the function 
of these two GTPases and thus will contribute to the molecular understanding of 
the endocytic-recycling pathway. In collaboration with other colleagues in the 
laboratory of Dr. Zerial, I have already started this project and obtained 
preliminary results. As Rab5, Rab4 and R ab ll also interact with a multiplicity of 
effectors. This finding per se does not yet add much information, but provides the 
necessary condition to support, at least theoretically, the idea that these three 
GTPases may function in a similar way. Most importantly, the discovery that 
some of the Rab4 effectors interact also with R ab ll suggests that, by analogy to 
the common Rab5 and Rab4 effectors, these molecules may regulate the 
association between Rab4 and R a b ll domains. Given that recycling cargo 
(transferrin) transits from Rab4 to R ab ll domains at a later stage of its cycle, the 
in vitro recycling assay which I developed during the first part of my Ph.D. thesis 
work, may represent a valid assay to study the function of the common Rab4 and 
R a b ll effectors. Indeed as already discussed in paragraphs 2.5 and 2.3, the 
experimental conditions established in this assay are presumably reconstituting 
late rather than early stage of recycling.
172
Recently it has been reported that one of the Rab5 effector, the lipid kinase 
VPS34, also interacts with Rab? (Stein et al. (2001) MBC Abstracts-1367- volume 
12, pg. 149), implying that these two GTPases are also functionally linked. Thus, 
it appears that divalent Rab effectors are a common theme in the mechanism of 
action of these GTPases. It will be interesting to investigate whether Rab7, which 
functions downstream of Rab5 in regulating trafficking from early to late 
endosomes, would also be localized to defined membrane domains. And if so, 
would these domains be linked to Rab5 domains as suggested by the finding of the 
common Rab5 and Rab? effector? If this will prove to be the case, it means that 
the model I have proposed to explain how Rab5 and Rab4 domains are linked can 
be applied also to explain the link between other Rab domains. This mechanism 
therefore may represent a general principle regulating the function and the sub- 
compartmentalization of early endosomes (see model in Figure 54). Even more, it 
is attractive to speculate that this model, based on functionally distinct Rab 
domains linked by common effectors, could be applied also to other organelles. 
Secondly, it will be necessary to incorporate the function of other regulatory 
components of the transport machinery, such as members of the Rho and ARF 
GTPases family and their effectors. Cross-talk between these machineries could 
possibly link vesicle formation with vesicle targeting and with the role of 
cytoskeleton in organelle structure and motility.
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Divalent Rab Effectors Regulate the 
Communication between Rab-domains
RabS Rab4 R a b ll
Rab?
Figure 54: M odel proposing  the fu nction  o f d ivalen t Rab effectors in  
regulating the com m unication betw een Rab dom ains along the endocytic  
pathway.
Rab5, Rab4, R ab ll and Rab? labelled endosomes are depicted as coloured 
rectangles. White arrows represent divalent Rab effectors linking two adjacent 
domains. Green arrows indicate the directionality of trafficking along the 
recycling route (Rab5-^Rab4—>Rabl 1) or the degradative route (Rab5^Rab7). 
See text for more details.
Another open question concerns the localization and the size of a Rab
domain. For example does a single Rab5 domain occupy the entire membrane 
surface of the vacuolar portion of the early endosome, or do many Rab5 micro­
domains concentrate in this region? To approach these problems it will be 
necessary to perform ultrastructural studies on both purified endosomes as well as
in intact cells. Such experiments are now in progress in the laboratory in
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collaboration with A. Mironov, P. Verkade and R. Parton. Important insights may 
come also from the analysis of endocytic organelles using atomic force 
microscopy. This technique may indeed allow a description of the surface of these 
organelles at atomic level. In addition, to better define the mechanisms responsible 
for the compartmentalization of biological membranes, it will be also necessary to 
reconstitute in vitro (for example using proteoliposome membranes) the clustering 
and the organization of the regulatory components of the membrane transport 
machinery.
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4. Materials and Methods
4.1 Cell culture
A431 and HeLa cells (American Type Culture Collection (ATCC)
Manassas, VA USA) were grown in D-MEM (Dulbecco’s Modified Eagle’s
Medium) supplemented with 10% (v/v) heat-inactivated fetal calf serum, lOOU/ml
penicillin, 100/rg/ml streptomycin and 2mM L-glutamine. Stable A431 cell line
over-expressing GFP-Rab4, GFP-Rab5 and GFP-Rabll were grown in the same
medium as A431 cells plus 0.4 mg/ml Neomicyin G418. CHO-Kl (American
Type Culture Collection (ATCC) Manassas, VA USA) were cultured in Ham’s F-
12 medium supplemented with 10% (v/v) heat-inactivated fetal calf
serum, lOOU/ml penicillin, and lOO/tg/ml streptomycin. 1 1 stocks of D-MEM
(Dulbecco’s Modified Eagle’s Medium) and Ham’s F-12 were prepared by the
Cell Biology department media kitchen EMBL (Heidelberg). Fetal Calf Serum
(FCS) was purchased from Gibco. To inactivate the serum complement, the FCS
was heated 30 min at 56°C, aliquoted and stored frozen at -20°C. Frozen stocks of
200 mM L-glutamine and antibiotics (10 mg/ml streptomycin - 10"^  U/ml
penicillin) were from Gibco-Brl. The solutions were distributed into 10-ml
aliquots and stored frozen at -20°C. Media were prepared by adding antibiotics, L-
glutamine, FCS and, if required, other components to the media stocks and stored
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at 4°C. Cells were routinely cultured in a H20-saturated atmosphere containing 
5% CO2 on 10 cm diam. plastic petri dishes (Nunc) with 10 ml of medium. For 
passaging, the cells were washed 1-2 times with Ca^VMg^^ free PBS (PBS") and 
detached from the dish using a 0.25% trypsin/EDTA solution (Gibco). After 
detachment of the cells, medium was added to 10 ml and the cells gently 
resuspended.
4.2 Transient expression systems in eukaryotic cells
4.2.1 Infection of HeLa cells with vaccinia virus T7
HeLa cells, grown on plastic dishes, were trypsinized 24 h prior to transfection,
and seeded onto 11 mm round coverslips. Infections with the purified virus were
done on 80% confluent BHK-21 cells. Trypsinized stock vaccinia virus prepared
as described in Bucci C. et al (1992), was thawed and diluted in D-MEM,
containing 20 mM HEPES, pH 7.2, 20 fig/ml soybean trypsin inhibitor (Sigma), to
a concentration of approximately 3.4 p.f.u/ml. Cells on coverslips were rinsed
once with D-MEM and infected with 200 [il of the virus mixture. The cells were
then incubated at room temperature for 30 min, with occasional rocking of the
dishes. Transfection were done by lipofection using the cationic lipid N -[l-
(2 .3D io leoy loxy)propy l]-N ,N ,N -trim ethy lam m onium su lfa te  (D O TA P)
(Boehringer Mannheim). The plasmid DNAs were first diluted to 20 /xl in
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transfection buffer (TB; 20 mM HEPES, 150 mM NaCl, pH 7.4) in a polystyrene 
tube. In a second polystyrene tube, 10 /d of DOTAP were diluted with 10 /d of 
TB. The plasmid solution was added dropwise to the DOTAP solution, mixed and 
left at room temperature for 10 min. From the infected cells, the medium was 
removed and the transfection mix added. 200 [Û of medium containing 10 mM 
hydroxyurea were also added in order to block the viral DNA replication. The 
cells were then incubated at 37°C in medium devoid of serum for 4 h. Thereafter, 
samples were processed for immuno-fluorescence experiments to assess 
transfection efficiency and protein over-expression level or processed for 
biochemical measurement of transferrin recycling and EOF degradation.
4.2.2 Microinjection of plasmid DNAs into A431 and CHO cell nucleus.
In order to study the effects of Rabenosyn-5 over-expression on the endosomal 
localisation of Rab proteins, appropriate plasmids were injected into the cell 
nucleus of A431 cells using a micromanipulator and transjector (Eppendorf). 
Expression of the CEP constructs was generally lower compared to the YFP 
fusion proteins. A mixture of Ing/pl YFP, 20ng//d CFP and 50ng/jnl Rabenosyn-5 
or Rabaptin-5 or EEAl plasmid DNAs were chosen as standard concentration in 
all microinjection experiments. CHO cells were grown on glass coverslips
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(MatTek Corp., Ashland, MA) and microinjected with 50ng//xl of the appropriate 
plasmids as described above.
4.3 Generation of A431 cells stably expressing GFP-Rab4
Rab4 cDNAs cloned in frame into pEGFP expression vector (Clontech) 
were cotransfected into A431 cells using lipofection technique. 20 pg of plasmid 
DNAs were diluted to 250 p\ of DOTAP buffer (20 mM Hepes, 150 mM NaCl, 
pH 7.4) in a polystyrene tube. In a second tube a 1:1 mixture of DOTAP:buffer 
was prepared. The plasmid solution was then added dropwise, gently mixed, and 
left 10 min at room temperature. This suspension was added dropwise to a 10 cm 
dish of A431 cells, which had been split, 1 : 5 from a confluent dish the previous 
day. After 20 min, 10 ml of fresh medium was added and the dish incubated for 6  
h at 37°C. The cells were cultured in 10 ml of fresh medium for 20 h. The 
following day, the transfected cells were split at different densities (1%, 2%, 5%, 
10%, and 82%) onto 10 cm dishes in medium containing 0.5 mg/ml G418 (Gibco). 
The selection media was changed every 4 days and after 1 2 - 1 5  days colonies 
were isolated using cloning rings ( 6  mm internal diam). The colonies were 
encircled at the bottom of the dish using a felt pen. The plates were washed once 
with PBS-. The cloning rings were put on the colonies using Glisseal™ (Borer 
Chemie A.G.) and -50  p\ of trypsin solution applied. The cells were resuspended
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and transferred into 24 well plates in 1 ml of medium containing 0.5 mg/ml G418 
and expanded.
Expressing colonies were screened by immunofluorescence microscopy. Positive 
clones were expanded, and lines were finally subcloned to obtain a high number 
of expression cells.
4.4 Permeabilization of A431 cells with Streptolysin O.
A431 cells were grown for 48 hours into 24-multiwell plates to 80-90 % 
confluence. Cells were washed twice with 1 ml of ice-cold buffer 1 (115 mM K- 
acetate, 25mM HEPES pH 7.4, 2.5 mM MgCl2) and placed on ice. Streptolysin O 
was obtained from Dr. Bhakdi S. (University of Mainz, Mainz, Germany). SL-O 
was activated in buffer 1 containing 10 mM DDT at 37° C for 30 minutes and 
incubated for further 10 minutes on ice before use. Cells were then incubated with 
200 pi of ice-cold buffer 1 containing different concentration of SL-O for 10 
minutes on ice, washed 2  times with 1 ml of ice cold buffer 1 , and incubated in 2 0 0  
pi of buffer 2 (115 mM K-acetate, 25mM HEPES pH 7.4, 2.5 mM MgCl2, 5 mM 
EGTA and 2.5 mM CaCO^, 1 mM DTT) at 37 ° C for 2 minutes to allow pore 
formation. Cells were then returned to ice and incubated with 500 pi of buffer 2 
for an additional 30 minutes to wash out the endogenous cytosol. The efficiency 
of permeabilisation was estimated by measuring the amount of cytosolic lactate
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dehydrogenase (LDH) released into the medium. LDH enzymatic activity 
measurements are based on the decrease in the absorbance at 340 nm of the 
NADH in the presence of pyruvate and LDH. This decrease within a defined 
period of time (OD/min.) is proportional to the concentration of LDH.
To quantify the amount of LDH released from SL-O-permeabilized cells, 
2 0 0  pi of samples containing the washed out cytosol were mixed with 800 pi of 
buffer 1, mixed and incubated with 5pi of 20 mg/ml NADH (Sigma) and 10 pi of 
60 mM Na-pyruvate. The absorbance at 340 nm was followed during the first 2 
minutes of the reaction, using the ultraspec 2 1 0 0  spectrophotometer, according to 
manufacturer’s instructions (Pharmacia).
4.5 In vitro recycling assay in SL-O-permeabilized A431 cells.
For each assay cells were grown and permeabilised as described above with 
the only exception that they were loaded with 1 0  pg/ml of biotinylated transferrin 
before permeabilisation. Following the incubation on ice to allow cytosol 
diffusion, cells were incubated in ice-cold buffer 2 for 10-30 min. The buffer 2 
was removed, and 300 pi of the regeneration solutions were added to the 
respective wells: donor cytosol and ATP regeneration solution (1 mM ATP, 8  mM 
creatine phosphate, and 40 units/ml creatine phosphokinase) in buffer 2, an ATP 
regeneration solution buffer 2, or buffer 2 alone. All regeneration solutions
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contained approximately 1 mg/ml of unlabelled transferrin. For most experiments, 
HeLa cytosol at 3 mg/ml was used. Cells were incubated in the regenerating 
solutions for 5 min at 4 °C, and the plate was then transferred to a 37 °C water 
bath. The medium (effluxed Tf) was removed and collected at various time points 
and the cells were washed once in phosphate-buffered saline. This wash was 
pooled with the efflux medium. The cells were solubilized in 2% Triton X-100. 
The efflux and cell-associated biotinylated transferrin were determined as 
described in paragraph 4.7.
4.6 Cytosol Preparation of Spinner Hela cells
Five confluent medium sized flasks (175 cm^) of Hela in S-MEM 
(containing L-Glutamine, non-essential amino acids Fetal Calf Serum (5%), 
Penicillin/Streptomycin) were trypsinized and added to 600 ml of S-MEM media 
in a 1 litre spinner flask (Wheaton), placed on a stirrer and incubated at 37°C for 2 
days. After this time, the 600 ml were split into two 3-litres spinner flasks, each 
scaled up to 2 litres, placed on a stirrer and incubated at 37°C for 4 days. At a 
confluency of about 0.8 xlO^ cells/ml, cells were harvested by sedimenting at 3000 
rpm, 10 min, at 4°C and washed 2 times in IX  PBS. The obtained pellet of about 
7.5 ml was resuspended in 7.5 ml buffer (containing 50 mM HEPES, pH 7.4, 50 
mM KCl, 2 mM MgCl2 , 1 mM DTT, lOpg/ml Aprotinin, lOptg/ml Leupetin,
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1 Ong/ml Pepstatin, 1 Op,g/ml Antipain and 0.4 mM Pheenylmethylsulfonyl 
Fluoride (PMSF)). Cells were cracked in a cell cracker (EMBL) using ball bearing 
size 8.004 and two 10-ml syringes by passing through the cracker 8-10 times. 
Efficient breakage was checked under the microscope. Homogenate was spun in 
TLA 100.4 Beckman ultracentifuge, at 80K rpm for 30 min, at 4°C resulting in 
about 6.5 ml supernatant (cytosol).
4.7 Kinetic Analysis of Transferrin recycling and EGF degradation
For T7 promoter driven over-expression experiments, HeLa cells were 
grown to 60% confluence, transfected with the appropriate plasmids and infected 
with T7 polymerase recombinant vaccinia virus as described in paragraph 4.2.1. 
Four hours post-infection cells were washed 2 times with PBS and biotinylated 
transferrin was internalised at a concentration of 1 0 p,g/ml for the indicated time. 
Unbound and surface bound transferrin was removed by washing the cells with ice 
cold PBS containing 1 mg/ml cold transferrin followed by cold low pH buffer (150 
mM N ad, lOmM acetic acid pH 3.5, 1 mg/ml cold transferrin) washes. This 
procedure was repeated 2 times resulting in the removal of 95-98% of surface- 
bound ligand (from cells that had been incubated with biotinylated transferrin for 
Ih on ice). To measure recycling, cells were returned to 37°C, and incubated with 
1ml of medium containing 1 mg/ml of unlabelled transferrin. At each time point an
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aliquot of the medium was collected. At the end of the time course cells were 
washed 2 times with ice cold PBS and homogenised in 1ml of lysis buffer (PBS 
containing 2% TRITON X-100, 0.4% Sodium dodecyl sulfate). 30pl of the 
collected medium containing the recycled biotinylated-transferrin, or 30 pi of the 
lysate, containing the cell-associated biotinylated-transferrin, were quantified as 
described below. For each time point, results were expressed as percent of the 
total signal.
EGF trafficking was followed by internalising InM of biotinylated-EGF for 
5 minutes at 37 °C and chased at the same temperature for the indicated time after 
extensive washes. EGF degradation was estimated by quantifying the amount of 
biotinylated-EGF accessible to anti-EGF antibody, by using the same 
electrochemiluminescence detection system utilised to quantify biotinylated- 
transferrin recycling (see below)
4.7.1 Detection systems -  Electrochemiluminescence (ECL) Detection System
An electrochemiluminescence-based technology was used to quantify 
transferrin recycling and EGF degradation. The ECL-Analyser System was 
purchased from IGEN (Igen, Rockville, MD, USA).The ECL reaction is 
illustrated in Figure 53.
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Photon(620 nm)
Electrode
Figure 55. The electrochemiluminescence reaction
The ruthenium TAG coupled with the secondary antibodies and the tripopilamine 
(TPA) supplied by the Assay Buffer (Igen) were activated by oxidation at the 
electrode which serves as a sink or source of electrons and whose potential 
controls the amplitude of the electrochemical reaction. The oxidised, active TAG 
then reacts with the oxidised TPA to create the electronically excited state of 
TAG. The excited state luminesces at 620 nm wavelength, and the light produced 
is directly proportional to the amount of TAG activated in the reaction. 
Streptavidin-coated paramagnetic beads were used in order to capture the 
follow ing im m une-com plexes: b io tiny lated  tran sfe rrin /an ti-tf  sheep
serum/ruthenium labelled anti-sheep IgG; or biotinylated EGF/anti-EGF rabbit
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IgG/ruthenium labelled goat anti-rat IgG. Within the Analyser electrochemical 
flow cell, the beads present in the sample are drawn to the electrode with a 
magnet. Subsequently a “cleaning cycle” is performed with the Cell Cleaner 
Buffer (Igen), the magnet is then dropped, a voltage waveform is applied to the 
cell, and the light generated is measured. After flushing the cell with Cell Cleaner 
Buffer, the electrochemical flow cell is reconditioned with Assay Buffer and the 
cycle is repeated for the next sample.
For transferrin recycling, samples containing biotinylated transferrin were 
incubated first with 1 fxi of M-280 Streptavidine Dynabeads, then with 1.25 /xl of 
sheep anti-human transferrin serum (SAPU, Law Hospital Carluke, Scotland) 
diluted in 400 fil of Wash Buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 2% 
Triton X-100, 0.2% BSA) and finally with 2 ptg/ml ruthenium-labelled rabbit anti­
sheep IgG. All the incubation steps were performed at RT for 1 h. Between the 
different incubation steps M-280 Streptavidine Dynabeads were washed 3 times 
with Wash Buffer using a Dynal MPC-E Magnetic Particle Concentrator (Dynal, 
Oslo, Norway). After the last washing step the Dynabeads were resuspended in 
100 [il of Wash Buffer and 100 [û of Assay Buffer and subsequently quantified by 
the ECL-Analyser. For EGF degradation assays, samples containing biotinylated 
EGF (500 |il, final volume) were incubated first with 2 /xl (5nM final) of rabbit 
anti-human EGF IgG (Dianova) for 30 minutes and then 1 /xl of M-280
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Streptavidin Dynabeads was added to the mixture and incubated for 1 hour. 
Thereafter, M-280 Streptavidin Dynabeads were washed 3 times with Wash 
Buffer diluted in 400 /xl of Wash Buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 
2% Triton X-100, 0.2% BSA) containing 2 /xg/ml (1:400) of ruthenium-labelled 
goat anti-rabbit IgG.
4.7.2 Ruthenium labelling of secondary antibodies
The N-hydroxysuccinimide ester of the ruthenium chelate (ORIGEN TAG- 
NHS ester, IGEN) was utilised to label the following secondary antibodies: 
affinity pure anti-rat IgG F(ab’ )2 fragment specific antibody and rabbit anti-sheep 
IgG (Dianova). All secondary antibodies were obtained from Dianova (Hamburg, 
Germany). The ruthenium chelate was dissolved immediately before use in the 
appropriate volume of DMSG in order to obtain a stock solution of 1.5 /xg//xl. To 
achieve a 10:1 labelling molar ratio, 24 /xl of Origen Tag-NHS ester stock were 
added to 278 /xl of the affinity pure secondary antibodies (1.8 mg/ml). The volume 
of the reaction was adjusted to 500 /xl by adding 198 /xl of Phosphate Buffer (0.01 
M Na2HP0 4 /NaH2P0 4 , pH 8.0, 0.25 M NaCl). The tube content was gently 
vortexed and incubated at room temperature for 60 min in the dark. The labelling 
reaction was stopped by adding 20 /xl of 2 M glycine, pH 2.8, and incubating at 
room temperature for 10 min in the dark. To remove the uncoupled Origen Tag
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label, the mixture was subsequently loaded onto a PD-10 column (Pharmacia) 
equilibrated with PBS-2 (0.15 M K2HPO4/KH2PO4 buffer, pH 7.2, 0.15 M NaCl) 
The labelled antibodies were eluted with PBS-2 and the protein concentration of 
the collected and pooled fractions was determined using the Biorad protein assay 
and the gamma globulin standard. In order to calculate the conjugation ratio 
obtained, the absorbance of the Origen Tag-IgG was measured at 455 nm using a 
1 cm path cuvette. The conjugation ratio typically ranged between 4 to 8  
molecules of Tag: molecule of antibody. The antibody conjugates were stabilized 
by adding BSA at the final concentration of 3%, aliquoted and stored at -20°C.
4.8 Confocal Microscopy, Image Processing and Quantitation of Signal 
Overlap on Fixed Cells
Confocal microscopy was performed on a Compact Confocal Camera 
(CCC). For multi-channel imaging, fluorescent dyes were imaged sequentially in 
either frame-interlace or line-interlace modes to eliminate cross talk between the 
channels. CFP was excited with a 430-nm laser line (Directly Doubled Diode/D3, 
Coherent) and imaged through a combination of 440-505nm bandpass and 525nm 
longpass emission filters. YFP was exited with the 514-nm Argon laser line and 
imaged through a 525-nm longpass emission filter. Texas-red was excited with the
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594-nm Helium Neon laser line and imaged through a 610-nm longpass emission 
filter.
Serial sections of images were acquired satisfying the Nyquist criteria for 
sampling and processed on a multiprocessor SGI Unix computer using the 
Huygens System 2.2 (Scientific Volume Imaging BY). A Maximum Likelihood 
Estimation (MLE) based algorithm was used for image reconstruction. Z-stacks of 
images were exported as TIFF files, and individual sections were analyzed for 
fluorescent signal overlap by visual inspection. Using Adobe Photoshop 5, a grid 
of 5 by 5cm was projected onto the image of the reference channel (for example 
Texas-red transferrin), and in every second grid square all fluorescent structures 
were marked on a separate, superimposed layer. Signals were referred to as 
individual structures if they comprised of a continuous patch of intensity values 
above 50 (in a range of 0 to 255). This layer was then projected onto the 
corresponding images for the other two channels (for example YFP-Rab4 and 
CFP-Rab5), and the underlying image was analyzed for fluorescent signal at the 
marked position. At least two sections per cell were counted, ensuring that 
peripheral and perinuclear structures were equally taken into account. 
Immunofluorescence labelling was performed according to standard procedures. 
Cells were mounted in ProLong™ Antifade (Molecular Probes).
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4.9 Electron Microscopy
A431 cells grown to 70% confluence in 10cm dishes were transfected with 
lOpg of pCDNA3-Rabenosyn-5 by using SuperFect (Qiagen). 24 hours post 
transfection cells were fixed by adding to 8  ml of growth medium an equal 
volume of 2X fixative consisting of 0.4% EM Grade glutaraldehyde (Merck) and 
4% paraformaldehyde in 0.4M potassium phosphate, pH7.4. After 10 minutes the 
mixture was replaced by fresh IX fixative and incubated for 3 hours at room 
temperature. Cells were washed with PBS and free aldehyde groups blocked by 
incubation for 10 minutes with 50mM ammonium chloride in PBS. Cells were 
washed with PBS, scraped and the pellet embedded in 2% low melting point 
agarose in PBS. After the agarose was hardened by chilling, small blocks were 
cut, infiltrated overnight in 2.1 M sucrose and frozen in liquid nitrogen. Ultrathin 
cryosection were cut at -100° with a Leica ECS cryomicrotome using a Drukker 
Knife. Sections were collected and transferred to grids coated with formva and 
carbon, and freshly glow-discharged. Unspecific binding sites were blocked with 
0.5 % (v/v) fish skin gelatine, 20mM glycine in PBS for lOmin. Antibodies 
against Rabenosyn-5 were diluted in blocking solution at 1/30. Protein A 
conjugated to lOnm gold was diluted according to the manufacturer’s instructions 
(Slot and Geuze, University of Utrecht). Labelled grids were embedded in 
aqueous 2% methylcellulose, 3% uranyl acetate to add contrast and prevent
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shrinking upon drying. Grids were observed with a Zeiss EM -10 microscope at 80 
KV.
4.10 Sequential Affinity Chromatography
To purify Rab5 effectors, bacterial D H 5a cells (30 1) were grown to 
express GST-Rab5 and the protein was purified using 5ml of glutathione beads 
according to the manufacturer’s instructions (Pharmacia). This material was then 
incubated with nucleotide-exchange buffer (buffer A) containing 20 mM HEPES, 
100 mM NaCl, 10 mM EDTA, 5 mM MgC12, ImM DTP, 1 mM GTPyS, pH 7.5, 
for 90 min at room temperature under rotation. Afterwards, buffer A was removed 
and the GTPyS form of GST-Rab5 was stabilized with buffer (buffer B) 
containing 20 mM HEPES, 100 mM NaCl, 5 mM MgC12, ImM DTT, pH 7.5, in 
the presence of 1 mM GTPyS for 20 min at room temperature under rotation. 
Beads were then incubated for 120 min at 4 °C with bovine brain cytosol. 
Thereafter, beads were washed with 10 column volumes of buffer B containing 10 
fiM  GTP-S, 10 column volumes of buffer B containing 250 mM NaCl final 
concentration and 10 [xM GTPyS, and 1 column volume of 20 mM HEPES, 250 
mM NaCl, 1 mM DTT, pH 7.5. Bound proteins were eluted with 1.5 column 
volumes of buffer C containing 20 mM HEPES, 1.5 M NaCl, 20 mM EDTA, 
ImM DTT, 5 mM GDP, pH 7.5, incubated with the beads for 20 min at room
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temperature under rotation. Eluted proteins were first treated twice for 1 h at 4 °C 
with 0.2 ml glutathione-Sepharose beads to remove GST-Rab5 which leaked from 
the affinity column during the elution step. The sample was then desalted using 
PDIO columns (Pharmacia) in a nucleotide free buffer containing 20 mM HEPES, 
150 mM NaCl, ImM DTT, pH 7.5. The Rab5 interacting proteins obtained were 
then incubated with 1ml of glutathione beads containing GST-Rab4 loaded with 
either GTPyS or as control GDP. GST-Rab4 was prepared as described above for 
GST-Rab5. For the GDP form of GST-Rab4 the following changes were made: 
all buffers contained GDP instead of GTPyS, except for the elution buffer which 
contained GTPyS (1 mM) instead of GDP. Bound proteins were eluted with buffer 
C, separated by SDS-PAGE and analysed by Western blot or mass spectroscopy.
4.11 In Vitro Binding Assay and affinity measurement
Rabenosyn5 and hVPS45 DNAs were in vitro transcribed and translated in
the presence of ^^S-methionine using a TnT coupled transcription-translation kit
(Promega). Binding assays were performed by incubating 50/il of the translated
proteins with 30 pl of GST-Rab5, Rab4 or R ab ll loaded with either GDP or
GTPyS. Bound proteins were eluted, separated by SDS-PAGE and analysed by
autoradiography. For the binding experiments using insect cells over-expressed
proteins, recombinant baculovirus carrying Rabenosyn-5 and hVPS45 cDNAs was
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generated according to manufacturer’s instructions (Life Technologies). To 
achieve optimal protein expression levels, 500 ml of suspension grown ExpresSf+
(Protein Science) insect cells (1 X 10^ cells/ml) were infected at M.O.I of 2 and 
incubated for a further 52 hours. Cells were harvested by centrifugation and 
cytosol prepared as described below. Approximately 8  mg of total proteins were 
incubated for 2 hours at 4° C with 100 jil beads containing -400 pg GST-Rab4 
loaded with GTPyS. After extensive washes with buffer B, beads were further 
incubated for 1 hour with -200 pg of purified Rab5:GTPyS and lOmg/ml BSA 
diluted in buffer B. Beads were washed with 10 ml of buffer B and bound proteins 
were eluted as described above.
The dissociation constants (Kd) of the interaction between Rab5-
Rabenosyn-5 and Rab4- Rabenosyn-5 were determined following the method of
Butner et al. to measure the affinity between tau proteins and tubulin Butner et al.
(1991). Briefly, Rabenosyn-5 was in vitro translated in the presence of ^^S-
methionine using a TnT coupled transcription-translation kit (Promega). 20
microliters of translated protein were incubated for 1 hour at room temperature
with serial dilution of glutathione-Sepharose beads containing GST-Rab4 or Rab5
in 200 pi of buffer B (with the total amount of Rabenosyn-5 being always well
below the concentration of GST-Rab to ensure maximal binding). Beads were
spun through a 1 ml 40 % sucrose cushion to separate bound from the unbound
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Rabenosyn-5. Proportional aliquots of bound, unbound and total loaded fractions 
were separated by SDS-PAGE, and analysed with a phosphoimager for 
quantification. Binding of Rabenosyn-5 to empty GST beads was considered as 
background and therefore subtracted from each binding value before calculating 
percentage of binding. The Kd was calculated by fitting the obtained saturation 
binding curve data to a model with a non-linear regression method using the 
Graph Prism program lhttp://www.graphpad.coml
4.12 Expression and purification of recombinant proteins
4.12.1 Production of GST fusion proteins in bacteria
1-litre stationary cultures of bacterial cells BL21 strain of E. Coli (transformed
with the corresponding construct designed to express GST fusion proteins) were
diluted to 12 litres of LB medium in the presence of Ampicillin (100 pg/ml) and
grown at 37° C with shaking (200 rpm) until an OD of 0.6 at 600 nm. Induction of
GST-fusion protein expression was achieved by adding 0.1 mM isopropyl-^-D-
thiogalactopyranoside (IPTG) to the culture and incubating for 3 additional hours.
The cells were sedimented by centrifugation at 4000 rpm for 20 minutes in a
Sorvall HG4L rotor at 4° C and then resuspended in 200 ml of PBS, containing
200 jil proteases inhibitor mixtures (Sigma). Cells were broken by pressure using
a french press (SLM AMINCO) and the lysates were centrifuged at 10000 rpm for
194
20 minutes in a SS34 rotor at 4° C. The supernatant was incubated with 1 ml of 
packed glutathione agarose beads for 2 hours at 4° C with shaking. Beads were 
sedimented by centrifugation at 1000 rpm for 5 minutes on a table-top centrifuge 
at 4° C and washed 3 times with 10 beads volume ice-cold PBS. Bound proteins 
were eluted from the beads with 1 ml elution buffer (15 mM glutathione, 50 mM 
Tris-HCL pH 8 ).
4.12.2 Production of Histidine-tagged proteins in bacteria
E. coli strain BL21 (DE3) were transformed with plasmid pRSET A containing 
Rab-GDI cDNA cloned into the BamHI site. A preculture of 10 ml was grown 
from a single colony in Terrific broth (TB) containing 50pg/ml ampicillin at 37°C 
for 6  hr. The preculture was used to inoculate a 10-litres overnight culture in TB 
containing 50pg/ml ampicillin that was shaken vigorously at 37°C without 
induction by IPTG. The bacteria were harvested by centrifugation in a Sorvall 
centrifuge (Norwalk, CT) with GS-3 rotor at 5000 rpm for 10 min at 4°C, and the 
pellet (70 g bacteria/10 liter) was washed once with BPS (resuspended and 
pelletted again). After freezing (-80°C) and thawing of the pellet, bacteria were 
resuspended in 140 ml (2 vol of wet weight) of lysis buffer (50 mM Na2HP0 4 , pH 
8 .0/0.3 M NaCl/10 mM 2-mercaptoethanol) containing 1 mg/ml lysozyme, 0.1 
mM phenylmethylsulfonyl fluoride, and 5pg/ml Dnasel and were incubated for 30
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min on ice. Cells were sonicated (Sonifier B-12, Branson, Danburry, CT) on ice in 
10 15-sec intervals with cooling on ice for 1 min between each sonication and the 
lysate was centrifuged at 25,000 rpm for Ihr at 4°C in a Beckman (Palo Alto, CA) 
SW 27 rotor. The supernatant was incubated on a rotating wheel for 1 h at 4°C 
with 10 ml Ni^^-NTA-agarose (Qiagen, Chatsworth, CA) equilibrated in lysis 
buffer. The beads were spun down at 1000 g for 2 min and washed (resuspended 
and pelleted again) in batches 3 times with 40 ml lysis buffer, pH 8.0; 3 times with 
40 ml of lysis buffer, pH 6.0, containing 0.3% Triton X-100; and 2 times in 40 ml 
lysis buffer, pH 8.0. Beads were loaded onto a 10-ml Poly-Prep chromatography 
column (Bio-Rad, Richmond, CA), washed with 10 cold volumes lysis buffer, pH 
8.0, and eluted with 20 ml of 200 mM imidazole in lysis buffer. Fractions of 1.5 
ml were collected, and the purity and protein concentration were analysed by SDS 
-PAGE followed by Coomassie blue staining. Eractions containing His^-Rab-GDI 
(fractions 5-10) were pooled, dialysed overnight against 20 mM HEPES/KOH, pH 
7.2/10 mM 2- mercaptoethanol, and stored at -80°C.
4.12.3 Expression and purification of Rab4 and R a b ll using the Baculovirus 
expression System.
Hi-5 insect cells adapted to serum free medium were cultured in suspension 
and infected at a concentration of 0.5x10^ cells/ml with 6.0 ml of P3 amplified
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baculovirus containg Histidine-tagged Rab4 or R a b ll in 250 ml. Cells were 
cultured in 1.8 liter Fembach shaking flasks and incubated at 27°C, 60 rpm for 72 
hours. The cells were harvested by sedimenting at 1600 rpm, 15 min, at 4°C, and 
washed one time in IX PBS. For purification of prenylated Rab4 and R ab ll 
membrane fraction were prepared by resuspending the cell pellet in 8.0 ml Lysis 
buffer (containing 20 mM HEPES, pH 7.4, 50 mM KCl, 10 mM MgCl2 and 1 mM 
DTT). Cells were cracked in the cell cracker (EMBL) using a ball bearing size
8.004 and two 10 ml syringes by passing through the cracker about 10 times. 
Efficient breakage was checked under the microscope. Post-nuclear supernatant 
(PNS) was obtained by centrifugation of the homogenate at 1000 g for 5 minutes 
at 4 °C. PNS was then centrifuged at 160,000 g (Beckman SW40 rotor 30,000 
rpm) for 30 minutes at 4 °C. The pellet (membrane fraction) was then resuspended 
in 4 ml of ice cold buffer containing 0.6% CHAPS (Sigma), 20 mM HEPES, pH 
7.4, 50 mM KCl, 10 mM MgCl2 and 1 mM DTT, sonicated for 10 seconds on ice 
and incubated for 1 hour at 4 °C on a rotating wheel. The suspension was 
centrifuged at 160,000 g for 30 minutes at 4 °C, and the supernatant (4 ml) 
containing Histidine-tagged Rab4 or R ab ll was incubated on a rotating wheel for 
1 hour with 200 /il Ni-NTA-agarose beads and Histidine-tagged Rab4 or R ab ll 
purified according to manufacturer’s instructions (Qiagen, Chatsworth, CA).
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4.12.4 Purification of Rab4 and Rabll- RabGDI complex by Gel -filtration column 
chromatography.
In order to allow complex formation between Rab5 or Rabl 1 and RabGDI, 
1 nmole of prenylated and purified Rab4 or Rabl 1 was incubated with 1 nmole of 
purified RabGDI in 500 jil buffer containing 20 mM HEPES pH7.4, 100 mM K- 
acetate 2.5mM MgC12, 1 pM GDP, and 0.005% Triton-xlOO. The samples were 
incubated for 10 minutes at 30 °C and then loaded onto a Superose 12 HR 10/30 
gel-filtration column (Pharmacia, NJ). Fractions of 0.4 pi were collected and 30 
ml aliquots analysed by SDS-PAGE and Coomassie blue staining.
4.12.5 Expression of Rabenosyn-5/hvps45 ExpresSf+ using the baculovirus 
expression system
Expression of the recombinant protein in insect cells was achieved with the 
use of baculovirus expression system (Life Technologies). The recombinant 
plasmid pfastBac-Dual-Rabenosyn-5/hvps45 was transformed into DHlOBac 
competent cells, which contain the bacmid with a mini-attTn7 target site and the 
helper plasmid. Colonies containing recombinant bacmids were identified by 
disruption of the lacZa gene. High molecular mini-prep DNA was prepared from 
selected E. coli clones containing the recombinant bacmid. This DNA was then 
transfected in Sf-9 insect cells After 3 rounds of virus amplification the protein
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was expressed by infection with the Rabenosyn-5/hvps45 baculovirus in 
ExprèsSf+ (Protein Science) insect cells according to the manufacturer’s 
instructions.
4.13 Rabenosyn-5/hvps45 ExpresSf+ Cytosol Preparation.
ExpresSf+ serum free insect cells were cultured in suspension and infected at a 
concentration of 1.0x10^ cells/ml with 3.6ml of P3 amplified baculovirus 
containing Rabenosyn-5 and hvps45 at a MOI of 4 in 500 ml. Cells were cultured 
in 1.8 liter Fernbach shaking flasks and incubated at 27°C, 60 rpm for 64 hours. 
Cells were harvested and sedimented at 1600 rpm, 15 min, at 4°C and the pellet 
was washed one time in IX  PBS. The obtained pellet of about 8.0 ml was 
resuspended in 8.0 ml Lysis buffer (containing 50 mM HEPES, pH 7.4, 50 mM 
KCl, 5 mM MgCl2 and 1 mM DTT). Cells were cracked in the cell cracker 
(EMBL) using ball bearing size 8.004 and two 10 ml syringes by passing through 
the cracker about 20 times. Efficient breakage was checked under the microscope. 
Homogenate was spun in a S100-AT6 Sorvall, at 100 K rpm for 30 min, at 4°C 
resulting in about 8  ml supernatant (cytosol).
4.14 Western Blot analysis
Immunoblot was carried out at room temperature on a rocking platform.
Unspecific binding sites were blocked by incubating the membrane with blocking
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solution (PBS containing 0.1% Tween- 20; 5% non-fat milk powder) for 30 
minutes. Subsequently, the membrane was incubated with the primary antibody 
diluted 1: 1,000 in blocking solution for 1 h. The membrane was washed 3 times 
before incubation for 1 h with the second antibody goat anti-rabbit IgG coupled to 
peroxidase (Dianova) diluted 1: 5,000 in blocking solution. The membrane was 
developed with the ECL system (Amersham) following the instructions of the 
manufacturer.
4.15 Silver staining of protein
The SDS-PAGE gel was fixed with Fixer buffer 2X times for 15-20 
minutes. Reducer buffer was added and incubated for 30 minutes. The gel was 
washed 3X times for 10 minutes with distilled water and incubated for 30 minutes 
in the silver nitrate buffer. The gel was then rinsed briefly with H2O, and with a 
small amount of Developer buffer. Developer buffer was added in excess and the 
developing reaction was stopped by addition of Quenching buffer.
4.16 Protein sequencing
Protein sequence information was obtained by nano-electrospray mass 
spectrometry (Wilm et al., 1996) in collaboration with the M. Wilm group at 
EMBL
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4.17 Antibodies and Plasmids
Polyclonal rabbit antibodies against Rabenosyn-5 and hVPS45 were available in 
the laboratory and have been described (Nielsen, E. et al. (2000)). Antibodies 
were affinity-purified as described below and used at (1:1000). Polyclonal rabbit 
antibodies against Rabaptin-5, Rabaptin-5p, p l lOP,  and Rabex-5 were used as 
crude serum at 1:1000 (Western blotting) or 1:200 (immunofluorescence). Human 
anti-EEAl serum (1:1000) was a gift from Ban Hok Toh (Monash Medical 
School, Adelaide, Australia). Monoclonal mouse anti-transferrin receptor 
antibodies (B3/25) were purchased from Roche (Mannheim). Secondary 
antibodies conjugates (HRP and fluorescently labelled) were purchased from 
Dianova.
Plasmids
Cloning was performed according to standard procedures (Sambrook et al. 1989). 
PCR amplified sequences were checked by sequencing. 
pEGFP-Rab4 and pEYFP-Rab4 construct
Human Rab4 cDNA was amplified by PCR from pGEM-Rab4 vector available in 
the laboratory with the insertion of (5%) Xhol and (3,) Hind III; using the 
following primers: forward 5’ AAAACTCGAG ATG TCC 
GAAACCTACGATTT; reverse 5’ AAAAAAGCTT
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CT A AC A ACC AC ACTCCTGA and cloned in frame into the pEGFP-C3 vector 
(Clontech) cut Xhol and (3,) Hind III. For cloning into the pEYFP vector, human 
Rab4 cDNA was amplified with the insertion of (5’,) Kpnl and (3,) BamHI. 
pFastBac Hta-Rab4 construct
To express Rab4 using the baculovirus expression the Rab4 cDNA was amplified 
by PCR from pGEM-Rab4 with the insertion of (5,) Xho I  and (3,) Hind III and 
cloned in frame into the Histidine-tagged vector pFastBacHta (Gibco) cut Xho I  
and (3,) FTmJ III.
Rabenosyn-5; Rabaptin-5; E E A l and hVPS45 constructs
Rabenosyn-5 was amplified by PCR from pGEM-myc-Rabenosyn-5 with the 
insertion of (5’) Hind III and (3’) EcoRI and cloned into pDNA3 cut Hindlll and 
EcoRI. To generate Rabenosyn-5 truncation mutant constructs (amino acid) 1- 
263; 264-784; 501-784; 264-500; 501-626; 627-784; the Rabenosyn-5 cDNA 
was amplified by PCR from pGEM-Rabenosyn-5 with the appropriate primers 
with the insertion of (5’) Hind III and (3’) EcoRI and cloned into pGEM-Myc4 
cut with EcoRI, Hindlll or into pCDNA3.1 Myc (frame3) vector cut EcoRI/ 
EcorV, (in this last case the Hindlll site was filled in). To generate recombinant 
Rabenosyn-5 / hvps45 complex baculovirus, Rabenosyn-5 was amplified by PCR 
from pGEM-myc-Rabenosyn-5 with the insertion of (5’) EcoR I  and (3’) Hind III; 
hvps45 was amplified from pGEX-hvps45 with insertion of (5’) Sma I  and (3’)
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Kpn I. These PCR products were then digested with EcoR I  and Hind HI 
(Rabenosyn-5), Sma I  and Kpn I  (hvps45) into pFastBac-Dual expression vector 
(Life Technologies) to yield in the untagged pFastBac-Dual-110Fyve-hvps45 
construct. The construct was confirmed by sequencing to avoid PCR-induced 
mutations. Rabaptin-5, E EA l, hVPS45 were subcloned into the mammalian 
expression vector pcDNAS (Clontech).
4.18 Preparation of competent E. coli for electroporation.
A single colony of a strain of E. coli XL 1 Blue, SURE was used to 
inoculate 10 ml of LB medium which was grown overnight at 37°C with shaking. 
2 ml of saturated culture were then transferred to 1000 ml of the same medium 
and the culture was grown until it reached an OD of 0.6 at 600 nm. Cells were 
then collected by centrifugation at 4000 rpm for 20 min at 4°C in 1 liter bottles 
using a Sorvall HG4L rotor. The resulting pellet was gently resuspended in 500 ml 
ice-cold water. Cells were then sedimented again by centrifugation and 
resuspended in 300 ml cold water. Cells were centrifuged at 4000 rpm for 10 
minutes at 4°C in a GSA rotor and pellets were then resuspended in 100 ml 10% 
glycerol. The pellets were sedimented again under the same conditions and 
resuspended in 20 ml of 10% glycerol. 100-pl aliquots were rapidly frozen in 
liquid N2 and stored at -80°C.
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4.19 Plasmid preparation in large scale (Maxi-prep) and small scale Mini- 
prep
Plasmid M axi-preps were done according to QIAGEN plasmid® 
purification protocols. The DNA concentration was estimated by comparison to 
serial dilutions of a DNA standard separated by electrophoresis on an agarose gel 
stained with ethidium bromide. The stained gel was photographed with 
HEROLAB UVT-20 M/W Gel Documentation System. Plasmid Mini-preps were 
done according to QIAGEN plasmid® purification protocols
4.20 Electroporation of E. coli
Electroporation of DNA into E. coli cells was performed with a BioRad 
Gene puiser with a pulse controller. 40 p i of a suspension of bacterial 
electrocompetent cells was mixed on ice with 5 pi of DNA dissolved in H2O and 
placed into the bottom of an ice cold electroporation cuvette (BioRad 0.2cm 
separation). The cuvette was then placed into a holder of the electroporator and 
the cells were subjected to an electric pulse of 2.5 kV (capacitance setting 25 pF 
and resistance setting 200 Ê2). 1 ml of LB medium was then added immediately to 
the cell suspension, which was incubated at 37°C for 60 min. Cells were then 
sedimented at 6000 rpm for 3 min in a bench top microcentrifuge and resuspended
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in 100 pi LB medium. Cells were plated on LB plates (containing lOOpg/ml 
ampicillin if selection was required) and incubated overnight at 37°C.
4.21 Restriction enzyme digestion of DNA
Restriction enzyme digestions of DNA were performed by incubation of 
DNA with 5 units of enzyme per pg of DNA for a minimum of 2 hr at 37°C, under 
the conditions recommended by the manufacturer’s (Roche). The digested DNA 
sample was then extracted with phenol/chloroform and chloroform, and 
precipitated with 100% ethanol. The pellet was washed with 80% ethanol and 
resuspended in 1 p i of H2O per pg of DNA. Cleavage was monitored by 
electrophoresis in an agarose gel stained with ethidium bromide.
4.22 Ligation of DNA
Standard ligation reactions were done in lOpl final volume (with 3:1 
insert:vector ratio) in the presence of Ip l of lOX Ligase buffer and 10 units of 
Ligase (NEB). The reactions were incubated from 4 to 12 h at 16°C.
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